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ABSTRACT 
 
The selective formation of new carbon-carbon bonds is a central challenge for organic 
synthesis; organic molecules are based on carbon scaffolds which must be assembled from 
simple building blocks.  Since Kolbe performed the first organic C-C bond forming reaction in 
his synthesis of acetic acid in 1845, the growth of organic synthesis has witnessed the 
proliferation of methods to forge C-C bonds.  A recurring theme among these methods is the use 
of pre-installed, oxidized “functional groups” to enable and control the bond forming reaction.  
For the past 50 years, however, C-H activation has beckoned to chemists as the synthetic “way of 
the future.”  Rather than relying upon a functional group, C-H activation promises the direct 
conversion of the inert, ubiquitous C-H bond to the desired C-C bond.  This strategy has inspired 
tremendous excitement and speculation, but only recently has it begun to be reduced to practice 
in synthetically useful reactions. 
This work describes the discovery of the first palladium(II)-catalyzed allylic C-H 
alkylation reaction.  Allylic alkylation has long been performed by palladium(0) catalysis with 
allylic oxygenate starting materials.  In contrast, this method proceeds directly from the readily 
accessible, chemically robust -olefin moiety.  The development of such a reaction was impeded 
by the inherent incompatibility of the various steps of the putative catalytic cycle.  In order to 
achieve catalytic turnover, an electrophilic C-H cleavage, a nucleophilic functionalization, and 
an oxidative Pd(II) regeneration step would all have to operate simultaneously.  This series of 
interlocking compatibility challenges was unraveled with the aid of stoichiometric model studies 
and mechanistic insights gleaned from previous allylic C-H functionalization reactions.  
Ultimately, a catalytic allylic C-H alkylation reaction was discovered.   
The original allylic C-H alkylation reaction had an olefin scope limited to allylarene 
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substrates.  These substrates could be described as “doubly activated” because the C-H bonds to 
be cleaved were both allylic and benzylic.  Less reactive allylic C-H bonds displayed only very 
low reactivity under the reported conditions.  This substrate limitation was investigated, and it 
was discovered that the catalytic cycle was inhibited by a necessary cosolvent, 
dimethylsulfoxide.  This solvent was speculated to act as a ligand for palladium, competitively 
binding to the metal and displacing the ligand required for C-H cleavage.  By identifying a more 
electron-rich C-H cleavage ligand which presumably could better compete with 
dimethylsulfoxide for binding to palladium, it was possible to overcome the inhibition and 
restore reactivity to the catalytic system.  This allowed the development of an allylic C-H 
alkylation with a general substrate scope. 
The nucleophile scope of the allylic C-H alkylation was explored with the goal of 
expanding the diversity and complexity of both coupling partners.  It was discovered that tertiary 
carbon nucleophiles, bearing two electron-withdrawing groups to stabilize a carbanion and one 
aliphatic side chain, could participate in the reaction.  The addition of the aliphatic side chain 
allowed for additional functional groups or rings to be incorporated into the nucleophile, thereby 
enabling the coupling of two relatively valuable components.  This work opened the door to 
future development of macrocyclization reactions and enantioselective alkylations. 
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CHAPTER 1 
CATALYTIC INTERMOLECULAR ALLYLIC C-H ALKYLATION 
1.1 INTRODUCTION 
The construction of new carbon-carbon bonds is a central challenge for organic synthesis.  
Organic molecules are based upon carbon frameworks, and the assembly of these frameworks 
from simpler starting materials has inspired the development of a vast library of C-C bond 
forming reactions.  A recurring theme throughout this literature can be described as a “functional 
group approach,” whereas a more recent movement in the scientific community has championed 
a “C-H activation approach” (Figure 1).1,2,3  These two strategies provide distinct and frequently 
complementary approaches to C-C bond formation, and the development of C-H activation into a 
more versatile approach with broad scope and reliable results is a frontier challenge for chemical 
methodology in the 21
st
 century.  The emergence of C-H activation as a competitor on equal 
footing with traditional methodology has the potential to transform the practice of organic 
synthesis in coming years, the repercussions of which would be felt in all of the fields of 
scientific research that rely upon small molecules.
4
  
Figure 1: Different approaches to C-C bond formation 
 
In the functional group approach, two fragments, each bearing a reactive chemical moiety 
or “functional group” are united to forge a new C-C bond.  The functional groups serve as 
synthetic handles, enabling the bond forming reaction and controlling the site at which the new 
bond is formed.  Some prominent categories of reactions that exemplify the functional group 
approach include cross-coupling,
5
 aldol
6
 and olefination
7
 reactions (Figure 2).  Even biosynthesis 
typically relies upon functional groups to generate new C-C bonds; for example, polyketides are 
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assembled from -keto acid building blocks and terpenes utilize pyrophosphate functional 
groups.
8
  The use of functional groups allows an unprecedented degree of control of chemo-, 
regio- and stereoselectivity in C-C bond forming reactions.  The introduction of new functional 
groups, for example potassium trifluoroborates for cross-coupling, can result in new or 
orthogonal reactivity relative to existing methods. 
Figure 2: Common C-C bond forming reactions from pre-oxidized starting materials. 
 
In the C-H activation approach, a new C-C bond is formed directly from the cleavage of a 
relatively strong, inert C-H bond.  Although there is no universally accepted set of criteria for 
what constitutes “activation” of a C-H bond versus routine deprotonation, this description is 
typically applied to C-H bonds which will not react with traditional strong bases such as 
alkoxides and amides.  The C-H cleavage step may occur by several mechanisms, including a 
radical homolytic cleavage and rebound, a concerted insertion mechanism, or a deprotonation 
type event.  The bond forming event follows directly, thus the process is described as the direct 
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conversion from C-H to C-C.  By definition, this process involves the oxidation of the substrate 
and therefore an oxidant is required, either in the form of the coupling partner of the reaction or 
as an external, terminal oxidant. 
Comparison of these two approaches reveals several fundamental differences.  If, at least 
in theory, any C-H bond may be considered a potential site of functionalization, the synthetic 
chemist has a tremendously expanded menu of options.  A functional group may install a specific 
bond at a specific location, but C-H bonds are ubiquitous in organic molecules.  However, this 
ubiquity also leads to the central challenge of C-H activation, the question of how to identify one 
C-H bond from among many in order to achieve selectivity in the reaction.  In addition, C-H 
activation by definition utilizes a synthetic handle, the C-H bond, which is inert to most 
traditional chemical reagents.  This may greatly simplify synthetic planning because it eliminates 
the need for protections and deprotections, and functional group manipulations such as oxidation 
and reduction, associated with the functional group approach to bond formation.  However, the 
inert character of these C-H bonds makes it challenging to develop a reaction which may achieve 
the desired C-H activation without resorting to conditions that are so harsh as to render the 
reaction intolerant of other functionality and thus useless in the context of complex molecule 
synthesis.  Finally, C-H activation may provide a significant synthetic advantage by eliminating 
the need to pre-install a functional group, potentially eliminating multiple steps from a synthetic 
sequence.   
A central challenge for C-H activation is the selection of one C-H bond from among 
many on any given substrate.  Numerous strategies have been developed to control which C-H 
bond of a substrate molecule is activated, and the strategies for C-H alkylation may generally be 
divided into three categories (Figure 3).  First, the use of a directing group, such as a pyridyl or 
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carbonyl, may be used to coordinate the transition metal catalyst and approximate it to the bond 
which will be activated.
9
  Alternatively, C-H activation may be performed on heteroaromatic 
substrates, which have electronic biases that make some C-H bonds more reactive than others 
and therefore more susceptible to activation.
10
  Finally, an activating group such as an olefin, -
heteroatom or an aromatic ring may be used to weaken a specific C-H bond and impart 
selectivity in the C-H activation step.
11
   
Figure 3: Common strategies for selectivity in C-H alkylation 
 
We targeted the development of an allylic C-H alkylation reaction, an exemplar of the 
activating group category of C-H activation.  This transformation had been known in the 
literature for more than forty years; it was initially reported as a two step process, stoichiometric 
in palladium, by Tsuji and Trost in the 1960s (Figure 4).  An initial C-H cleavage step, effected 
by an electrophilic palladium(II) salt, generated a -allyl intermediate which could be trapped 
and isolated.
12
  The -allyl was subsequently exposed to attack by a nucleophile, forging the 
desired allylic C-C bond.
13
  Despite this strong stoichiometric precedent, and despite the early 
enthusiasm for developing the reactivity into a catalytic cycle, no palladium(II) catalyzed allylic 
C-H alkylation was ever reported.
14
  We attribute this gap in the literature to the fundamental 
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challenge of combining these dissimilar steps—electrophilic C-H cleavage, nucleophilic 
functionalization, and oxidative regeneration of Pd(II)—in one reaction vessel, and identifying 
conditions and reagents where each step would not interfere with the others.   
Figure 4: Stoichiometric allylic C-H alkylation 
 
We believed that previous efforts in our lab in the discovery of allylic C-H 
esterification
15,16
 and amination reactions
17,18
 had laid a solid groundwork for the development of 
an allylic C-H alkylation reaction (Figure 5).  We had discovered palladium(II)/bis-sulfoxide 
catalyst 1, capable of performing allylic C-H activation under relatively mild conditions and with 
superb functional group tolerance.  We had studied the mechanism of the reaction and identified 
the roles of each of the reaction components.  And finally, we had previously attempted to 
develop an alkylation procedure and encountered some of the challenges we would need to  
Figure 5: Allylic C-H functionalization reactions 
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overcome in order to achieve a catalytic system. 
1.2 RESULTS AND DISCUSSION 
The first challenge that we faced was the identification of a nucleophile that would be 
suitable for allylic alkylation.  In order to effect C-H cleavage, a highly electrophilic 
palladium(II) species must coordinate to the olefin substrate, acidifying the adjacent allylic 
protons for a soft deprotonation event.  Many common nucleophiles would be expected to 
coordinate to the palladium, thereby attenuating its electrophilicity and inhibiting C-H cleavage.  
We thus recognized the importance of discovering conditions under which these two species 
could coexist without detrimental interactions. 
We initially explored organometallic reagents, such as vinyl and aryl stannanes, 
boronates and zincs.  These nucleophiles have broad and well-precedented functional group 
tolerance.  Furthermore, they do not behave like traditional nucleophiles—their reactivity can be 
largely limited to transmetallation with the transition metal catalyst.  Allylic alkylation might 
therefore be achieved through a sequence of C-H cleavage followed by transmetallation and 
reductive elimination.  The use of these organometallic nucleophiles to functionalize -allyl 
intermediates generated either stoichiometrically or catalytically through displacement of allylic 
functional groups provided good precedent for their reactivity.
19
 
In stoichiometric model studies, we investigated transmetallation and reductive 
elimination under our desired reaction conditions.  Beginning from pre-formed -allyl 
intermediates, we found that vinyl boronic acids and esters were most effective for the desired 
functionalization reaction (Figure 6).  We isolated the 1,4-diene product 4 arising from 
functionalization at the least hindered terminus of the -allyl as the major product.  Although we 
were able to detect some trace product formation using aryl nucleophiles or other metals such as 
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tin and zinc, vinyl boronates such as 3 and 5 were clearly the most effective nucleophiles.  We 
limited our studies to conditions we knew to be suitable for C-H cleavage, specifically, slightly 
elevated temperatures (typically 45C) and ethereal or chlorinated solvents.  We also did not 
investigate activators such as fluoride or hydroxide which we expected would inhibit C-H 
cleavage. 
Figure 6: Stoichiometric functionalization with vinyl boronates 
 
Although we had demonstrated that vinylboronic acids and esters could functionalize a -
allyl, our efforts to develop a catalytic reaction using these nucleophiles were unsuccessful.  We 
found that under catalytic conditions the reaction consistently generated homocoupled 
nucleophile and a range of constitutional isomers of the product (Figure 7).  These isomers were 
most likely the result of an unselective oxidative Heck reaction.  This reactivity had been 
previously documented for -olefin substrates with allylic substitution, where C-H cleavage is 
not feasible.
20
  Our results indicated that this competing pathway was simply too fast even for 
substrates that could undergo C-H cleavage.  Transmetallation of the nucleophile with palladium 
was substantially faster than C-H activation, and the resulting organopalladium species would 
divert reactivity down the undesired homocoupling and Heck pathways.  Consequently, we 
determined that organometallic nucleophiles were not suitable reagents for our desired allylic C-
H alkylation reaction. 
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Figure 7: Attempted catalytic allylic alkylation with vinyl boronic acid 
 
We subsequently turned our attention to a series of stabilized soft carbanion nucleophiles.  
We suspected in particular that the most acidic nucleophiles could be suitable for the proposed 
alkylation reaction.  During previous experimentation in the course of developing allylic C-H 
esterification and amination reactions, we had observed that highly acidic, weak nucleophiles 
were most reactive.  This seemingly counterintuitive result may be rationalized by 
acknowledging that the nucleophile is activated in situ via an equilibrium deprotonation process.  
Therefore, nucleophiles with the lowest pKa have the highest equilibrium population of 
deprotonated anion under the reaction conditions, which is presumably the species responsible 
for functionalization.  In practice we found that nucleophiles with pKa similar to acetic acid, in 
the range of 3-6, were most effective.  Additionally, we hypothesized that the use of weak 
nucleophiles served to circumvent the challenge of a nucleophile coordinating to the palladium 
catalyst and attenuating its electrophilicity; a very weak nucleophile would be expected to have 
only a weak and transient interaction with the electrophilic metal and therefore a negligible effect 
on its electronics.   
We therefore synthesized a series of soft carbanion nucleophiles bearing a variety of 
electron withdrawing stabilizing groups (Figure 8).  The pKa of the acidic C-H bonds in these 
molecules ranged from as high as 13 to as low as 5.  In order to render the reaction 
intramolecular and improve the reactivity of the system, we tethered the nucleophiles to the 
substrate via a homoallylic ester linkage, which would provide -lactones as the desired product.  
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However, extensive experimentation utilizing these substrates failed to furnish even trace 
quantities of the desired alkylated products.  Reactions typically resulted in low conversions; 
only small amounts of diene product were observed which were derived from elimination of the 
homoallylic ester.   
Figure 8: Intramolecular stabilized carbanion substrates 
 
In an effort to discern the reasons for the failure of the alkylation reaction, we performed 
an experiment that provided a valuable insight (Figure 9).  The experiment was designed to allow 
observation of the functionalization of the -allyl intermediate in a stoichiometric model system.  
We generated the -allyl in situ by exposing the substrate to one equivalent of palladium(II) 
trifluoroacetate/bis(phenylsulfinyl)ethane complex.  The trifluoroacetate counterions were used 
in this case in order to stop the reaction at the -allyl intermediate and avoid functionalization; 
the reduced pKa of trifluoroacetate relative to acetate means that it is not able to deprotonate the 
nucleophile to initiate its attack on the electrophile.  The -allyl was observed in situ by 1H NMR 
spectroscopy.  Tetrabutylammonium acetate was subsequently added to the reaction mixture in 
order to deprotonate the nucleophile and effect functionalization.  However, analysis of the crude 
reaction mixture revealed that even from a stoichiometrically formed -allyl intermediate, no 
alkylated product was generated.   
This result was particularly notable because an analogous protocol for intramolecular 
allylic amination resulted in smooth functionalization of the -allyl (Figure 9).17  Because the 
nitrogen and carbon nucleophiles of these related substrates had similar pKa and should both be 
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readily deprotonated by acetate base, we reasoned that allylic alkylation was encountering a 
unique, previously unidentified obstacle.  We speculated that perhaps the attack of the carbanion 
nucleophile on the -allyl was inhibited by stereoelectronic constraints.  Specifically, the 
deprotonated nitrogen nucleophile attacks with electrons in a sp
2
 hybridized orbital perpendicular 
to the conjugated  orbital system of the carbamate and sulfonyl groups.  However, the 
deprotonated carbon nucleophile would have to attack with electrons that are part of the  system 
with the nitro and ester groups.  Both the -allyl and the deprotonated nucleophile are locked in a 
planar conformation by orbital overlap, leaving only two bonds with free rotation.  We wondered 
if the substrate was too constrained in its geometry to reach a conformation where orbital overlap 
would allow allylic alkylation to occur.   
Figure 9: Stoichiometric comparison of alkylation vs. amination 
 
Inspired by this theory, we advanced a counterintuitive solution: in order to improve 
reactivity, the tether between the nucleophile and substrate should be cleaved and the reaction 
should be rendered intermolecular.  The functionalization of a pre-formed -allyl with methyl 
nitroacetate was thus found to proceed smoothly with the addition of acetate base to activate the 
nucleophile (Figure 10).   
The success of methyl nitroacetate as a nucleophile, however, engendered another 
problem in the development of a catalytic alkylation reaction.  The product forming steps reduce  
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Figure 10: Stoichiometric allylic alkylation 
 
palladium(II) to palladium(0), and in order to close the catalytic cycle the metal must be 
reoxidized.  This step was accomplished using 1,4-benzoquinone in our previous allylic C-H 
esterification and amination reactions.  However, benzoquinone is incompatible with soft 
carbanion nucleophiles, oxidizing them directly in a Michael reaction.
21
  This incompatibility 
was manifested in our initial efforts to develop a catalytic reaction—only low yields of the 
desired alkylated product were formed, and conversion of the nucleophile and oxidant was 
observed.   
We concluded that benzoquinone would have to be eliminated from the reaction 
conditions in order to develop a catalytic reaction.  This was a challenging endeavor, however, 
because benzoquinone has been shown to play several important roles in the allylic C-H 
functionalization catalytic cycle (Figure 11).
16
  In mechanistic experiments to probe the allylic 
esterification reaction, it was found that benzoquinone promoted the functionalization of the -
allyl intermediate.  It coordinated the -allyl and, acting as a -acidic ligand, activated the 
intermediate to attack by the weakly nucleophilic carboxylate.  Additionally, benzoquinone 
served as the terminal oxidant for the reaction, regenerating palladium(II).  In the course of 
reoxidation it generated two equivalents of acetate which acted as a catalytic source of 
endogenous base.  We realized that these roles were critical to the catalytic cycle and that 
surrogates would have to be identified if benzoquinone were removed from the reaction. 
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Figure 11: Catalytic cycle for allylic C-H functionalization catalyzed by 1 
 
In search of a suitable surrogate to promote functionalization of the -allyl, we surveyed 
a variety of known -acceptor ligands.22  Stoichiometric model studies showed that maleic 
anhydride, dimethyl maleate, dimethyl fumarate, and electron deficient styrene derivatives were 
all unable to promote functionalization of the -allyl.  Alkylated product was obtained in the 
presence of phosphine ligands, however, these ligands were unstable to the oxidative reaction 
conditions.  Our studies eventually identified dimethylsulfoxide (DMSO) as an oxidatively stable 
ligand which could mediate alkylation of a pre-formed -allyl (Table 1).  The use of solvent 
quantities of DMSO to promote nucleophile addition to a -allyl was well precedented from  
Table 1: Stoichiometric allylic alkylation 
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early studies in organopalladium chemistry.
23
 
A number of previously reported systems for the reoxidation of palladium catalysts were 
examined to find a successor to benzoquinone in the role of terminal oxidant (Table 2).  We 
found common oxidants such as hypervalent iodine
24
 and copper salts
25
 to be ineffective under 
our conditions (entries 1, 2).  As our use of DMSO as a cosolvent was reminiscent of Larock’s 
early reports of palladium oxidations involving direct reoxidation with oxygen, we also 
investigated reactions under oxygen atmosphere.
26
  We found that modest catalyst turnover could 
be achieved with atmospheric oxygen pressure, and pressurized oxygen reaction conditions 
performed somewhat better (entries 3, 4).  However, we were unable to further optimize these 
conditions and higher oxygen pressures did not improve turnover.  Similarly, catalysts which 
facilitate the reoxidation of palladium by molecular oxygen were not successful (entries 5, 6).  
Instead, we returned to quinone oxidants and selected 2,6-dimethylbenzoquinone.  This quinone 
is more sterically hindered than the parent benzoquinone, which we hoped would impair the 
Michael reaction, but its oxidation potential remains similar.
27
  To our delight, we found that the 
addition of 2,6-dimethylbenzoquinone did result in efficient reoxidation, providing conditions for  
Table 2: Catalytic allylic C-H alkylation 
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the first palladium(II) catalyzed allylic C-H alkylation reaction (entries 7, 11).
14a  Notably, 
reactivity was significantly diminished when either adding stoichiometric Bu4NOAc or omitting 
all sources of catalytic acetate (entries 8, 9). These results underscore the importance of 
quinone/AcOH as a source of catalytic acetate base. 
The discovery of optimized catalytic conditions allowed us to explore the substrate scope 
of the reaction (Table 3).  Consistent with our observations in the development of allylic 
esterification and amination reactions, this reaction demonstrated excellent functional group 
tolerance.  A wide variety of both electron-donating (entries 1-3) and electron-withdrawing 
(entries 5-11) substituents were tolerated on the aryl moiety. Alkylated products were generated 
in high yields with good regioselectivities and excellent E/Z selectivities (>20:1). Significantly, 
pure linear compound was readily obtained for all substrates in good yields (50-70%) using 
standard column chromatography.  Functionalities that are unstable to traditional palladium(0)-
catalyzed allylic alkylations, such as aryl halides and triflates, were inert to these oxidative 
conditions (entries 5, 17, 22-23). A variety of pharmacophoric functionalities such as catechol, 
indanone, phthalide, and salicylate were also well-tolerated (entries 19-23). Notably, 
heteroaromatic rings including benzotriazole and unprotected indole could be subjected to the 
reaction conditions (entries 24-25).  This functional group tolerance was unexpected given that 
heteroaromatics are often reactive with and/or attenuate the electrophilicity of palladium(II) 
catalysts.  The reaction was not suitable for substrates containing strongly coordinating 
functional groups.  Basic nitrogen moieties, such as pyridine and unprotected alkyl amines, were 
not tolerated; no desired product was formed.  Similarly, unprotected phenols resulted in 
somewhat reduced yields of alkylated products.  In addition, the reaction conditions were 
unsuitable for unactivated substrates (see Chapter 2).   
15 
 
Table 3: Scope of the allylic C-H alkylation reaction 
 
We noted a strong correlation between the electronic properties of the aryl ring and the 
regioselectivity of the allylic alkylation reaction. Electron-withdrawing moieties significantly 
16 
 
increased linear isomer ratios (entries 8-11, 20-21), whereas electron-donating moieties eroded 
linear selectivity (e.g., entries 1-2). In the case of extremely electron-rich 3-allylindole, a 
complete reversal of selectivity was observed furnishing the branched isomer as the major 
product (entry 25). A steric influence on regioselectivity was also observed with ortho 
substitution leading to significant increases in the linear to branched product ratio (entries 14, 15 
vs 2, 10). The electronic and steric influences upon selectivity may both derive from modulation 
of the stability of a high energy palladium -benzyl intermediate, which would exist in 
equilibrium with the palladium -allyl and which might favor alkylation at the internal, branched 
position (Figure 12).
28
  Features of the substrate that stabilize this intermediate, such as donating 
groups that increase the electron density of the aromatic ring or para substitution that offers no 
steric interference, would be expected to increase the proportion of branched isomer produced.  
These observations coincided with previously reported regioselectivities for functionalization of 
electronically biased -allyl intermediates.29 
Figure 12: Mechanistic rationale for regioselectivity 
 
The scope of nucleophiles that could participate in this alkylation reaction was also 
briefly surveyed (Table 4).  Consistent with the hypothesis that the nucleophile must be activated 
in situ by an equilibrium deprotonation process, the most acidic nucleophiles tested proved to be 
the most effective coupling partners.  Nucleophiles with a higher pKa value such as 1,3-diketones 
and methyl (phenylsulfonyl)acetate were simply too sluggish to be useful in the alkylation 
reaction (entries 1, 2), though slow functionalization could be observed in stoichiometric 
reactions from the pre-formed -allyl (see Table 1).  More acidic carbon nucleophiles were more 
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effective coupling partners (entries 3-6).  Except in special cases such as Meldrum’s acid, the use 
of a nitro group was generally necessary—no special interactions were ascribed to this moiety, it 
was simply used to sufficiently acidify the adjacent methylene.  Notably, the 
(phenylsulfonyl)nitromethane nucleophile 17, despite having a very low pKa, was very slow to 
functionalize under standard reaction conditions, perhaps as a consequence of its steric bulk.  By 
switching the catalyst ligand to 1,2-bis(benzylsulfinyl)ethane, complex 49, we were able to 
restore reactivity, an observation that would prove important in later work.  We speculate that 
further optimization could incrementally expand the nucleophile scope of this methodology.  The 
theoretical upper limit for nucleophile pKa is likely close to 10, the pKa of dihydroquinone, 
which acts as the terminal proton acceptor in the reaction.   
Table 4: Nucleophile scope of the allylic C-H alkylation reaction 
 
Having established the optimized reaction conditions and explored the scope of the 
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alkylation reaction, we sought to demonstrate the utility of the products as synthetic 
intermediates by developing strategies for their further elaboration (Figure 13).  We found that 
the action of zinc dust in acidic media would selectively reduce the nitro group in the presence of 
the olefin and ester, furnishing the -amino ester 50 in quantitative yield.30  This reduction opens 
a ready route to unnatural amino acids and amino alcohols.  Alternatively, we sought to exploit 
the latent nucleophilicity of the product by performing a second alkylation.  Using the modified 
cinchona alkaloid catalyst 51, we effected a conjugate addition into -nitrostyrene.31  The 
product of this reaction is a precursor to ,-disubstituted amino acids, which have been shown 
to introduce conformational bias in peptide chains
32
 and to resist the activity of protease 
enzymes.
33
  The reaction proceeded in high yield and with excellent diastereoselectivity and 
enantioselectivity.  The conjugate addition was also performed using a para-bromo substituted 
aromatic substrate, which allowed for the unambiguous assignment of both relative and absolute 
stereochemistry by X-ray crystallography.  
Figure 13: Synthetic elaboration of the allylic alkylation products 
 
1.3 CONCLUSIONS 
This work resulted in the discovery of the first palladium(II) catalyzed allylic C-H 
alkylation reaction.  The development of such a reaction had first been proposed in the literature 
nearly four decades prior to our work based on strong stoichiometric precedent, yet no catalytic 
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system had been reported.  Our studies indicated that the major challenge in developing this 
methodology would be identifying conditions which could simultaneously satisfy the dissimilar 
requirements of each individual step of the proposed catalytic cycle.  We had to address two 
principal problems: the compatibility of the electrophilic palladium(II) catalyst with the carbon 
nucleophile, and the compatibility of the nucleophile with the oxidant.   
We were able to apply our understanding of the catalytic cycle of allylic C-H 
functionalization, established in the course of the development of the branched allylic 
esterification reaction, to guide our experimentation.  When a component of the reaction mixture 
was changed, we used this mechanistic construct to better understand how other parts of the 
reaction were affected, and to suggest stoichiometric model studies to probe certain steps of the 
reaction.  This approach was important to reduce the complexity of a reaction with many 
subtleties and many finely balanced equilibria.  Consequently, we were able to identify a series 
of acidic carbon nucleophiles which were compatible with the palladium catalyst, and we 
replaced benzoquinone with DMSO and 2,6-dimethylbenzoquinone as -acceptor and oxidant, 
respectively, to achieve compatibility of nucleophile and oxidant.  These insights provided for 
catalytic conditions for the desired allylic C-H alkylation.  The method demonstrated excellent 
functional group compatibility and good reactivity.  It also served as a launching pad for 
development of more general and more synthetically useful allylic alkylation reactions. 
1.4 EXPERIMENTAL SECTION 
General Information: All commercially obtained reagents for the allylic alkylation reaction 
were used as received: 2,6-dimethylbenzoquinone, methyl phenylsulfonylacetate, 
benzoylnitromethane, (phenylsulfonyl)nitromethane, allylbenzene, 4-allylanisole, safrole, 
Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 “Catalyst 1” (Sigma-Aldrich); glacial acetic acid 
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(Fisher Scientific). Methyl nitroacetate 13 was prepared according to the published procedure.
34
 
Catalyst 49 was prepared according to the published procedure.
15
 Catalyst 51 was prepared 
according to the published procedure.
31
 Catalyst 1 was stored at -20 °C and weighed out in air 
prior to use. Dioxane and tetrahydrofuran were purified prior to use by passage through a bed of 
activated alumina (Glass Contour, Laguna Beach, California). Dimethyl sulfoxide was obtained 
from Fisher Scientific and used as received.  All allylic alkylation reactions were run under air 
with no precautions taken to exclude moisture.  Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with UV 
and potassium permanganate stain.  Flash chromatography was performed as described by Still 
using ZEOprep 60 ECO 43-60 micron silica gel (American International Chemical, Inc.).
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1
H 
NMR spectra were recorded on a Varian Unity-400 (400 MHz), Varian Inova-500 (500 MHz), or 
Varian Unity-500 (500 MHz) spectrometer and are reported in ppm using solvent as an internal 
standard (CDCl3 at 7.26 ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p 
= pentet, m = multiplet, b = broad, ap = apparent; coupling constant(s) in Hz; integration. Proton-
decoupled 
13
C NMR spectra were recorded on a Varian Unity-500 (125 MHz) spectrometer and 
are reported in ppm using solvent as an internal standard (CDCl3 at 77.16 ppm). 
19
F spectra were 
recorded on a Varian Unity-500 (470 MHz) spectrometer and are reported in ppm using a CFCl3 
standard referenced to 0 ppm. Regioselectivity of the allylic alkylation reaction was determined 
by 
1
H NMR analysis of the crude reaction mixture. IR spectra were recorded as thin films on 
NaCl plates on a Perkin-Elmer Spectrum BX and are reported in frequency of absorption (cm
-1
). 
HPLC analysis was performed on an Agilent Technologies 1100 HPLC system with a model 
1100 Quaternary Pump, Diode Array Detector, Thermostat, and Autosampler using a Daicel 
Chemical Industries Chiralcel OD-H column (0.46 cm x 25 cm). High-resolution mass spectra 
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were obtained at the University of Illinois Mass Spectrometry Laboratory. Optical rotations were 
obtained using a JAS.CO DIP-360 digital polarimeter and a 3.5 x 50 mm cell and are reported as 
follows: concentration (c = g / 100 mL), solvent.  
 
General Procedure for the Allylic Alkylation: To a two-dram (8 mL) borosilicate vial was 
added Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 (0.10 equiv, 0.050 mmol) and 2,6-
dimethylbenzoquinone (1.5 equiv, 0.75 mmol). Olefin (1 equiv, 0.50 mmol), methyl nitroacetate 
(3 equiv, 1.50 mmol), and acetic acid (0.50 equiv, 0.25 mmol) in dioxane (1.2 mL); 
dimethylsulfoxide (0.30 mL); and a stir bar were added sequentially. No precautions were taken 
to exclude air or moisture. The olefin, nucleophile and acid were weighed out in a ½ dram vial 
and transferred via dioxane (3 x 0.4 mL). The reaction vial was capped and stirred at 45 °C for 
12-24 hours. The allylic alkylation was monitored until complete conversion of the α-olefin 
starting material was observed by TLC. The vial was cooled to room temperature, and the 
reaction mixture was diluted with saturated aqueous NH4Cl (40 mL) and extracted with ethyl 
acetate (3 x 40 mL). The combined organic extracts were dried over MgSO4. The mixture was 
filtered and concentrated in vacuo. Purification by flash chromatography (SiO2, EtOAc/hexanes 
mixtures) provided the pure linear product. In all cases branched product was readily separated 
and generally possessed a higher Rf value than linear product. 
 
Procedure for preparation of Catalyst 1: 
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1,2-bis(phenylsulfinyl)ethane: A 50 mL flask was charged with a stir bar, 1,2-
bis(phenylthio)ethane (2.0 g, 8.12 mmol, 1 equiv.), and acetic acid (12.2 mL).  A solution of H-
2O2 (50 wt%, 1.10 mL, 16.2 mmol, 2 equiv.) in acetic acid (6.7 mL) was added dropwise at room 
temperature.  After approximately 15 min. the solution became homogeneous and turned a pale 
yellow.  An additional 1.4 mL of acetic acid was then added and the solution was allowed to stir 
for 24 h at room temperature.  The acetic acid was removed with mild heating (45 
o
C) under high 
vacuum. The pale yellow solid was emulsified in cold ethanol and cold-filtered to yield a mixture 
of the meso and racemic 1,2-bis(phenylsulfinyl)ethane (2.088g, 92% yield). Meso-1,2-
bis(phenylsulfinyl)ethane 
1
H NMR (500 MHz, CDCl3) δ 7.56-7.52 (m, 10H), 3.05 (s, 4H).  
13
C 
NMR (500 MHz, CDCl3) 142.29, 131.55, 129.63, 124.10, 47.06.  IR (neat, cm
-1
) 3049, 2970, 
2922, 1442, 1036, 745, 696; racemic-1,2-bis(phenylsulfinyl)ethane 
1
H NMR (500 MHz, CDCl3) 
δ 7.51-7.48 (m, 10H), 3.40 (m, 2H), 2.74 (m, 2H); 13C NMR (125 MHz, CDCl3) 142.55, 131.53, 
129.64, 124.08, 47.94.  IR (neat, cm
-1
) 3053, 2911, 1443, 1084, 1043, 749.  HRMS (ESI) m/z 
calculated for C14H14O2S2Na [M+Na]
+
: 301.0333, found 301.0320. 
 
Recrystallization of 1,2-bis(phenylsulfinyl)ethane: To a solution of refluxing acetone (~100 
ml) was added the crude ligand mixture (~2 g).  Acetone was then added slowly to the mixture 
with reflux until the powder dissolved completely.  The mixture was allowed to cool to room 
temperature.  (NOTE:  In the event of over-oxidation, the mono- or di-sulfone will recrystallize 
first as large plates in approximately 6-8 hours. In this case the mixture was filtered, rinsing with 
minimal cold acetone).  The sulfone free mixture was left at room temperature for an hour, then 
cooled to 4
o
C over night.  IMPORTANT:  The meso isomer crystallizes first as small white 
prisms. Extended time is needed to allow the racemic (long white needles) to crystallize.  The 
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meso crystals were collected via filtration with a Buchner funnel and rinsed with cold acetone to 
give ~75% yield.  Additional crops may be obtained by evaporating the mother liquor and 
redissolving the white solid in minimal refluxing acetone. 
 
Recrystallization of Pd(OAc)2: Pd(OAc)2 (~2 g) was dissolved in minimal refluxing benzene 
(~25 mL).  A black precipitate was removed by hot Acrodisc® filtration.  The resulting solution 
was cooled to room temperature without further manipulation.  Amber crystals began to form 
after ~2 h.  After 24 h the slurry was filtered to give the recrystallized Pd(OAc)2.  A difference in 
NMR purity was noted between “old” and recrystallized Pd(OAc)2 samples.  Reported hydrogen 
values are normalized ratios of the smallest peak in the acetate region.  “Old” Pd(OAc)2 
1
H NMR 
(500 MHz, CDCl3) δ 2.17 (s, 1H), 2.10 (s, 3.6H), 2.07 (s, 6.1H), 2.06 (s, 6.1H), 2.03 (m, 15.3H), 
2.00 (m, 95.7H), 1.97 (s, 5.7H), 1.95 (s, 6.3), 1.89 (s, 9.4H).  Recrystallized Pd(OAc)2 
1
H NMR 
(500 MHz, CDCl3) δ 2.10 (s, 1H), 2.03 (s, 2.8H), 2.00 (s, 40.1H), 1.97 (s, 1.2H), 1.90 (s, 2.3H).  
 
Catalyst 1:  A flame-dried 250 mL flask fitted with a condenser under argon 
atmosphere was charged with meso-1,2-bis(phenylsulfinyl)ethane (2.53 g, 9.1 
mmol), Pd(OAc)2 (2.04 g, 9.1 mmol), and CH2Cl2 (101 mL). The mixture was stirred at 40 
o
C 
for 24h.  The solution becomes dark red and homogenous during the reaction time.  The solution 
was concentrated in vacuo and dried with a stream of N2 for 6 h to give a dark red solid used 
without further purification.  NOTE: The catalyst must be stored at or below 4 
o
C.  The 
catalyst slowly decomposes at ambient temperature; however, it may be stored for prolonged 
periods (months) at reduced temperatures. 
1
H NMR and IR spectra of this catalyst resemble 1,2-
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bis(phenylsulfinyl)ethane and Pd(OAc)2. Trace amounts of phenyl vinyl sulfoxide can be 
observed by 
1
H NMR. 
 
NOTE: Commercially available catalyst 1 (Sigma-Aldrich) and homemade catalyst were used 
interchangeably in the entries of Table 3. While catalyst batch variability is occasionally 
observed, no significant variability was observed between commercial and homemade catalyst.  
Stoichiometric allylic alkylation  
 
 
bis[chloro(1,2,3-trihapto-allylbenzene)palladium (II)]: A 50 mL flask was 
charged with allylbenzene (264 μL, 2.0 mmol, 1.0 equiv), catalyst 1 (1.01 g, 2.0 
mmol, 1.0 equiv), and a stir bar. To this was added 6 mL dioxane. The solution was allowed to 
stir for 60 min at room temperature under air, at which time an acetone solution (6 mL) of n-
Bu4NCl (2.22 g, 8.0 mmol, 4 equiv) was added via syringe. The anion exchange proceeded at 
room temperature for 60 min. The mixture was filtered over a plug of Celite (to remove metallic 
Pd), concentrated and purified via column chromatography (10%→50% EtOAc/hexanes 
gradient) to afford bis[chloro(1,2,3-trihapto-allylbenzene)palladium (II)] as a yellow solid (182 
mg, 0.752 mmol, 35% yield). 
1
H NMR (500 MHz, CDCl3) δ7.50 (d, J = 7.6 Hz, 4H), 7.35 (m, 
2H), 7.27 (d, J = 7.6 Hz, 4H), 5.80 (td, J = 11.6, 6.8 Hz, 2H), 4.62 (d, J = 11.2 Hz, 2H), 3.97 (d, 
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J = 6.6 Hz, 2H), 3.04 (d, J = 11.7 Hz, 2H). Spectral data match those of the reported 
compound.
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In order to investigate the low isolated yields of bis[chloro(1,2,3-trihapto-
allylbenzene)palladium (II)] (vide supra) formation of the product was observed by 
1
H NMR. To 
a ½ dram borosilicate vial were added allylbenzene (11.8 mg, 0.10 mmol, 1.0 equiv). Catalyst 1 
(50.3 mg, 0.10 mmol, 1.0 equiv), dioxane-d8 (300 μL) and a stir bar were added sequentially. No 
precautions were taken to exclude air or moisture. The vial was capped and stirred for 60 min at 
45 °C. The vial was cooled to room temperature and n-Bu4NCl (111.2 mg, 0.40 mmol, 4.0 equiv) 
was added in one portion. The anion exchange proceeded at room temperature for 60 min. To the 
crude reaction mixture was added nitrobenzene (4.9 mg, 0.040 mmol, 0.40 equiv) and the 
solution was shaken vigorously. A sample was removed for 
1
H NMR analysis and diluted with 
CDCl3. Yield was determined by integration of product peaks at 5.80, 4.62, 3.97 ppm relative to 
nitrobenzene. Run 1 (72% yield); run 2 (74% yield). Average yield: 73%. A low isolated yield 
may therefore be attributed to streaking during column chromatography rather than to low 
reactivity of the olefin and catalyst 1. 
 
bis[acetato(1,2,3-trihapto-allylbenzene)palladium (II)] (12): A flame-dried 
10 mL flask was charged with bis[chloro(1,2,3-trihapto-
allylbenzene)palladium (II)] (51.8 mg, 0.20 mmol, 1.0 equiv) and a stir bar. To this was added 
silver acetate (33.4 mg, 0.20 mmol, 1.0 equiv) dissolved in 2 mL of CHCl3, followed by a rinse 
with 1 mL CHCl3. The reaction was allowed to stir for 60 min at room temperature under Ar 
atmosphere. The mixture was filtered over a plug of Celite (to remove metallic Pd) and 
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concentrated in vacuo, and blown dry under a stream of N2 to afford bis[acetato(1,2,3-trihapto-
allylbenzene)palladium (II)] as a yellow oil which solidified when stored at -20 °C. 
1
H NMR 
(500 MHz, CDCl3) δ7.6-7.1 (m, 10H), 6.0-5.8 (m, 2H), 4.64 (bd, J = 9.5 Hz, 2H), 3.88 (bd, J = 
6.3 Hz, 2H), 2.92 (m, 2H), 2.0-1.2 (m, 6H).  
 
General stoichiometric screening procedure (see Table 1): To a 40 mL borosilicate vial were 
added sequentially bis[acetato(1,2,3-trihapto-allylbenzene)palladium (II)] (28.3 mg, 0.100 
mmol, 1.0 equiv) and nucleophile (1.00 mmol, 10 equiv), and a stir bar. Dioxane (2.4 mL) and 
dimethylsulfoxide (0.60 mL) were added. No precautions were taken to exclude air or moisture. 
The vial was capped and stirred for 3.5 h at 45 °C. The vial was cooled to room temperature and 
the reaction mixture was diluted with saturated aqueous NH4Cl (20 mL) and extracted with ethyl 
acetate (3 x 20 mL). The combined organics were dried over MgSO4. The mixture was filtered 
and concentrated in vacuo. To the crude reaction mixture was added nitrobenzene (4.9 mg, 0.040 
mmol, 0.40 equiv). The crude mixture was dissolved completely in CDCl3 and a sample was 
removed for 
1
H NMR analysis. Yield was determined by integration of olefinic product peaks 
relative to nitrobenzene.  
 
Entry 1: Bis[acetato(1,2,3-trihapto-allylbenzene)palladium (II)] (14.1 mg, 0.050 mmol, 1.0 
equiv), methyl phenylsulfonylacetate (107.1 mg, 0.50 mmol, 10 equiv), and nitrobenzene (4.9 
mg, 0.040 mmol, 0.80 equiv) were used. Run 1 (9% yield); run 2 (9% yield). Average yield: 
9%. Spectral data match those of the reported compound.
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Entry 2: Bis[acetato(1,2,3-trihapto-allylbenzene)palladium (II)] (28.3 mg, 0.10 mmol, 1.0 
equiv), benzoylnitromethane (165.2 mg, 1.0 mmol, 10 equiv), and nitrobenzene (4.9 mg, 0.040 
mmol, 0.40 equiv) were used. Run 1 (79% yield, 8.0:1 L:B); run 2 (84% yield, 7.9:1 L:B). 
Average yield: 82%. 
1
H NMR (500 MHz, CDCl3) δ 7.99 (m, 2H), 7.67 (m, 1H), 7.54 (m, 2H), 
7.30 (m, 4H), 7.24 (m, 1H), 6.56 (d, J = 15.9 Hz, 1H), 6.17 (dd, J = 9.0, 5.1 Hz, 1H), 6.13 (dt, J 
= 15.7, 7.2 Hz, 1H), 3.26 (dddd, J = 15.1, 8.9, 7.6, 1.3 Hz, 1H), 3.08 (dddd, J = 15.0, 6.8, 5.2, 1.5 
Hz, 1H); 
13
C NMR (125 MHz, CDCl3) 188.4, 136.4, 135.4, 135.0, 134.0, 129.4, 129.0, 128.8, 
128.1, 126.5, 121.7, 89.3, 34.2; IR (film, cm
-1
): 3064, 3027, 2922, 1695, 1559, 1449, 967; 
HRMS (ESI) m/z calculated for C17H15NO3Na [M+Na]
+
: 304.0950, found 304.0941. 
 
Entry 3: Bis[acetato(1,2,3-trihapto-allylbenzene)palladium (II)] (28.3 mg, 0.10 mmol, 1.0 
equiv), (phenylsulfonyl)nitromethane (201.2 mg, 1.0 mmol, 10 equiv), and nitrobenzene (4.9 mg, 
0.040 mmol, 0.40 equiv) were used. Run 1 (87% yield, 17:1 L:B); run 2 (91% yield, 15:1 L:B). 
Average yield: 89%. 
1
H NMR (500 MHz, CDCl3) δ 7.93 (m, 2H), 7.80 (m, 1H), 7.65 (m, 2H), 
7.29 (m, 4H), 7.24 (m, 1H), 6.54 (d, J = 15.6 Hz, 1H), 5.97 (ddd, J = 15.7, 7.8, 6.7 Hz, 1H), 5.59 
(dd, J = 11.2, 3.4 Hz, 1H), 3.22 (dddd, J = 14.9, 6.4, 3.5, 1.4 Hz, 1H), 3.12 (dddd, J = 15.0, 11.2, 
7.9, 1.1 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) 136.6, 135.9, 135.7, 134.0, 130.1, 129.7, 128.7, 
128.4, 126.5, 119.0, 101.4, 31.5; IR (film, cm
-1
): 3063, 3031, 2981, 2929, 2258, 1562, 1449, 
1342, 1158, 909, 732, 689; HRMS (ESI) m/z calculated for C16H15NO4SNa [M+Na]
+
: 340.0620, 
found 340.0629. Spectral data match those of the reported compound.
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Entry 4: Bis[acetato(1,2,3-trihapto-allylbenzene)palladium (II)] (28.3 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (119.1 mg, 1.0 mmol, 10 equiv), and nitrobenzene (4.9 mg, 0.040 
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mmol, 0.40 equiv) were used. Run 1 (87% yield, 4.1:1 L:B); run 2 (84% yield, 4.3:1 L:B). 
Average yield: 86%. 
1
H NMR (500 MHz, CDCl3) δ 7.32 (m, 4H), 7.25 (m, 1H), 6.65 (d, J = 
15.6 Hz, 1H), 6.08 (dt, J = 15.6, 7.3 Hz, 1H), 5.23 (dd, J = 9.2, 5.5 Hz, 1H), 3.85 (s, 3H), 3.16 
(m, 1H), 3.07 (m, 1H); 
13
C NMR (100 MHz, CDCl3) 164.6, 136.3, 135.6, 128.7, 128.2, 126.5, 
121.1, 87.6, 53.8, 33.9; IR (film, cm
-1
): 3028, 2958, 1954, 1884, 1754, 1563, 1495, 1438; HRMS 
(ESI) m/z calculated for C12H13NO4Na [M+Na]
+
: 258.0742, found 258.0729. Spectral data match 
those of the reported compound.
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Entry 5: Bis[acetato(1,2,3-trihapto-allylbenzene)palladium (II)] (28.3 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (119.1 mg, 1.0 mmol, 10 equiv), and nitrobenzene (4.9 mg, 0.040 
mmol, 0.40 equiv) were used. Dioxane (3.0 mL) used as solvent. Run 1 (<1% yield); run 2 (<1% 
yield). Average yield: <1%. 
Catalytic allylic C-H alkylation 
 
 
General catalytic screening procedure (see Table 2): To a ½ dram borosilicate vial were 
added catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv) and dimethylbenzoquinone (20.4 mg, 0.15 
mmol, 1.5 equiv). Allylbenzene (11.8 mg, 0.10 mmol, 1.0 equiv), methyl nitroacetate (11.9 mg, 
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0.10 mmol, 1.0 equiv), and acetic acid (2.9 μL, 0.050 mmol, 0.50 equiv) in dioxane (240 μL); 
dimethylsulfoxide (60 μL); and a stir bar were added sequentially. No precautions were taken to 
exclude air or moisture. The olefin, nucleophile and acid were weighed out in a ½ dram vial and 
transferred via dioxane (2 x 120 μL). The vial was capped and stirred for 24 h at 45°C. The vial 
was cooled to room temperature and the reaction mixture was diluted with saturated aqueous 
NH4Cl (10 mL) and extracted with ethyl acetate (3 x 10 mL). The combined organics were dried 
over MgSO4. The mixture was filtered and concentrated in vacuo. To the crude reaction mixture 
was added nitrobenzene (4.9 mg, 0.040 mmol, 0.40 equiv). The crude mixture was dissolved 
completely in CDCl3 and a sample was removed for 
1
H NMR analysis. Yield was determined by 
integration of olefinic product peaks relative to nitrobenzene.  
 
Entry 1: Catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (11.9 mg, 0.10 mmol, 1.0 equiv), (diacetoxyiodo)benzene (48.3 mg, 
0.15 mmol, 1.5 equiv) and nitrobenzene (4.9 mg, 0.040 mmol, 0.40 equiv) were used. Run 1 
(<5% yield); run 2 (<5% yield). Average yield: <5%. 
 
Entry 2: Catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (11.9 mg, 0.10 mmol, 1.0 equiv), copper(II) acetate (27.2 mg, 0.15 
mmol, 1.5 equiv) and nitrobenzene (4.9 mg, 0.040 mmol, 0.40 equiv) were used. Run 1 (9% 
yield); run 2 (7% yield). Average yield: 8%. 
 
Entry 3: Catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (11.9 mg, 0.10 mmol, 1.0 equiv), and nitrobenzene (4.9 mg, 0.040 
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mmol, 0.40 equiv) were used. The reaction vial was fitted with a balloon of O2. Run 1 (26% 
yield, 4.1:1 L:B); run 2 (28% yield, 4.3:1 L:B). Average yield: 27%. 
 
Entry 4: Catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (11.9 mg, 0.10 mmol, 1.0 equiv), and nitrobenzene (4.9 mg, 0.040 
mmol, 0.40 equiv) were used. The reaction vial pressurized with O2 to 7 atm. Run 1 (35% yield, 
4.2:1 L:B); run 2 (34% yield, 4.3:1 L:B). Average yield: 35%. 
 
Entry 5: Catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (11.9 mg, 0.10 mmol, 1.0 equiv), HPMV (5.0 mg) and nitrobenzene 
(4.9 mg, 0.040 mmol, 0.40 equiv) were used. The reaction vial was fitted with a balloon of O2. 
Run 1 (8% yield, 4.0:1 L:B); run 2 (12% yield, 3.9:1 L:B). Average yield: 10%. 
 
Entry 6: Catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (11.9 mg, 0.10 mmol, 1.0 equiv), copper(II) acetate (1.8 mg, 0.010 
mmol, 0.10 equiv) and nitrobenzene (4.9 mg, 0.040 mmol, 0.40 equiv) were used. The reaction 
vial was fitted with a balloon of O2. Run 1 (15% yield, 4.1:1 L:B); run 2 (19% yield, 4.1:1 L:B). 
Average yield: 17%. 
 
Entry 7: Catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (11.9 mg, 0.10 mmol, 1.0 equiv), dimethylbenzoquinone (20.4 mg, 
0.15 mmol, 1.5 equiv), acetic acid (2.9 μL, 0.050 mmol, 0.50 equiv), and nitrobenzene (4.9 mg, 
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0.040 mmol, 0.40 equiv) were used. Run 1 (71% yield, 3.8:1 L:B); run 2 (72% yield, 3.8:1 L:B). 
Average yield: 72%. 
 
Entry 8: Catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (11.9 mg, 0.10 mmol, 1.0 equiv), tetrabutylammonium acetate (30.2 
mg, 0.10 mmol, 1.0 equiv), dimethylbenzoquinone (20.4 mg, 0.15 mmol, 1.5 equiv), acetic acid 
(2.9 μL, 0.050 mmol, 0.50 equiv), and nitrobenzene (4.9 mg, 0.040 mmol, 0.40 equiv) were 
used. Run 1 (<1% yield); run 2 (<1% yield). Average yield: <1%. 
 
Entry 9: Pd(TFA)2 (3.3 mg, 0.010 mmol, 0.10 equiv), meso-1,2-bis(phenylsulfinyl)ethane (2.8 
mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 equiv), methyl nitroacetate 
(11.9 mg, 0.10 mmol, 1.0 equiv), dimethylbenzoquinone (20.4 mg, 0.15 mmol, 1.5 equiv), and 
nitrobenzene (4.9 mg, 0.040 mmol, 0.40 equiv) were used. Run 1 (5% yield); run 2 (4% yield). 
Average yield: 4%. 
 
Entry 10: Pd(OAc)2 (2.2 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (11.9 mg, 0.10 mmol, 1.0 equiv), dimethylbenzoquinone (20.4 mg, 
0.15 mmol, 1.5 equiv), acetic acid (2.9 μL, 0.050 mmol, 0.50 equiv), and nitrobenzene (4.9 mg, 
0.040 mmol, 0.40 equiv) were used. Run 1 (63% yield, 3.7:1 L:B); run 2 (63% yield, 3.9:1 L:B). 
Average yield: 63%. 
 
Entry 11: Catalyst 1 (5.0 mg, 0.010 mmol, 0.10 equiv), allylbenzene (11.8 mg, 0.10 mmol, 1.0 
equiv), methyl nitroacetate (35.7 mg, 0.30 mmol, 3.0 equiv), dimethylbenzoquinone (20.4 mg, 
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0.15 mmol, 1.5 equiv), acetic acid (2.9 μL, 0.050 mmol, 0.50 equiv), and nitrobenzene (4.9 mg, 
0.040 mmol, 0.40 equiv) were used. Run 1 (84% yield, 3.4:1 L:B); run 2 (82% yield, 3.5:1 L:B). 
Average yield: 83%. 
1
H NMR (500 MHz, CDCl3) δ 7.32 (m, 4H), 7.25 (m, 1H), 6.65 (d, J = 
15.6 Hz, 1H), 6.08 (dt, J = 15.6, 7.3 Hz, 1H), 5.23 (dd, J = 9.2, 5.5 Hz, 1H), 3.85 (s, 3H), 3.16 
(m, 1H), 3.07 (m, 1H); 
13
C NMR (100 MHz, CDCl3) 164.6, 136.3, 135.6, 128.7, 128.2, 126.5, 
121.1, 87.6, 53.8, 33.9; IR (film, cm
-1
): 3028, 2958, 1954, 1884, 1754, 1563, 1495, 1438; HRMS 
(ESI) m/z calculated for C12H13NO4Na [M+Na]
+
: 258.0742, found 258.0729. Spectral data match 
those of the reported compound.
37
 This reaction was also run at 0.5 mmol scale, and pure linear 
product was isolated in 62% yield (vide infra). 
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Scope of the allylic C-H alkylation reaction 
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(E)-methyl 5-(4-methoxyphenyl)-2-nitropent-4-enoate [20]: 4-
allylanisole (74.1 mg, 0.5 mmol, 1.0 equiv) was reacted for 24h 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 1.7:1 and the E/Z isomer ratio was >20:1. Flash chromatography (20% 
EtOAc/hexanes) yielded pure linear product as a light yellow solid. Run 1 (66.9 mg, 0.252 
mmol, 50% yield); run 2 (66.6 mg, 0.251 mmol, 50% yield). Average yield: 50%. 
1
H NMR 
(400 MHz, CDCl3) δ 7.27 (d, J = 8.8 Hz, 2H), 6.84 (d, J = 8.8 Hz, 2H), 6.49 (d, J = 15.6 Hz, 
1H), 5.93 (dt, J = 15.8, 7.3 Hz, 1H), 5.22 (dd, J = 9.2, 5.5 Hz, 1H), 3.85 (s, 3H), 3.80 (s, 3H), 
3.13 (m, 1H), 3.04 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 164.7, 159.6, 135.0, 129.1, 127.7, 
118.8, 114.1, 87.8, 55.4, 53.8, 34.0; IR (film, cm
-1
): 3033, 3005, 2958, 2839, 1891, 1756, 1608, 
1566, 1514, 1250, 1176, 1033, 971; HRMS (ESI) m/z calculated for C13H15NO5Na [M+Na]
+
: 
288.0848, found 288.0848. 
 
(E)-methyl 2-nitro-5-p-tolylpent-4-enoate [21]: 4-allyltoluene 
(68.6 mg, 96% pure, 0.5 mmol, 1.0 equiv) was reacted for 24h 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 3.3:1 and the E/Z isomer ratio was >20:1. Flash chromatography (15% 
EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (75.5 mg, 0.303 mmol, 
61% yield); run 2 (76.8 mg, 0.308 mmol, 62% yield). Average yield: 61%. 
1
H NMR (500 MHz, 
CDCl3) δ 7.22 (d, J = 8.1 Hz, 2H), 7.11 (d, J = 8.1 Hz, 2H), 6.52 (d, J = 15.6 Hz, 1H), 6.02 (dt, J 
= 15.7, 7.2 Hz, 1H), 5.22 (dd, J = 9.2, 5.5 Hz, 1H), 3.85 (s, 3H), 3.15 (m, 1H), 3.05 (m, 1H), 2.33 
(s, 3H); 
13
C NMR (125 MHz, CDCl3) 164.6, 138.1, 135.4, 133.5, 129.4, 126.4, 120.0, 87.7, 53.8, 
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33.9, 21.3; IR (film, cm
-1
): 3025, 2958, 2924, 2859, 1906, 1758, 1567, 1514, 1438, 1264, 1214, 
971, 791; HRMS (ESI) m/z calculated for C13H15NO4Na [M+Na]
+
: 272.0899, found 272.0897. 
 
(E)-methyl 2-nitro-5-(4-vinylphenyl)pent-4-enoate [22]: 4-
allylstyrene (72.1 mg, 0.5 mmol, 1.0 equiv) was reacted for 24h 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 3.3:1 and the E/Z isomer ratio was >20:1. Flash chromatography (15% 
EtOAc/hexanes) yielded pure linear product as a light yellow solid. Run 1 (77.3 mg, 0.296 
mmol, 59% yield); run 2 (84.8 mg, 0.325 mmol, 65% yield); run 3 (22.7 mg, 0.087 mmol, 0.132 
mmol scale, 66%). Average yield: 63%. 
1
H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 8.4 Hz, 2H), 
7.29 (d, J = 8.1 Hz, 2H), 6.69 (dd, J = 17.6, 10.9 Hz, 1H), 6.54 (d, J = 15.9 Hz, 1H), 6.08 (dt, J = 
15.7, 7.3 Hz, 1H), 5.75 (d, J = 17.6 Hz, 1H), 5.24 (m, 2H), 3.85 (s, 3H), 3.16 (m, 1H), 3.07 (m, 
1H); 
13
C NMR (125 MHz, CDCl3) 164.6, 137.4, 136.4, 135.8, 135.2, 126.7, 126.6, 121.1, 114.2, 
87.6, 53.8, 33.9; IR (film, cm
-1
): 2958, 2927, 2850, 1750, 1627, 1563, 1436, 1218, 978, 914, 814; 
HRMS (ESI) m/z calculated for C14H16NO4 [M+H]
+
: 262.1079, found 262.1066. 
 
(E)-methyl 2-nitro-5-phenylpent-4-enoate [14]: Allylbenzene (59.1 
mg, 0.5 mmol, 1.0 equiv) was reacted for 24h following the general 
procedure. By 
1
H NMR analysis of the crude product, the linear:branched ratio was 4.4:1 and the 
E/Z isomer ratio was >20:1. Flash chromatography (15% EtOAc/hexanes) yielded pure linear 
product as a light yellow oil. Run 1 (73.8 mg, 0.314 mmol, 63% yield); run 2 (71.2 mg, 0.303 
mmol, 61% yield). Average yield: 62%. 
1
H NMR (500 MHz, CDCl3) δ 7.32 (m, 4H), 7.25 (m, 
1H), 6.65 (d, J = 15.6 Hz, 1H), 6.08 (dt, J = 15.6, 7.3 Hz, 1H), 5.23 (dd, J = 9.2, 5.5 Hz, 1H), 
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3.85 (s, 3H), 3.16 (m, 1H), 3.07 (m, 1H); 
13
C NMR (100 MHz, CDCl3) 164.6, 136.3, 135.6, 
128.7, 128.2, 126.5, 121.1, 87.6, 53.8, 33.9; IR (film, cm
-1
): 3028, 2958, 1954, 1884, 1754, 1563, 
1495, 1438; HRMS (ESI) m/z calculated for C12H13NO4Na [M+Na]
+
: 258.0742, found 258.0729. 
Spectral data match those of the reported compound.
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(E)-methyl 5-(4-bromophenyl)-2-nitropent-4-enoate [23]: 4-
bromoallylbenzene (98.5 mg, 0.5 mmol, 1.0 equiv) was reacted for 
24h following the general procedure. By 
1
H NMR analysis of the crude product, the 
linear:branched ratio was 4.2:1 and the E/Z isomer ratio was >20:1. Flash chromatography (15% 
EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (86.4 mg, 0.275 mmol, 
55% yield); run 2 (85.2 mg, 0.271 mmol, 0.454 mmol scale, 60% yield); run 3 (83.6 mg, 0.266 
mmol, 0.400 mmol scale, 67%). Average yield: 60%. 
1
H NMR (500 MHz, CDCl3) δ 7.43 (d, J 
= 8.4 Hz, 2H), 7.19 (d, J = 8.4 Hz, 2H), 6.49 (d, J = 15.7 Hz, 1H), 6.08 (dt, J = 15.7, 7.3 Hz, 1H), 
5.23 (dd, J = 9.2, 5.4 Hz, 1H), 3.85 (s, 3H), 3.15 (m, 1H), 3.05 (m, 1H); 
13
C NMR (125 MHz, 
CDCl3) 164.5, 135.2, 134.4, 131.9, 128.1, 122.0, 122.0, 87.4, 53.9, 33.8; IR (film, cm
-1
): 3033, 
2960, 1760, 1568, 1488, 1439, 1342, 1224, 1009, 693; HRMS (ESI) m/z calculated for 
C12H12NO4BrNa [M+Na]
+
: 335.9847, found 335.9841. 
 
(E)-methyl 5-(4-(N,4-dimethylphenylsulfonamido)phenyl)-2-
nitropent-4-enoate [24]: N-(4-allylphenyl)-N,4-
dimethylbenzenesulfonamide (151 mg, 0.5 mmol, 1.0 equiv) was 
reacted for 24h following the general procedure. By 
1
H NMR analysis of the crude product, the 
linear:branched ratio was 4.0:1 and the E/Z isomer ratio was >20:1. Flash chromatography (30% 
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EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (133 mg, 0.318 mmol, 
64% yield); run 2 (128 mg, 0.306 mmol, 61% yield). Average yield: 63%. 
1
H NMR (500 MHz, 
CDCl3) δ 7.42 (d, J = 8.1 Hz, 2H), 7.24 (m, 4H), 7.04 (d, J = 8.6 Hz, 2H), 6.52 (d, J = 15.9 Hz, 
1H), 6.07 (dt, J = 15.8, 7.2 Hz, 1H), 5.24 (dd, J = 9.3, 5.3 1H), 3.86 (s, 3H), 3.16 (m, 1H), 3.13 
(s, 3H), 3.07 (m, 1H), 2.42 (s, 3H); 
13
C NMR (125 MHz, CDCl3) 164.5, 143.8, 141.3, 135.2, 
134.5, 133.3, 129.5, 127.9, 126.9, 126.6, 122.0, 87.5, 53.8, 38.0, 33.8, 21.6; IR (film, cm
-1
): 
3035, 2959, 2934, 2259, 1921, 1756, 1598, 1563, 1505, 1348, 1172, 911, 729; HRMS (ESI) m/z 
calculated for C20H23N2O6S [M+H]
+
: 419.1277, found 419.1289. 
 
(E)-methyl 5-(4-fluorophenyl)-2-nitropent-4-enoate  [25]: 4-
Fluoroallylbenzene (68.1 mg, 0.5 mmol, 1.0 equiv) was reacted for 
24h following the general procedure. By 
1
H NMR analysis of the crude product, the 
linear:branched ratio was 4.3:1 and the E/Z isomer ratio was >20:1. Flash chromatography (20% 
EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (84.3 mg, 0.333 mmol, 
67% yield); run 2 (80.5 mg, 0.318 mmol, 64% yield). Average yield: 65%. 
1
H NMR (400 MHz, 
CDCl3) δ 7.30 (m, 2H), 7.00 (m, 2H), 6.52 (d, J = 15.9 Hz, 1H), 6.00 (dt, J = 15.6, 7.3 Hz, 1H), 
5.23 (dd, J = 9.0, 5.4 Hz, 1H), 3.85 (s, 3H), 3.15 (m, 1H), 3.05 (m, 1H); 
13
C NMR (125 MHz, 
CDCl3) 164.4, 162.5 (d, JCF = 247.7 Hz), 134.2, 132.3 (d, JCF = 2.8 Hz), 127.9 (d, JCF = 8.3 Hz), 
120.8, 115.5 (d, JCF = 21.1 Hz), 87.4, 53.7, 33.7; 
19
F NMR (470 MHz, CDCl3) 98.9; IR (film, 
cm
-1
): 2959, 2924, 2851, 1759, 1602, 1567, 1511, 1228, 970; HRMS (ESI) m/z calculated for 
C12H12NO4FNa [M+Na]
+
: 276.0648, found 276.0646. 
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(E)-methyl 4-(5-methoxy-4-nitro-5-oxopent-1-enyl)benzoate 
[26]: Methyl 4-allylbenzoate (73.6 mg, 95.8% pure, 0.4 mmol, 
1.0 equiv) was reacted for 12h following the general procedure. 
By 
1
H NMR analysis of the crude product, the linear:branched ratio was 10.1:1 and the E/Z 
isomer ratio was >20:1. Flash chromatography (25% EtOAc/hexanes), followed by short silica 
plug (100% CH2Cl2), followed by flash chromatography (25% EtOAc/hexanes), followed by 
repeated extractions as necessary to remove methyl nitroacetate (sat. aq. NaHCO3), yielded 
linear product contaminated by ca. 6% methyl 6-(4-(methoxycarbonyl)phenyl)-5,6-dihydro-4H-
1,2-oxazine-3-carboxylate as a light yellow oil. A pure spectroscopic sample was obtained by 
column chromatography (15% EtOAc/hexanes). Run 1 (76.6 mg, 0.261 mmol, 65% yield); run 2 
(79.6 mg, 0.271 mmol, 0.479 mmol scale, 54% yield), run 3 (43.2 mg, 0.147 mmol, 0.234 mmol 
scale, 63%). Average yield: 61%. 
1
H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 8.5 Hz, 2H), 7.39 
(d, J = 8.3 Hz, 2H), 6.59 (d, J = 15.9 Hz, 1H), 6.21 (dt, J = 15.7, 7.3 Hz, 1H), 5.26 (dd, J = 9.0, 
5.4 Hz, 1H), 3.91 (s, 3H), 3.86 (s, 3H), 3.19 (m, 1H), 3.10 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 
166.9, 164.5, 140.6, 134.7, 130.1, 129.6, 126.4, 124.0, 87.3, 53.9, 52.3, 33.9; IR (film, cm
-1
): 
3004, 2956, 2849, 1931, 1759, 1716, 1608, 1563, 1438, 1286, 1111, 761; HRMS (ESI) m/z 
calculated for C14H16NO6 [M+H]
+
: 294.0978, found 294.0969. 
  
(E)-methyl 5-(4-acetylphenyl)-2-nitropent-4-enoate [27]: 4’-
allylacetophenone (86.5 mg, 92.6% pure, 0.5 mmol, 1.0 equiv) was 
reacted for 12h following the general procedure. By 
1
H NMR 
analysis of the crude product, the linear:branched ratio was 10.3:1 and the E/Z isomer ratio was 
>20:1. Flash chromatography (25→35% EtOAc/hexanes gradient), followed by short silica plug 
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(100% CH2Cl2), followed by flash chromatography (25→35% EtOAc/hexanes gradient) yielded 
linear product contaminated by ca. 6% methyl 6-(4-acetylphenyl)-5,6-dihydro-4H-1,2-oxazine-3-
carboxylate as a light yellow oil. A pure spectroscopic sample was obtained by column 
chromatography (15% EtOAc/hexanes). Run 1 (96.2 mg, 0.347 mmol, 69% yield); run 2 (71.6 
mg, 0.258 mmol, 0.400 mmol scale, 65% yield), run 3 (88.3 mg, 0.318 mmol, 0.509 mmol scale, 
63%). Average yield: 66%. 
1
H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 8.5 Hz, 2H), 7.41 (d, J = 
8.3 Hz, 2H), 6.60 (d, J = 15.9 Hz, 1H), 6.23 (dt, J = 15.8, 7.3 Hz, 1H), 5.26 (dd, J = 9.3, 5.4 Hz, 
1H), 3.86 (s, 3H), 3.20 (m, 1H), 3.10 (m, 1H), 2.59 (s, 3H); 
13
C NMR (125 MHz, CDCl3) 197.6, 
164.5, 140.8, 136.5, 134.6, 128.9, 126.6, 124.2, 87.3, 53.9, 33.9, 26.8; IR (film, cm
-1
): 2957, 
2926, 2853, 1755, 1679, 1604, 1562, 1360, 1267; HRMS (ESI) m/z calculated for C14H16NO5 
[M+H]
+
: 278.1028, found 278.1017. 
 
(E)-methyl 2-nitro-5-(4-(trifluoromethyl)phenyl)pent-4-enoate 
[28]: 4-allylbenzotrifluoride (93.1 mg, 0.5 mmol, 1.0 equiv) was 
reacted for 18h following the general procedure. By 
1
H NMR analysis of the crude product, the 
linear:branched ratio was 10.2:1 and the E/Z isomer ratio was >20:1. Flash chromatography 
(20% EtOAc/hexanes) yielded linear product contaminated by ca. 5% methyl 6-(4-
(trifluoromethyl)phenyl)-5,6-dihydro-4H-1,2-oxazine-3-carboxylate as a light yellow oil. A pure 
spectroscopic sample was obtained by column chromatography (10% EtOAc/hexanes). Run 1 
(83.7 mg, 0.276 mmol, 55% yield); run 2 (87.5 mg, 0.289 mmol, 58% yield). Average yield: 
56%. 
1
H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 8.1 Hz, 2H), 7.43 (d, J = 8.3 Hz, 2H), 6.59 (d, J 
= 15.9 Hz, 1H), 6.20 (dt, J = 15.8, 7.3 Hz, 1H), 5.25 (dd, J = 9.3, 5.4 1H), 3.86 (s, 3H), 3.19 (m, 
1H), 3.10 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 164.5, 139.7, 134.3, 130.0 (q, JCF = 32.2 Hz), 
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126.7, 125.7 (q, JCF = 3.7 Hz), 124.2 (q, JCF = 271.6 Hz), 124.0, 87.3, 53.9, 33.8; 
19
F NMR (470 
MHz, CDCl3) -62.8; IR (film, cm
-1
): 3047, 3012, 2961, 2936, 2854, 1921, 1760, 1616, 1564, 
1439, 1330, 1167, 1122, 1068, 733; HRMS (ESI) m/z calculated for C13H12NO4F3Na [M+Na]
+
: 
326.0616, found 326.0631. 
 
(E)-methyl 5-(4-cyanophenyl)-2-nitropent-4-enoate [29]: 4-
allylbenzonitrile (72.6 mg, 98.6% pure, 0.5 mmol, 1.0 equiv) was 
reacted for 12h following the general procedure. By 
1
H NMR 
analysis of the crude product, the linear:branched ratio was 12:1 and the E/Z isomer ratio was 
>20:1. Flash chromatography (30% EtOAc/hexanes), followed by short silica plug (100% 
CH2Cl2), followed by flash chromatography (25→35% EtOAc/hexanes gradient) yielded linear 
product contaminated by ca. 11% methyl 6-(4-cyanophenyl)-5,6-dihydro-4H-1,2-oxazine-3-
carboxylate as a light yellow oil. A pure spectroscopic sample was obtained by column 
chromatography (15% EtOAc/hexanes). Run 1 (83.7 mg, 0.322 mmol, 64% yield); run 2 (84.6 
mg, 0.325 mmol, 65% yield). Average yield: 65%. 
1
H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 
8.3 Hz, 2H), 7.41 (d, J = 8.3 Hz, 2H), 6.57 (d, J = 15.6 Hz, 1H), 6.24 (dt, J = 15.6, 7.3 Hz, 1H), 
5.26 (dd, J = 9.2, 5.2 Hz, 1H), 3.86 (s, 3H), 3.19 (m, 1H), 3.11 (m, 1H); 
13
C NMR (125 MHz, 
CDCl3) 164.3, 140.6, 134.0, 132.6, 127.1, 125.4, 118.9, 111.5, 87.1, 54.0, 33.8; IR (film, cm
-1
): 
3063, 2959, 2929, 2853, 2227, 1756, 1606, 1567, 1439, 1267, 972, 738; HRMS (ESI) m/z 
calculated for C13H13N2O4 [M+H]
+
: 261.0875, found 261.0876. 
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(E)-methyl 5-(3-methoxyphenyl)-2-nitropent-4-enoate [30]: 3-
allylanisole (74.1 mg, 0.5 mmol, 1.0 equiv) was reacted for 24h 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 4.5:1 and the E/Z isomer ratio was >20:1. Flash chromatography (20% 
EtOAc/hexanes) yielded pure linear product as a light yellow solid. Run 1 (77.6 mg, 0.293 
mmol, 59% yield); run 2 (61.8 mg, 0.233 mmol, 0.400 mmol scale, 58% yield). Average yield: 
58%. 
1
H NMR (500 MHz, CDCl3) δ 7.22 (t, J = 7.9 Hz, 1H), 6.93 (bd, J = 7.6 Hz, 1H), 6.86 (m, 
1H), 6.81 (m, 1H), 6.53 (d, J = 15.9 Hz, 1H), 6.08 (dt, J = 15.8, 7.3 Hz, 1H), 5.23 (dd, J = 9.2, 
5.5 Hz, 1H), 3.85 (s, 3H), 3.81 (s, 3H), 3.16 (m, 1H), 3.06 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 
164.6, 159.9, 137.7, 135.5, 129.7, 121.5, 119.1, 113.7, 111.9, 87.5, 55.3, 53.8, 33.8; IR (film, cm
-
1
): 3006, 2959, 2838, 1761, 1568, 1436, 1264, 1046, 971, 777, 689; HRMS (ESI) m/z calculated 
for C13H16NO5 [M+H]
+
: 266.1028, found 266.1024. 
 
(E)-methyl 5-(3-(diphenylmethyleneamino)phenyl)-2-
nitropent-4-enoate [31]: 3-allyl-N-(diphenylmethylene)aniline 
(149 mg, 91% pure, 0.456 mmol, 1.0 equiv) was reacted for 48h following the general 
procedure. By 
1
H NMR analysis of the crude product, the linear:branched ratio was 8.6:1 and the 
E/Z isomer ratio was >20:1. Flash chromatography (20% EtOAc/hexanes) yielded pure linear 
product as a light yellow solid. Run 1 (119.8 mg, 0.289 mmol, 64% yield); run 2 (108.5 mg, 
0.262 mmol, 57% yield); run 3 (61.1 mg, 0.147 mmol, 0.274 mmol scale, 54% yield). Average 
yield: 58%. 
1
H NMR (500 MHz, CDCl3) δ 7.74 (m, 2H), 7.48 (m, 1H), 7.41 (m, 2H), 7.27 (m, 
3H), 7.11 (m, 2H), 7.07 (t, J = 7.8 Hz, 1H), 6.88 (bd, J = 7.8 Hz, 1H), 6.76 (m, 1H), 6.57 (m, 
1H), 6.42 (d, J = 15.9 Hz, 1H), 5.90 (dt, J = 15.7, 7.2 Hz, 1H), 5.18 (dd, J = 9.2, 5.5 Hz, 1H), 
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3.85 (s, 3H), 3.10 (m, 1H), 3.01 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 168.7, 164.6, 151.5, 
139.7, 136.6, 136.2, 135.5, 130.9, 129.6, 129.4, 128.8, 128.8, 128.3, 128.1, 121.7, 121.1, 120.8, 
119.2, 87.6, 53.8, 33.8; IR (film, cm
-1
): 3060, 3030, 2956, 1758, 1563, 1447, 1267, 910, 735, 
698; HRMS (ESI) m/z calculated for C25H23N2O4 [M+H]
+
: 415.1658, found 415.1668. 
 
(E)-methyl 2-nitro-5-o-tolylpent-4-enoate [32]: 2-allyltoluene (69.5 
mg, 95% pure, 0.5 mmol, 1.0 equiv) was reacted for 24h following the 
general procedure. By 
1
H NMR analysis of the crude product, the linear:branched ratio was 4.7:1 
and the E/Z isomer ratio was >20:1. Flash chromatography (15% EtOAc/hexanes) yielded pure 
linear product as a light yellow oil. Run 1 (73.5 mg, 0.295 mmol, 59% yield); run 2 (64.5 mg, 
0.258 mmol, 0.400 mmol scale, 65% yield); run 3 (63.5 mg, 0.255 mmol, 0.400 mmol scale, 
64% yield). Average yield: 62%. 
1
H NMR (400 MHz, CDCl3) δ 7.35 (m, 1H), 7.16 (m, 3H), 
6.77 (d, J = 15.6 Hz, 1H), 5.95 (dt, J = 15.5, 7.3 Hz, 1H), 5.25 (dd, J = 9.0, 5.6 Hz, 1H), 3.86 (s, 
3H), 3.18 (m, 1H), 3.09 (m, 1H), 2.31 (s, 3H); 
13
C NMR (125 MHz, CDCl3) 164.6, 135.6, 135.6, 
133.7, 130.4, 128.0, 126.3, 125.9, 122.6, 87.7, 53.8, 34.1, 19.8; IR (film, cm
-1
): 3020, 2957, 
2859, 1962, 1919, 1756, 1568, 1439, 1264, 1217, 969, 911, 751; HRMS (ESI) m/z calculated for 
C13H15NO4Na [M+Na]
+
: 272.0899, found 272.0898. 
 
(E)-methyl 2-nitro-5-(2-(trifluoromethyl)phenyl)pent-4-enoate [33]: 
1-allyl-2-(trifluoromethyl)benzene (93.1 mg, 0.5 mmol, 1.0 equiv) was 
reacted for 24h following the general procedure. By 
1
H NMR analysis of the crude product, the 
linear:branched ratio was >20:1 and the E/Z isomer ratio was >20:1. Flash chromatography (15% 
EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (91.1 mg, 0.300 mmol, 
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60% yield); run 2 (88.3 mg, 0.291 mmol, 58% yield). Average yield: 59%. 
1
H NMR (400 MHz, 
CDCl3) δ 7.62 (bd, J = 8.1 Hz, 1H), 7.51 (m, 2H), 7.36 (m, 1H), 6.94 (d, J = 15.6 Hz, 1H), 6.07 
(dt, J = 15.2, 7.5 Hz, 1H), 5.26 (dd, J = 8.8, 5.9 Hz, 1H), 3.86 (s, 3H), 3.20 (m, 1H), 3.12 (m, 
1H); 
13
C NMR (125 MHz, CDCl3) 164.5, 135.5, 132.1, 131.7, 127.9, 127.8, 127.5 (q, JCF = 29.9 
Hz), 125.9 (q, JCF = 5.8 Hz), 125.7, 125.3 (q, JCF = 273.7 Hz), 87.2, 53.8, 33.8; 
19
F NMR (470 
MHz, CDCl3) -59.8; IR (film, cm
-1
): 2961, 2930, 2852, 1755, 1568, 1439, 1318, 1165, 1124, 
1036, 970, 767; HRMS (ESI) m/z calculated for C13H12NO4F3Na [M+Na]
+
: 326.0616, found 
326.0607. 
 
(E)-methyl 5-(2-(tert-butyldimethylsilyloxy)phenyl)-2-nitropent-4-
enoate [34]: (2-allylphenoxy)(tert-butyl)dimethylsilane (124.2 mg, 0.5 
mmol, 1.0 equiv) was reacted for 24h following the general procedure. 
By 
1
H NMR analysis of the crude product, the linear:branched ratio was 2.7:1 and the E/Z 
isomer ratio was >20:1. Flash chromatography (10% CH2Cl2/toluene) followed by flash 
chromatography (15% EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 
(93.5 mg, 0.256 mmol, 51% yield); run 2 (111.7 mg, 0.306 mmol, 61% yield); run 3 (67.4 mg, 
0.184 mmol, 0.300 mmol scale, 61% yield). Average yield: 58%. 
1
H NMR (500 MHz, CDCl3) δ 
7.37 (dd, J = 7.8, 1.7 Hz, 1H), 7.13 (m, 1H), 6.89 (m, 2H), 6.78 (dd, J = 8.2, 1.1 Hz, 1H), 6.01 
(dt, J = 15.9, 7.2 Hz, 1H), 5.22 (dd, J = 9.3, 5.4 Hz, 1H), 3.85 (s, 3H), 3.16 (m, 1H), 3.06 (m, 
1H), 1.02 (s, 9H), 0.21 (s, 6H); 
13
C NMR (125 MHz, CDCl3) 164.7, 153.0, 130.9, 129.0, 127.8, 
126.6, 121.5, 120.9, 119.7, 87.7, 53.8, 34.4, 25.9, 18.5, -4.1, -4.1; IR (film, cm
-1
): 3035, 2957, 
2931, 2859, 1756, 1566, 1485, 1261, 914, 838, 783, 734; HRMS (ESI) m/z calculated for 
C18H27NO5SiNa [M+Na]
+
: 388.1556, found 388.1556. 
44 
 
 
(E)-methyl 2-nitro-5-(2-(trifluoromethylsulfonyloxy)phenyl)pent-4-
enoate [35]: 2-allylphenyl trifluoromethanesulfonate (133.1 mg, 0.5 
mmol, 1.0 equiv) was reacted for 24h following the general procedure. By 
1
H NMR analysis of 
the crude product, the linear:branched ratio was 15:1 and the E/Z isomer ratio was >20:1. Flash 
chromatography (20% EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 
(98.9 mg, 0.258 mmol, 52% yield); run 2 (70.7 mg, 0.184 mmol, 0.300 mmol scale, 61% yield); 
run 3 (68.3 mg, 0.178 mmol, 0.300 mmol scale, 59% yield). Average yield: 57%. 
1
H NMR (500 
MHz, CDCl3) δ 7.54 (m, 1H), 7.34 (m, 2H), 7.26 (m, 1H), 6.76 (d, J = 15.9 Hz, 1H), 6.21 (dt, J = 
15.8, 7.2 Hz, 1H), 5.26 (dd, J = 8.9, 5.5 Hz, 1H), 3.87 (s, 3H), 3.21 (m, 1H), 3.14 (m, 1H); 
13
C 
NMR (125 MHz, CDCl3) 164.4, 146.8, 130.0, 129.7, 128.7, 127.9, 127.6, 126.5, 121.9, 118.7 (q, 
JCF = 320.1 Hz), 87.1, 53.9, 33.9; 
19
F NMR (470 MHz, CDCl3) -73.8; IR (film, cm
-1
): 3061, 
2963, 2930, 2857, 1761, 1564, 1485, 1419, 1140, 1075, 970, 894, 737; HRMS (ESI) m/z 
calculated for C13H12NO7SF3Na [M+Na]
+
: 406.0184, found 406.0178. 
 
(E)-methyl 5-(naphthalen-2-yl)-2-nitropent-4-enoate [36]: 2-
allylnaphthalene (84.1 mg, 0.5 mmol, 1.0 equiv) was reacted for 
24h following the general procedure. By 
1
H NMR analysis of the crude product, the 
linear:branched ratio was 4.2:1 and the E/Z isomer ratio was >20:1. Flash chromatography (20% 
EtOAc/hexanes) yielded pure linear product as a light yellow solid. Run 1 (91.0 mg, 0.319 
mmol, 64% yield); run 2 (76.0 mg, 0.266 mmol, 0.400 mmol scale, 67% yield). Average yield: 
65%. 
1
H NMR (500 MHz, CDCl3) δ 7.79 (m, 3H), 7.70 (bs, 1H), 7.53 (dd, J = 8.6, 1.7 Hz, 1H), 
7.46 (m, 2H), 6.72 (d, J = 15.9 Hz, 1H), 6.21 (dt, J = 15.7, 7.3 Hz, 1H), 5.28 (dd, J = 9.2, 5.6 Hz, 
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1H), 3.87 (s, 3H), 3.22 (m, 1H), 3.13 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 164.6, 135.6, 133.7, 
133.6, 133.2, 128.4, 128.1, 127.8, 126.7, 126.5, 126.2, 123.4, 121.5, 87.6, 53.8, 34.0; IR (film, 
cm
-1
): 3057, 2960, 2925, 2852, 1756, 1564, 1438, 1267, 1215, 967, 811, 749; HRMS (ESI) m/z 
calculated for C16H15NO4Na [M+Na]
+
: 308.0899, found 308.0896. 
 
(E)-methyl 5-(benzo[d][1,3]dioxol-5-yl)-2-nitropent-4-enoate 
[37]: Safrole (81.1 mg, 0.5 mmol, 1.0 equiv) was reacted for 24h 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 3.0:1 and the E/Z isomer ratio was >20:1. Flash chromatography (20% 
EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (80.2 mg, 0.287 mmol, 
57% yield); run 2 (77.1 mg, 0.276 mmol, 55% yield). Average yield: 56%. 
1
H NMR (500 MHz, 
CDCl3) δ 6.86 (d, J = 1.5 Hz, 1H), 6.75 (m, 2H), 6.46 (d, J = 15.9 Hz, 1H), 5.95 (s, 2H), 5.90 (dt, 
J = 15.7, 7.3 Hz, 1H), 5.21 (dd, J = 9.2, 5.4 Hz, 1H), 3.85 (s, 3H), 3.12 (m, 1H), 3.03 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 164.6, 148.2, 147.7, 135.1, 130.8, 121.4, 119.2, 108.4, 105.7, 
101.3, 87.7, 53.8, 33.9; IR (film, cm
-1
): 2959, 2901, 2782, 1756, 1671, 1607, 1557, 1504, 1447, 
1040, 927, 734; HRMS (ESI) m/z calculated for C13H14NO6 [M+H]
+
: 280.0821, found 280.0822. 
 
 
(E)-methyl 2-nitro-5-(1-oxo-2,3-dihydro-1H-inden-5-yl)pent-4-
enoate [38]: 5-allylindanone (110.5 mg, 77.9% pure, 0.5 mmol, 1.0 
equiv) was reacted for 24h following the general procedure. By 
1
H 
NMR analysis of the crude product, the linear:branched ratio was 12:1 and the E/Z isomer ratio 
was >20:1. Flash chromatography (0.8% MeOH/CH2Cl2), followed by flash chromatography 
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(30→45% EtOAc/hexanes gradient) yielded linear product contaminated by ca. 6% methyl 6-(1-
oxo-2,3-dihydro-1H-inden-5-yl)-5,6-dihydro-4H-1,2-oxazine-3-carboxylate as a light yellow oil. 
A pure spectroscopic sample was obtained by column chromatography (20% EtOAc/hexanes). 
Run 1 (82.6 mg, 0.286 mmol, 57% yield); run 2 (55.0 mg, 0.190 mmol, 0.300 mmol scale, 63% 
yield); run 3 (24.4 mg, 0.0843 mmol, 0.127 mmol scale, 66%). Average yield: 62%. 
1
H NMR 
(500 MHz, CDCl3) δ 7.69 (d, J = 8.1 Hz, 1H), 7.41 (s, 1H), 7.34 (d, J = 7.8 Hz, 1H), 6.62 (d, J = 
15.9 Hz, 1H), 6.26 (dt, J = 15.8, 7.3 Hz, 1H), 5.26 (dd, J = 9.0, 5.4 Hz, 1H), 3.87 (s, 3H), 3.20 
(m, 1H), 3.11 (m, 3H), 2.70 (m, 2H); 
13
C NMR (125 MHz, CDCl3) 206.5, 164.4, 155.9, 142.5, 
136.8, 134.9, 125.9, 124.7, 124.5, 124.1, 87.3, 53.9, 36.6, 33.9, 25.8; IR (film, cm
-1
): 2959, 2928, 
2851, 1758, 1704, 1608, 1571, 1557, 1439, 1277, 1032, 973; HRMS (ESI) m/z calculated for 
C15H16NO5 [M+H]
+
: 290.1028, found 290.1016. 
 
 
(E)-methyl 2-nitro-5-(1-oxo-1,3-dihydroisobenzofuran-5-
yl)pent-4-enoate [39]: 5-allylphthalide (113.1 mg, 77.0% pure, 0.5 
mmol, 1.0 equiv) was reacted for 24h following the general 
procedure. [NOTE: The substrate contained 23% 5-(prop-1-enyl)phthalide, which was inert 
under standard alkylation conditions. In run 1 this material was re-isolated following the reaction 
(25.8 mg, 99%).] By 
1
H NMR analysis of the crude product, the linear:branched ratio was 15:1 
and the E/Z isomer ratio was >20:1. Flash chromatography (1% MeOH/CH2Cl2), followed by 
flash chromatography (40% EtOAc/hexanes) yielded linear product contaminated by ca. 8% 
methyl 6-(1-oxo-1,3-dihydroisobenzofuran-5-yl)-5,6-dihydro-4H-1,2-oxazine-3-carboxylate as a 
light yellow oil. A pure spectroscopic sample was obtained by column chromatography (25% 
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EtOAc/hexanes). Run 1 (94.5 mg, 0.324 mmol, 65% yield); run 2 (104.4 mg, 0.358 mmol, 72% 
yield); run 3 (38.7 mg, 0.133 mmol, 0.180 mmol scale, 74% yield). Average yield: 70%. 
1
H 
NMR (500 MHz, CDCl3) δ 7.86 (d, J = 8.1 Hz, 1H), 7.49 (d, J = 7.8 Hz, 1H), 7.42 (s, 1H), 6.66 
(d, J = 15.9 Hz, 1H), 6.29 (dt, J = 15.7, 7.3 Hz, 1H), 5.30 (s, 2H), 5.27 (dd, J = 9.3, 5.4 Hz, 1H), 
3.87 (s, 3H), 3.21 (m, 1H), 3.12 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 170.8, 164.3, 147.4, 
142.2, 134.4, 127.6, 126.2, 125.5, 125.3, 119.8, 87.2, 69.6, 54.0, 33.8; IR (film, cm
-1
): 2961, 
2921, 2852, 1755, 1746, 1618, 1562, 1438, 1211, 1047, 1005; HRMS (ESI) m/z calculated for 
C14H14NO6 [M+H]
+
: 292.0821, found 292.0816. 
 
(E)-methyl 3-methoxy-5-(5-methoxy-4-nitro-5-oxopent-1-
enyl)-2-(trifluoromethylsulfonyloxy)benzoate [40]: Methyl 5-
allyl-3-methoxy-2-(trifluoromethylsulfonyloxy)benzoate (177.2 
mg, 0.5 mmol, 1.0 equiv) was reacted for 24h following the general procedure. By 
1
H NMR 
analysis of the crude product, the linear:branched ratio was 7.2:1 and the E/Z isomer ratio was 
>20:1. Flash chromatography (32% EtOAc/hexanes) yielded linear product contaminated by ca. 
8% methyl 6-(3-methoxy-5-(methoxycarbonyl)-4-(trifluoromethylsulfonyloxy)phenyl)-5,6-
dihydro-4H-1,2-oxazine-3-carboxylate as a light yellow oil. A pure spectroscopic sample was 
obtained by column chromatography (20% EtOAc/hexanes). Run 1 (146.3 mg, 0.310 mmol, 62% 
yield); run 2 (149.5 mg, 0.317 mmol, 63% yield). Average yield: 63%. 
1
H NMR (500 MHz, 
CDCl3) δ 7.53 (d, J = 2.2 Hz, 1H), 7.10 (d, J = 2.0 Hz, 1H), 6.54 (d, J = 15.6 Hz, 1H), 6.19 (dt, J 
= 15.8, 7.3 Hz, 1H), 5.25 (dd, J = 9.3, 5.4 Hz, 1H), 3.95 (s, 3H), 3.93 (s, 3H), 3.87 (s, 3H), 3.19 
(m, 1H), 3.10 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 164.4, 164.3, 152.0, 137.0, 136.9, 133.4, 
125.8, 124.7, 121.2, 118.8 (q, JCF = 320.8 Hz), 114.2, 87.2, 56.6, 54.0, 52.9, 33.7; 
19
F NMR (470 
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MHz, CDCl3) -73.8; IR (film, cm
-1
): 3017, 2958, 2851, 2260, 1758, 1732, 1564, 1425, 1219, 
1136, 1067, 911, 878, 735; HRMS (ESI) m/z calculated for C16H17NO10SF3 [M+H]
+
: 472.0525, 
found 472.0533. 
 
(E)-methyl 5-(3-methoxy-4-
(trifluoromethylsulfonyloxy)phenyl)-2-nitropent-4-enoate [41]: 
eugenol trifluoromethanesulfonate (88.9 mg, 0.3 mmol, 1.0 equiv) was reacted for 24h following 
the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched ratio was 
4.8:1 and the E/Z isomer ratio was >20:1. Flash chromatography (30% EtOAc/hexanes), 
followed by flash chromatography (10% CH2Cl2/toluene), followed by flash chromatography 
(15→40% EtOAc/hexanes gradient) yielded pure linear product as a light yellow oil. Run 1 (78.3 
mg, 0.189 mmol, 63% yield); run 2 (81.3 mg, 0.197 mmol, 66% yield). Average yield: 64%. 
1
H 
NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.4 Hz, 1H), 6.94 (m, 2H), 6.53 (d, J = 15.9 Hz, 1H), 
6.11 (dt, J = 15.7, 7.3 Hz, 1H), 5.26 (dd, J = 9.2, 5.1 Hz, 1H), 3.92 (s, 3H), 3.86 (s, 3H), 3.17 (m, 
1H), 3.08 (m, 1H); 
13
C NMR (125 MHz, CDCl3) 164.4, 151.6, 138.4, 137.7, 134.2, 123.5, 122.7, 
119.1, 118.8 (q, JCF = 306.6 Hz), 110.9, 87.3, 56.3, 53.9, 33.7; 
19
F NMR (470 MHz, CDCl3) 
‒74.1; IR (film, cm-1): 3017, 2960, 2850, 1759, 1602, 1567, 1423, 1212, 1139, 1108, 884, 740; 
HRMS (ESI) m/z calculated for C14H14NO8SF3Na [M+Na]
+
: 436.0290, found 436.0284. 
 
(E)-methyl 5-(3-(2H-benzo[d][1,2,3]triazol-2-yl)-2-(tert-
butyldiphenylsilyloxy)-5-methylphenyl)-2-nitropent-4-
enoate [42]: 2-(3-allyl-2-(tert-butyldiphenylsilyloxy)-5-
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methylphenyl)-2H-benzo[d][1,2,3]triazole (151.1 mg, 0.3 mmol, 1.0 equiv) was reacted for 24h 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 5.5:1 and the E/Z isomer ratio was >20:1. Flash chromatography (15% 
EtOAc/hexanes) yielded pure linear product as a light yellow solid. Run 1 (129.3 mg, 0.208 
mmol, 69% yield); run 2 (123.1 mg, 0.198 mmol, 66% yield). Average yield: 68%. 
1
H NMR 
(500 MHz, CDCl3) δ 7.60 (m, 2H), 7.46 (m, 4H), 7.33 (m, 5H), 7.20 (m, 5H), 6.80 (d, J = 15.9 
Hz, 1H), 5.70 (dt, J = 15.8, 7.1 Hz, 1H), 4.78 (dd, J = 9.0, 5.6 Hz, 1H), 3.83 (s, 3H), 2.72 (m, 
1H), 2.60 (m, 1H), 2.31 (s, 3H), 0.72 (s, 9H); 
13
C NMR (125 MHz, CDCl3) 164.5, 144.9, 144.7, 
135.1, 132.4, 132.2, 132.1, 131.5, 130.1, 129.8, 128.8, 127.7, 127.5, 126.7, 122.9, 118.3, 87.2, 
53.8, 33.6, 26.1, 20.5, 20.0; IR (film, cm
-1
): 3073, 2957, 2933, 2858, 1962, 1906, 1758, 1564, 
1478, 1429, 1272, 1114, 911, 736; HRMS (ESI) m/z calculated for C35H37N4O5Si [M+H]
+
: 
621.2533, found 621.2521. 
 
Methyl 3-(1H-indol-3-yl)-2-nitropent-4-enoate [43]: 3-allylindole (78.6 mg, 
0.5 mmol, 1.0 equiv) was reacted for 24h following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched ratio was 1:4.7. Flash 
chromatography (25% EtOAc/hexanes), followed by repeated extractions as necessary to remove 
methyl nitroacetate (sat. aq. NaHCO3), yielded pure branched product as a dark yellow oil as a 
1.2:1 mixture of diastereomers. Spectroscopic samples of each diastereomer were obtained by 
flash chromatography (20% EtOAc/hexanes). Run 1 (59.2 mg, 0.216 mmol, 43% yield); run 2 
(54.7 mg, 0.199 mmol, 40% yield). Average yield: 42%. Nonpolar diastereomer*: 
1
H NMR 
(500 MHz, CDCl3) δ 8.12 (bs, 1H), 7.63 (d, J = 7.9 Hz, 1H), 7.37 (d, J = 8.1 Hz, 1H), 7.22 (m, 
1H), 7.15 (m, 2H), 6.13 (ddd, J = 17.1, 10.1, 8.1 Hz, 1H), 5.62 (d, J = 10.1 Hz, 1H), 5.29 (d, J = 
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16.9 Hz, 1H), 5.22 (d, J = 10.1 Hz, 1H), 4.73 (ap t, J = 9.1 Hz, 1H), 3.82 (s, 3H); 
13
C NMR (125 
MHz, CDCl3) 164.0, 136.4, 133.8, 125.9, 122.8, 122.6, 120.2, 119.1, 119.0, 111.7 (2C), 90.8, 
53.6, 43.4; IR (film, cm
-1
): 3420, 3058, 2956, 2926, 2855, 1756, 1567, 1458, 1365, 1266, 1173, 
933, 741; HRMS (ESI) m/z calculated for C14H15N2O4 [M+H]
+
: 275.1032, found 275.1021. 
Polar diastereomer*: 
1
H NMR (400 MHz, CDCl3) δ 8.14 (bs, 1H), 7.64 (d, J = 7.6 Hz, 1H), 7.38 
(d, J = 7.8 Hz, 1H), 7.23 (m, 1H), 7.17 (m, 1H), 7.12 (d, J = 2.4 Hz, 1H), 6.20 (ddd, J = 17.0, 
10.2, 8.1 Hz, 1H), 5.59 (d, J = 9.5 Hz, 1H), 5.30 (d, J = 17.1 Hz, 1H), 5.23 (d, J = 10.0 Hz, 1H), 
4.71 (ap t, J = 8.9 Hz, 1H), 3.56 (s, 3H); 
13
C NMR (125 MHz, CDCl3) 163.8, 136.3, 134.3, 
125.9, 122.9, 122.8, 120.2, 118.9, 118.7, 111.6, 111.1, 91.2, 53.5, 42.7; IR (film, cm
-1
): 3419, 
3056, 2956, 2930, 2851, 1751, 1557, 1458, 1368, 1173, 744; HRMS (ESI) m/z calculated for 
C14H15N2O4 [M+H]
+
: 275.1032, found 275.1028.  
*By correlating the 
1
H NMR chemical shift of the methyl ester to previously reported data, it can 
be suggested that the configuration of the nonpolar diastereomer is anti (R,R) + (S,S) and the 
polar diastereomer is syn (R,S) + (S,R).  See: a) Sui, Y.; Liu, L.; Zhao, J.-L.; Wang, D.; Chen, Y.-
J. Tetrahedron, 2007, 63, 5173. b) Behforouz, M.; Zarrinmayeh, H.; Ogle, M. E.; Riehle, T. J.; 
Bell, F. W. J. Heterocyclic Chem. 1988, 25, 1627. 
 
Methyl 3-(4-methoxyphenyl)-2-nitropent-4-enoate: 4-allylanisole 
(74.1 mg, 0.5 mmol, 1.0 equiv) was reacted for 24h following the general 
procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 1.7:1. Flash chromatography (20% EtOAc/hexanes) yielded pure branched product as a 
yellow oil as a 1.2:1 mixture of diastereomers. Run 1 (45.4 mg, 0.171 mmol, 34% yield). 
1
H 
NMR (500 MHz, CDCl3) Major diastereomer: δ 7.16 (m, 2H), 6.86 (m, 2H), 6.04 (ddd, J = 17.0, 
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10.3, 8.2 Hz, 1H), 5.40 (d, J = 8.1 Hz, 1H), 5.20 (m, 2H), 4.32 (m, 1H), 3.79 (s, 3H), 3.60 (s, 
3H); Diagnostic peaks for minor diastereomer: 5.95 (ddd, J = 17.1, 10.0, 8.3, 1H), 5.42 (d, J = 
8.3 Hz, 1H), 3.83 (s, 3H), 3.78 (s, 3H),; 
13
C NMR (125 MHz, CDCl3) Mixture of diastereomers: 
163.8, 163.5, 159.4, 134.8, 134.4, 129.4, 129.0, 128.9, 128.2, 118.9, 118.8, 114.6, 114.5, 91.6, 
91.5, 55.4, 53.6, 53.5, 50.4, 50.1; IR (film, cm
-1
): 3008, 2958, 2839, 2258, 2056, 1882, 1756, 
1611, 1562, 1514, 1252, 1181, 1034, 912, 735; HRMS (ESI) m/z calculated for C13H15NO5Na 
[M+Na]
+
: 288.0848, found 288.0835. 
 
Methyl 3-(3-(2H-benzo[d][1,2,3]triazol-2-yl)-2-(tert-
butyldiphenylsilyloxy)-5-methylphenyl)-2-nitropent-4-enoate: 2-
(3-allyl-2-(tert-butyldiphenylsilyloxy)-5-methylphenyl)-2H-
benzo[d][1,2,3]triazole (151.1 mg, 0.3 mmol, 1.0 equiv) was reacted 
for 24h following the general procedure. By 
1
H NMR analysis of the crude product, the 
linear:branched ratio was 5.5:1 and the E/Z isomer ratio was >20:1. Flash chromatography (15% 
EtOAc/hexanes) yielded pure branched product as a light yellow oil as a 1.4:1 mixture of 
diastereomers. 
1
H NMR (500 MHz, CDCl3) Major diastereomer: δ 7.53 (m, 2H), 7.38-7.03 (m, 
14H), 6.07 (m, 1H), 5.51 (d, J = 6.8 Hz, 1H), 5.34 (m, 1H), 5.30 (m, 1H), 5.16 (m, 1H), 3.76 (s, 
3H), 2.32 (s, 3H), 0.94 (s, 9H); Diagnostic peaks for minor diastereomer: δ 7.47 (m, 2H), 5.53 
(d, J = 7.6 Hz, 1H), 5.49 (m, 1H), 3.84 (s, 3H);
13
C NMR (125 MHz, CDCl3) Mixture of 
diastereomers: 163.6, 144.7, 144.6, 135.3, 134.8, 134.4, 134.3, 134.1, 133.7, 131.8, 131.7, 131.5, 
130.7, 129.6, 129.5, 129.4, 129.4, 129.3, 127.9, 127.3, 127.2, 127.1, 126.5, 126.3, 120.1, 119.4, 
118.2, 118.2, 91.3, 90.3, 53.8, 42.5, 42.4, 26.5, 26.4, 20.6, 20.3; IR (film, cm
-1
): 3073, 2963, 
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2930, 2857, 1889, 1758, 1566, 1486, 1116, 913, 702; HRMS (ESI) m/z calculated for 
C35H37N4O5Si [M+H]
+
: 621.2533, found 621.2530.  
 
Nucleophile scope of the allylic C-H alkylation reaction 
 
(E)-2-nitro-1,5-diphenylpent-4-en-1-one [47]: Allylbenzene (355 
mg, 3.0 mmol, 1.0 equiv) and benzoylnitromethane (1.49 g, 9.0 mmol, 
3.0 equiv) were reacted for 24h following the general procedure. By 
1
H NMR analysis of the 
crude product, the linear:branched ratio was 7:1 and the E/Z isomer ratio was >20:1. Flash 
chromatography (15% EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 
(526 mg, 1.87 mmol, 62% yield). 
1
H NMR (500 MHz, CDCl3) δ 7.99 (m, 2H), 7.67 (m, 1H), 
7.54 (m, 2H), 7.30 (m, 4H), 7.24 (m, 1H), 6.56 (d, J = 15.9 Hz, 1H), 6.17 (dd, J = 9.0, 5.1 Hz, 
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1H), 6.13 (dt, J = 15.7, 7.2 Hz, 1H), 3.26 (dddd, J = 15.1, 8.9, 7.6, 1.3 Hz, 1H), 3.08 (dddd, J = 
15.0, 6.8, 5.2, 1.5 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) 188.4, 136.4, 135.4, 135.0, 134.0, 
129.4, 129.0, 128.8, 128.1, 126.5, 121.7, 89.3, 34.2; IR (film, cm
-1
): 3064, 3027, 2922, 1695, 
1559, 1449, 967; HRMS (ESI) m/z calculated for C17H15NO3Na [M+Na]
+
: 304.0950, found 
304.0941.  
(E)-(4-nitro-4-(phenylsulfonyl)but-1-enyl)benzene [48]: 
Allylbenzene (59.1 mg, 0.5 mmol, 1.0 equiv), 
(phenylsulfonyl)nitromethane (301.8 mg, 1.5 mmol, 3.0 equiv) and 1,2-
bis(benzylsulfinyl)ethane/Pd(OAc)2 49 (26.5 mg, 0.05 mmol, 0.1 equiv) were reacted for 24h 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 13:1 and the E/Z isomer ratio was >20:1. Flash chromatography (20% EtOAc/hexanes) 
yielded pure linear product as a light yellow oil. Run 1 (101.0 mg, 0.318 mmol, 64% yield). 
1
H 
NMR (500 MHz, CDCl3) δ 7.93 (m, 2H), 7.80 (m, 1H), 7.65 (m, 2H), 7.29 (m, 4H), 7.24 (m, 
1H), 6.54 (d, J = 15.6 Hz, 1H), 5.97 (ddd, J = 15.7, 7.8, 6.7 Hz, 1H), 5.59 (dd, J = 11.2, 3.4 Hz, 
1H), 3.22 (dddd, J = 14.9, 6.4, 3.5, 1.4 Hz, 1H), 3.12 (dddd, J = 15.0, 11.2, 7.9, 1.1 Hz, 1H); 
13
C 
NMR (125 MHz, CDCl3) 136.6, 135.9, 135.7, 134.0, 130.1, 129.7, 128.7, 128.4, 126.5, 119.0, 
101.4, 31.5; IR (film, cm
-1
): 3063, 3031, 2981, 2929, 2258, 1562, 1449, 1342, 1158, 909, 732, 
689; HRMS (ESI) m/z calculated for C16H15NO4SNa [M+Na]
+
: 340.0620, found 340.0629. 
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(E)-methyl 2-amino-5-phenylpent-4-enoate [50]:
38
 A 2 dram 
borosilicate vial was charged with (E)-methyl 2-nitro-5-phenylpent-4-
enoate (47.0 mg, 0.2 mmol, 1.0 equiv) and a stir bar. To the vial was added MeOH (2.0 mL, 
0.10M) and concentrated HCl (392 μL, 4.0 mmol, 20 equiv). The vial was placed in a 20°C 
water bath and zinc dust (524 mg, 8.0 mmol, 40 equiv) was added slowly with vigorous stirring. 
The reaction vial was capped and stirred for 20 min at room temperature. The reaction was 
diluted with saturated aqueous NaHCO3 (40 mL—CAUTION: gas evolves) and extracted with 
ethyl acetate (3 x 30 mL). The combined organics were dried over MgSO4. The mixture was 
filtered and concentrated in vacuo. Purification by flash chromatography (SiO2, 1% MeOH, 0.5% 
NH4OH/CH2Cl2) provided the pure product. Run 1 (40.6 mg, 0.198 mmol, 99%); run 2 (40.9 mg, 
0.199 mmol, 99%). Average yield: 99%. 
1
H NMR (500 MHz, CDCl3) δ 7.36 (m, 2H), 7.30 (m, 
2H), 7.22 (m, 1H), 6.50 (d, J = 15.9 Hz, 1H), 6.14 (dt, J = 15.7, 7.4 Hz, 1H), 3.75 (s, 3H), 3.63 
(dd, J = 7.2, 5.2 Hz, 1H), 2.66 (m, 1H), 2.55 (m, 1H) 1.57 (bs, 2H); 
13
C NMR (125 MHz, CDCl3) 
175.8, 137.1, 133.8, 128.6, 127.5, 126.3, 124.9, 54.4, 52.2, 38.6; IR (film, cm
-1
): 3381, 3059, 
3027, 2951, 2848, 1745, 1438, 1201, 968, 744, 695; HRMS (ESI) m/z calculated for C12H16NO2 
[M+H]
+
: 206.1181, found 206.1176.  
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(+)-(S,E)-methyl 2-nitro-2-((S)-2-nitro-1-phenylethyl)-5-
phenylpent-4-enoate [52]: A ½ dram borosilicate vial was charged 
with (E)-methyl 2-nitro-5-phenylpent-4-enoate (37.9 mg, 0.161 
mmol, 1.0 equiv), catalyst 51 (6.4 mg, 0.0161 mmol, 0.10 equiv), and a stir bar. To the vial was 
added THF (161μL, 1.0M). The flask was stirred for 5 min at -20°C, at which point trans-β-
nitrostyrene was added (48.1 mg, 0.322 mmol, 2.0 equiv). The reaction vial was capped and 
stirred for 72 h at -20°C. By 
1
H NMR analysis of the crude product, the diastereomeric ratio was 
12:1. The reaction solution was transferred with Et2O to a flask and evaporated in vacuo. Flash 
chromatography (9% EtOAc/hexanes) yielded a white solid. By HPLC analysis of the purified 
product (vide infra), the enantiomeric excess was 95% (Chiralcel OD-H, 90:10 hexanes:2-
propanol, tR(major) = 10.59 min., tR(minor) = 16.45 min.). Run 1 (54.6 mg, 0.142 mmol, 88% 
yield); run 2 (53.8 mg, 0.140 mmol, 87% yield). Average yield: 88%. 
1
H NMR (500 MHz, 
CDCl3) δ 7.37 (m, 3H), 7.33 (m, 4H), 7.28 (m, 1H), 7.14 (m, 2H), 6.44 (d, J = 15.6 Hz, 1H), 5.98 
(ddd, J = 15.5, 8.7, 6.5 Hz, 1H), 5.17 (dd, J = 13.9, 2.7 Hz, 1H), 5.02 (dd, J = 13.9, 10.7 Hz, 1H), 
4.48 (dd, J = 10.7, 2.9 Hz, 1H), 3.84 (s, 3H), 2.95 (ddd, J = 14.5, 6.2, 1.6 Hz, 1H), 2.67 (ddd, J = 
14.6, 8.5, 1.0 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) 166.0, 136.7, 136.2, 132.3, 129.7, 129.6, 
128.9, 128.9, 128.4, 126.6, 120.0, 97.1, 77.7, 54.1, 47.7, 38.9; IR (film, cm
-1
): 3030, 2959, 2926, 
1752, 1556, 1378, 1216, 970, 742, 703; HRMS (ESI) m/z calculated for C20H20N2O6Na 
[M+Na]
+: 407.1219, found 407.1219; [α]D
24
 = +114.3° (c = 1.0, CHCl3). 
 
(+)-(S,E)-methyl 5-(4-bromophenyl)-2-nitro-2-((S)-2-nitro-1-
phenylethyl)pent-4-enoate: A ½ dram borosilicate vial was 
charged with (E)-methyl 5-(4-bromophenyl)-2-nitropent-4-enoate 
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(48.5 mg, 0.154 mmol, 1.0 equiv), catalyst 51 (6.2 mg, 0.0154 mmol, 0.10 equiv), and a stir bar. 
To the vial was added THF (154μL, 1.0M). The flask was stirred for 5 min at -20°C, at which 
point trans-β-nitrostyrene was added (46.1 mg, 0.309 mmol, 2.0 equiv). The reaction vial was 
capped and stirred for 72 h at -20°C. By 
1
H NMR analysis of the crude product, the 
diastereomeric ratio was 11:1. The reaction solution was transferred with Et2O to a flask and 
evaporated in vacuo. Flash chromatography (9% EtOAc/hexanes) yielded a white solid. By 
HPLC analysis of the purified product (vide infra), the enantiomeric excess was 81% (Chiralcel 
OD-H, 90:10 hexanes:2-propanol, tR(major) = 12.35 min., tR(minor) = 22.13 min.). Run 1 (51.4 
mg, 0.111 mmol, 72% yield). 
1
H NMR (500 MHz, CDCl3) δ 7.45 (d, J = 8.6 Hz, 2H), 7.37 (m, 
3H), 7.19 (d, J = 8.4 Hz, 2H), 7.12 (m, 2H), 6.37 (d, J = 15.9 Hz, 1H), 5.98 (ddd, J = 15.7, 8.6, 
6.4 Hz, 1H), 5.15 (dd, J = 13.9, 2.8 Hz, 1H), 5.02 (dd, J = 13.9, 10.7 Hz, 1H), 4.46 (dd, J = 10.7, 
2.8 Hz, 1H), 3.83 (s, 3H), 2.92 (ddd, J = 14.8, 6.2, 1.5 Hz, 1H), 2.65 (dd, J = 14.8, 8.6 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) 166.0, 135.4, 135.1, 132.2, 132.0, 129.8, 129.6, 128.9, 128.0, 
122.3, 121.0, 97.1, 77.6, 54.2, 47.9, 38.9; IR (film, cm
-1
): 2958, 2925, 1753, 1556, 1488, 1378, 
1216, 1073, 703; HRMS (ESI) m/z calculated for C20H19N2O6BrNa [M+Na]
+
: 485.0324, found 
485.0314; [α]D
24
 = +95.6° (c = 1.0, CHCl3).  
 
Enantiomeric Excess 
 
Enantiopurity of the product 52 was determined by HPLC analysis 
with a Daicel Chemical Industries, Ltd. Chiralcel OD-H 0.46 cm x 25 
cm column. A flow rate of 1.0 mL/min at 25.0°C with 90:10 
hexanes:2-propanol with detection at 254 nm gave the major enantiomer at 10.59 min and the 
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minor enantiomer at 16.45 min. Enantiopurity was determined to be 95%. Relative and absolute 
stereochemistry of the product was assigned by analogy to (+)-(S,E)-methyl 5-(4-bromophenyl)-
2-nitro-2-((S)-2-nitro-1-phenylethyl)pent-4-enoate (vide infra). 
 
Enantiopurity of the product was determined by HPLC analysis 
with a Daicel Chemical Industries, Ltd. Chiralcel OD-H 0.46 cm 
x 25 cm column. A flow rate of 1.0 mL/min at 25.0°C with 90:10 
hexanes:2-propanol with detection at 260 nm gave the major enantiomer at 12.35 min and the 
minor enantiomer at 22.13 min. Enantiopurity was determined to be 81%. Relative and absolute 
stereochemistry of the product was determined by x-ray crystallographic analysis of a single 
crystal obtained by recrystallization from acetone. The x-ray data crystal was determined to 
contain the major enantiomer by direct HPLC analysis. The crystal was transferred from the 
mount to a glass insert (National Scientific, part no. C4010-S630) and dissolved in 15μL 2-
propanol. HPLC analysis (vide supra) confirmed the crystal to be the major enantiomer. 
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FIGURE 14. Structure of (+)-(S,E)-methyl 5-(4-bromophenyl)-2-nitro-2-((S)-2-nitro-1-
phenylethyl)pent-4-enoate. 
Crystal data and structure refinement for ba67bas. 
Identification code  ba67bas 
Empirical formula  C20 H19 Br N2 O6 
Formula weight  463.28 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21  
Unit cell dimensions a = 6.0498(2) Å a= 90°. 
 b = 18.4635(6) Å b= 90°. 
 c = 18.5718(5) Å g = 90°. 
Volume 2074.48(11) Å3 
Z 4 
Density (calculated) 1.483 Mg/m3 
Absorption coefficient 2.020 mm-1 
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F(000) 944 
Crystal size 0.50 x 0.06 x 0.06 mm3 
Theta range for data collection 1.56 to 25.45°. 
Index ranges -7<=h<=7, -22<=k<=22, -22<=l<=21 
Reflections collected 25713 
Independent reflections 3844 [R(int) = 0.0478] 
Completeness to theta = 25.45° 99.8 %  
Absorption correction Integration 
Max. and min. transmission 0.8933 and 0.4228 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3844 / 0 / 319 
Goodness-of-fit on F2 1.018 
Final R indices [I>2sigma(I)] R1 = 0.0313, wR2 = 0.0583 
R indices (all data) R1 = 0.0488, wR2 = 0.0624 
Absolute structure parameter -0.003(7) 
Largest diff. peak and hole 0.319 and -0.508 e.Å-3 
 
Racemic standards: 
 
Major diastereomer was isolated pure following column chromatography (9% EtOAc/hexanes). 
 
Starting Materials 
 
General procedure for allylation of aryl halides:
39
 An oven-dried 10 mL Schlenk flask under 
argon atmosphere was charged with Pd(dba)2 (34.5 mg, 0.060 mmol, 0.03 equiv), PCy3 (33.7 
mg, 0.12 mmol, 0.06 equiv), CsF (668 mg, 4.40 mmol, 2.2 equiv), aryl halide (2.00 mmol, 1 
equiv), and a stir bar. Allyltributyltin (644 μL, 2.10 mmol, 1.05 equiv) and dioxane (2 mL, 1.0M) 
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were added via syringe. The mixture was stirred and heated to 80-100°C. Conversion was 
monitored by GC. When complete consumption of aryl halide was observed (8-24 h), the 
reaction was cooled to room temperature. The reaction mixture was diluted with saturated 
aqueous NH4Cl (40 mL) and extracted with diethyl ether (2 x 40 mL). The combined organics 
were dried over MgSO4. The mixture was filtered and concentrated in vacuo. Purification by 
flash chromatography (SiO2, Et2O/pentane mixtures) provided the pure product.  
NOTE: In some cases isomerization was observed, yielding small amounts of internal olefin 
product [characteristic peaks, 
1
H NMR: 6.4 (m, 2H), 1.9 (d, 3H)]. This isomer was generally not 
separable from the desired allyl compound by column chromatography. However, the internal 
isomer was unreactive under standard allylic alkylation conditions and could be recovered 
quantitatively from the reaction mixture. 
 
Spectral data for known compounds: 
1-allyl-4-fluorobenzene
40
 
N-(4-allylphenyl)-N,4-dimethylbenzenesulfonamide
41
 
1-allyl-4-(trifluoromethyl)benzene
42
 
Methyl 4-allylbenzoate
43
 
1-allyl-4-methylbenzene
44
 
4-allylbenzonitrile
45
 
1-(4-allylphenyl)ethanone
42
 
1-allyl-4-bromobenzene
46
 
1-allyl-3-methoxybenzene
42
 
1-allyl-2-methylbenzene
47
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1-allyl-2-(trifluoromethyl)benzene
48
 
(2-allylphenoxy)(tert-butyl)dimethylsilane
49
 
2-allylphenyl trifluoromethanesulfonate
50
 
2-allylnaphthalene
42
 
3-allylindole
51
 
 
3-allyl-N-(diphenylmethylene)aniline: 
1
H NMR (500 MHz, CDCl3) δ 
7.74 (m, 2H), 7.47 (m, 1H), 7.40 (m, 2H), 7.25 (m, 2H), 7.11 (m, 2H), 
7.06 (t, J = 7.6 Hz, 1H), 6.74 (d, J = 7.7 Hz, 1H), 6.57 (m, 2H), 5.80 (ddt, J = 16.9, 10.2, 6.6 Hz, 
1H), 4.95 (dd, J = 10.1, 1.7 Hz, 1H), 4.88 (dd, J = 17.0, 1.8 Hz, 1H), 3.23 (d, J = 6.4 Hz, 2H); 
13
C NMR (125 MHz, CDCl3) 168.3, 151.4, 140.4, 139.8, 137.5, 136.4, 130.8, 129.6, 129.4, 
128.6, 128.6, 128.3, 128.0, 123.7, 121.5, 118.9, 115.7, 40.1; IR (film, cm
-1
): 3081, 3061, 3039, 
3023, 2978, 1621, 1595, 1578, 1447, 1317, 911, 734, 696; HRMS (ESI) m/z calculated for 
C22H20N [M+H]
+
: 298.1596, found 298.1601. 
Methyl 5-allyl-3-methoxy-2-(trifluoromethylsulfonyloxy)benzoate: 
1
H 
NMR (500 MHz, CDCl3) δ 7.39 (d, J = 2.0 Hz, 1H), 7.01 (d, J = 2.0 Hz, 
1H), 5.93 (ddt, J = 16.8, 10.2, 6.8 Hz, 1H), 5.15 (m, 2H), 3.94 (s, 3H), 
3.91 (s, 3H), 3.42 (d, J = 6.5 Hz, 2H); 
13
C NMR (125 MHz, CDCl3) 164.7, 151.7, 141.3, 136.0, 
135.7, 125.3, 123.1, 118.8 (q, JCF = 320.4 Hz), 117.6, 117.1, 56.5, 52.8, 39.9; 
19
F NMR (470 
MHz, CDCl3) –73.9; IR (film, cm
-1
): 3088, 3015, 2957, 2850, 1731, 1595, 1425, 1339, 1209, 
1068, 878, 787; HRMS (ESI) m/z calculated for C13H14O6F3S [M+H]
+
: 355.0463, found 
355.0455. 
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2-(3-allyl-2-(tert-butyldiphenylsilyloxy)-5-methylphenyl)-2H-
benzo[d][1,2,3]triazole: 
1
H NMR (400 MHz, CDCl3) δ 7.47-7.41 (m, 
6H), 7.32-7.23 (m, 5H), 7.16 (m, 4H), 7.03 (d, J = 2.0 Hz, 1H), 5.73 
(ddt, J = 16.9, 10.1, 6.6 Hz, 1H), 5.05 (dd, J = 10.0, 1.7 Hz, 1H), 4.98 
(dd, J = 17.1, 1.7 Hz, 1H), 3.34 (d, J = 6.6 Hz, 2H), 2.29 (s, 3H), 0.79 (s, 9H); 
13
C NMR (125 
MHz, CDCl3) 144.8, 136.4, 135.0, 132.6, 132.4, 132.0, 131.8, 131.2, 129.6, 127.2, 126.4, 126.2, 
118.3, 116.6, 35.2, 26.3, 20.5, 20.1; IR (film, cm
-1
): 3076, 2933, 2859, 1485, 1274, 1115, 910, 
718; HRMS (ESI) m/z calculated for C32H34N3OSi [M+H]
+
: 504.2471, found 504.2478. 
4-allyl-2-methoxyphenyl trifluoromethanesulfonate: 
1
H NMR (500 MHz, 
CDCl3) δ 7.13 (d, J = 8.1 Hz, 1H), 6.85 (d, J = 1.9 Hz, 1H), 6.79 (dd, J = 
8.2, 2.0 Hz, 1H), 5.94 (m, 1H), 5.12 (m, 2H), 3.90 (s, 3H), 3.39 (d, J = 6.6 Hz, 2H); 
13
C NMR 
(125 MHz, CDCl3) 151.3, 141.9, 137.2, 136.4, 122.3, 120.9, 118.9 (q, JCF = 320.3 Hz), 116.9, 
113.5, 56.2, 40.1; 
19
F NMR (470 MHz, CDCl3) –74.2; IR (film, cm
-1
): 3084, 3018, 2982, 2944, 
2920, 2849, 1640, 1607, 1504, 1422, 1211, 1142, 1108, 879, 619; HRMS (EI) m/z calculated for 
C11H11F3O4S [M]
+
: 296.0330, found 296.0331. 
5-allyl-2,3-dihydro-1H-inden-1-one: 
1
H NMR (500 MHz, CDCl3) δ 7.69 (d, 
J = 7.7 Hz, 1H), 7.30 (bs, 1H), 7.21 (d, J = 7.9 Hz, 1H), 5.96 (m, 1H), 5.12 
(m, 2H), 3.47 (d, J = 6.6 Hz, 2H), 3.11 (m, 2H), 2.69 (m, 2H); 
13
C NMR (125 MHz, CDCl3) 
206.8, 155.9, 147.8, 136.4, 135.5, 128.3, 126.7, 123.8, 116.9, 40.6, 36.5, 25.8; IR (film, cm
-1
): 
3076, 3018, 2928, 2858, 1711, 1608, 1435, 1287, 1031, 917, 756, 733; HRMS (ESI) m/z 
calculated for C12H13O [M+H]
+
: 173.0966, found 173.0960. 
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5-allylisobenzofuran-1(3H)-one: 
1
H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 
7.8 Hz, 1H), 7.34 (d, J = 7.8 Hz, 1H), 7.30 (bs, 1H), 5.94 (ddt, J = 16.9, 10.2, 
6.7 Hz, 1H), 5.26 (s, 2H), 5.11 (m, 2H), 3.50 (d, J = 6.6 Hz, 2H); 
13
C NMR (125 MHz, CDCl3) 
171.1, 147.4, 147.3, 136.0, 129.9, 125.7, 123.8, 122.1, 117.3, 69.6, 40.4; IR (film, cm
-1
): 3079, 
3022, 2979, 2941, 2879, 2254, 1764, 1621, 1440, 1360, 1241, 1121, 1049, 1003, 920, 751; 
HRMS (ESI) m/z calculated for C11H11O2 [M+H]
+
: 175.0759, found 175.0743. 
1-allyl-4-vinylbenzene: 
1
H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 8.1 Hz, 
2H), 7.15 (d, J = 8.1 Hz, 2H), 6.70 (dd, J = 17.6, 10.7 Hz, 1H), 5.96 (ddt, J = 
16.9, 10.2, 6.7 Hz, 1H), 5.71 (dd, J = 17.6, 1.0 Hz, 1H), 5.20 (dd, J = 10.8, 0.9 Hz, 1H), 5.08 (m, 
2H), 3.38 (d, J = 6.8 Hz, 2H); 
13
C NMR (125 MHz, CDCl3) 139.9, 137.4, 136.8, 135.7, 128.9, 
126.4, 116.0, 113.3, 40.1; IR (film, cm
-1
): 3083, 3007, 2979, 2909, 2852, 1909, 1821, 1639, 
1511, 1406, 990, 908, 822; HRMS (EI) m/z calculated for C11H12 [M]
+
: 144.0939, found 
144.0941. 
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CHAPTER 2 
ALLYLIC C-H ALKYLATION OF UNACTIVATED -OLEFINS: SERIAL LIGAND 
CATALYSIS RESUMED 
2.1 INTRODUCTION 
The allylic alkylation reaction, the development of which was described in Chapter 1, 
was shown to have excellent functional group tolerance and good yields.  However, it was 
observed in the course of exploring the substrate scope that the reaction was limited to allylarene 
substrates.  Olefins with aliphatic substitution were found to react very slowly under these 
conditions, with very low conversion of substrate and only about 10% yield of the desired allylic 
alkylated product recovered after 72 hours of reaction time (Figure 15).  This limitation in 
substrate scope was unexpected because in previous allylic esterification and amination 
reactions,
15-18
 virtually any -olefin substrate could be functionalized in synthetically useful 
yields.   
The two classes of substrate, activated and unactivated olefins, were expected to react at 
different rates—the allylic C-H bond is cleaved in a heterolytic C-H activation step, and the pKa 
in DMSO of the allylic C-H bonds of allylbenzene is 33,
52
 compared to a pKa of 44 for 
unactivated allylic C-H bonds
53—but the difference in overall reactivity was surprising 
nonetheless.  Remarkably, the same effect was observed independently by another team of 
researchers in their efforts to develop a similar allylic C-H alkylation reaction.
14b
  Shi and 
coworkers reported a reaction using an earlier version of our palladium(II)/sulfoxide catalyst, 
complex 49, bearing benzyl substituents in place of phenyl.
15
  The reaction used 1,3-diketone 
nucleophiles to effect allylic alkylation of -olefin substrates (Figure 15).  Despite using 
different reaction conditions (1.4 equiv. nucleophile, 1.3 equiv. benzoquinone, 0.2M toluene, 
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60C, 48h) and different nucleophiles, Shi reported that this reaction too was limited to activated 
allylarene substrates.  The attempted alkylation of unactivated substrates resulted in the isolation 
of methyl ketones from Wacker oxidation rather than the desired allylic functionalization.  
Intrigued by these results, we wondered if this recurring observation of limited substrate scope 
indicated a more general problem for the catalytic reaction, and whether we could identify and 
solve it to discover an allylic C-H alkylation with a truly general substrate scope.
54
 
Figure 15: Substrate scope limitation in allylic C-H alkylation reactions 
 
2.2 RESULTS AND DISCUSSION 
We initially questioned whether one of the basic product forming steps of the catalytic 
cycle, either C-H activation or functionalization, was performing poorly in the allylic C-H 
alkylation.  The relative stability and easy isolation of the -allyl palladium intermediate makes 
it a convenient tool to probe the individual steps of the catalytic cycle.  Stoichiometric model 
studies demonstrated that C-H cleavage promoted by catalyst 1 proceeded smoothly for both 
activated and unactivated substrates to form the -allyl, which was trapped as the chloride dimer 
for the purposes of purification and characterization.  Similarly, beginning from the -allyl, the 
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DMSO mediated functionalization step was found to furnish similar yields of both aromatic and 
aliphatic products (Figure 16).  Although these results did not provide insight to the challenges 
facing the catalytic reaction, they did demonstrate that the basic product forming steps were 
possible and therefore there was no fundamental reason why unactivated substrates could not 
undergo the alkylation reaction. 
Figure 16: Stoichiometric studies of unactivated and activated substrates 
 
Despite the promising foundation of the stoichiometric models, however, we found that 
our efforts to optimize the catalytic conditions provided only meager returns.  After screening 
various nucleophiles, solvents, quinones and additives we were able to obtain no more than a 
25% yield of the desired alkylated product (Figure 17).  Analysis of the crude reaction mixture 
revealed that at the end of the reaction, substantial amounts of substrate, nucleophile and oxidant 
remained.  In addition, palladium metal was observed to precipitate from the reaction mixture 
and form a mirror in the vial.  A more detailed analysis of the time course of the reaction 
revealed that substrate conversion and product formation essentially ceased after 12 hours, an 
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unusually short lifespan for a class of reactions that typically continue for 24-72 hours.  These 
results collectively implied that the catalytic cycle was being inhibited by an unidentified source, 
prematurely deactivating the catalyst and leading to decomposition.  We hoped that if we could 
identify the source of inhibition we might devise a solution to solve the limited substrate scope. 
Figure 17: Low reactivity under optimized catalytic conditions 
 
 
Initially, it appeared possible that the reaction was subject to product inhibition.  The rate 
of reaction slowed substantially after approximately the first catalytic turnover, and by the time 
the ratio of product to catalyst reached 2:1 the reaction had essentially ended.  However, product 
inhibition was conclusively ruled out by catalytic kinetic studies (Figure 18).  The reaction was 
run with known quantities of the product added at time = 0, and the initial rates were measured.  
The reaction was thus shown to be zero order in product, eliminating product inhibition from 
consideration. 
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Figure 18: Catalytic kinetics rule out product inhibition 
 
 
 
In search of another hypothesis to explain the observed inhibition of catalysis, we 
returned to our understanding of the mechanism of the reaction.  In the previously reported 
branched allylic esterification reaction, we had described a rather unusual catalytic cycle we 
called “serial ligand catalysis” (SLC).  This name reflected the fact that the individual steps of 
the catalytic cycle were each promoted by different ligands which coordinate reversibly to the 
palladium catalyst.  The C-H cleavage step was effected by the bis-sulfoxide ligand and the 
functionalization and re-oxidation steps were promoted by benzoquinone (Figure 11).  Notably, 
each ligand was only effective for its particular step; neither ligand was capable of promoting the 
whole catalytic cycle.  Unlike palladium(0) reactions in which a strong phosphine ligand may 
remain bound to the metal throughout the entire cycle, a SLC mechanism relies upon a rapid 
interchange of ligands at palladium in order to achieve catalytic turnover.
55
  Each ligand must 
coordinate to the metal, promote the desired step, and then dissociate in order to make way for 
the ligand which will promote the subsequent step.   
We hypothesized that the allylic C-H alkylation of unactivated -olefins could occur via 
a SLC mechanism (Figure 19).  Specifically, the reaction could proceed as follows: 1) catalytic 
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palladium(II)/bis-sulfoxide-promoted C-H cleavage to furnish a -allyl intermediate, 2) 
stoichiometric DMSO-promoted functionalization through ionization of the -allyl intermediate, 
and 3) re-oxidation of Pd
0
 to Pd
II
 with a quinone. In the previously described C-H alkylation of 
allylarenes we found that the complex formed by Pd(OAc)2 and DMSO was sufficiently active to 
cleave the doubly activated allylic/benzylic C-H bond in the absence of bis-sulfoxide ligands, 
thus obviating the requirement for a SLC mechanism (Table 2, entry 10).  However, unactivated 
allylic C-H bonds may be cleaved only via the much more active Pd/bis-sulfoxide complex.   
The SLC mechanism is characterized by multiple kinetically labile ligands exchanging 
rapidly at palladium in a delicate balance.  We wondered if an overly competitive ligand might 
disrupt the equilibrium required for efficient catalytic turnover.  If one ligand bound the metal 
more strongly than the others, it could potentially disrupt the SLC mechanism by preventing 
subsequent steps in the cycle.  Specifically, we wondered if DMSO, which was present in solvent 
quantities, was out-competing bis-sulfoxide, present in catalytic quantities, for binding to 
palladium acetate (Figure 19).  This could slow the C-H cleavage step, inhibiting the allylic 
alkylation and eventually allowing the catalyst to decompose prior to complete conversion of  
Figure 19: Mechanistic proposal for inhibition of catalysis 
 
72 
 
substrate. 
If it could be verified, competitive ligand binding would be an intriguing explanation for 
the observed inhibition, with potential ramifications beyond the immediate context of allylic 
alkylation.  However, it would prove quite challenging to test.  Because DMSO was posited to 
play both a detrimental role in the C-H cleavage step and a productive role in the 
functionalization step, we found techniques such as catalytic kinetics to be intractably complex.  
In order to probe this theory it would be preferable to develop a method which could disentangle 
the positive and negative effects of DMSO on the reaction.  The most straightforward way to 
detect only the detrimental role for DMSO would be to directly observe the ligands coordinating 
to palladium and to examine how additional DMSO perturbed the equilibrium.  This effort was 
unsuccessful because the binding of palladium(II) acetate/sulfoxide ligand could not be observed 
by any standard spectroscopic technique (see 2.4 Experimental Section).  Infrared, UV-visible 
and NMR spectra all showed no shifts in peaks between the component spectra and the metal-
ligand complex spectra.  Lowering the temperature or changing the ratio of metal to ligand did 
not affect the results.  To account for the possibility of competitive ligand binding at another 
point in the catalytic cycle, we also examined the interaction of the sulfoxides and the -allyl 
intermediate, but once again no binding was observed.  These results indicated that the 
interaction between the metal and the ligand was weak and transient, and that the species 
observed in situ was likely not the active catalyst but rather a resting state.   
In order to probe the hypothesis of competitive ligand binding, we concluded that a more 
indirect approach was needed.  We proposed to use the previously reported branched allylic C-H 
esterification and linear allylic amination reactions as chemical reactivity probes.
16,56
  Both of 
these reactions depended upon the action of the palladium(II)/bis-sulfoxide catalyst to effect 
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allylic C-H cleavage.  However, unlike the allylic alkylation there could be no productive role 
for DMSO in these reactions, so any inhibition resulting from the addition of DMSO would be 
readily evident.  Thus, in the absence of any additives, both reactions produced the desired 
functionalized products in good yields (Table 5 entry 1; Table 6 entry 1).  Upon the addition of 
only 1 equivalent of DMSO, a dramatic reduction in reactivity was observed, with diminished 
yields and low conversion of substrate (entry 2).  These results supported the conclusion that 
DMSO was interfering with coordination of the bis-sulfoxide ligand to the metal and inhibiting 
C-H cleavage.  Notably, in the allylic alkylation reaction reported by Shi and coworkers, the 
reaction conditions did not include DMSO.  However, we suspected that a similar mechanism of 
inhibition could be at play with a ligand other than DMSO.  Shi reported alkylation by 1,3-
diketone nucleophiles, which are well known ligands for palladium(II).
57
  When 1 equivalent of 
benzoylacetone 59 was added to either the allylic amination or esterification reaction conditions, 
almost complete disruption of the reactivity was observed, which also supported the concept of 
competitive ligand binding (entry 3). 
Table 5: Effect of additives on the branched allylic C-H esterification 
 
74 
 
Table 6: Effect of additives on the linear allylic C-H amination 
 
The equilibrium exchange of bis-sulfoxide and DMSO ligands at the palladium center 
was thought to be the underlying cause of inhibition of the catalytic allylic alkylation.  We 
reasoned that, if balance could be restored to the equilibrium, perhaps reactivity could be 
recovered as well.  Therefore, it would be necessary to discover a new ligand for C-H cleavage 
which could better compete with DMSO for binding to palladium.  Inspired by this line of 
reasoning, we synthesized a series of bis-sulfoxide ligands.  The aryl substituents of the parent 
bis-sulfoxide were replaced by various aliphatic groups.  This substitution was motivated by the 
expectation that more electron rich aliphatic substituents would make the sulfoxide a better -
donor ligand and therefore better able to compete with DMSO.  We were delighted to discover 
that a range of aliphatic bis-sulfoxide ligands restored good reactivity to the catalytic allylic 
alkylation (Table 7, entries 5, 8-10).  The bis(benzylsulfinyl)ethane ligand was selected for 
further exploration because its complex with palladium, 49, was the most crystalline and hence 
most operationally convenient catalyst.  When 49 was used as a catalyst for the allylic amination 
and esterification reactions, it was observed that the addition of DMSO or benzoylacetone 
diminished the reactivity to a lesser extent than for reactions catalyzed by 1 (Table 5 entries 4-6; 
Table 6 entries 4-6).  We concluded that 49 is relatively insensitive to competitive ligand binding 
by DMSO or benzoylacetone.   
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Table 7: Catalytic allylic C-H alkylation of unactivated -olefins 
 
We endeavored to further elucidate the interplay between the two sulfoxide ligands.  
Consistent with the hypothesis that allylic C-H alkylation of unactivated substrates proceeds 
through a SLC mechanism, the omission of either sulfoxide ligand dramatically reduced the 
reactivity (no DMSO, 59%<5%; no bis-sulfoxide, 59%6%; Table 7, entries 4 and 7).  
Stoichiometric studies demonstrated that catalyst 1 had rates comparable to or faster than 49 for 
the C-H cleavage and functionalization steps (see 2.4 Experimental Section). However, in 
contrast to 1, catalyst 49 was active in solution for an extended period of time, presumably 
because it resisted inhibition and premature catalyst decomposition by DMSO (Figure 20, blue 
diamond). 
Having developed conditions suitable for the allylic alkylation of unactivated -olefins, 
we proceeded to examine the substrate scope of the method.  In all cases the reaction proceeded 
with high regioselectivity and excellent E/Z selectivity (>20:1).  The alkylation was tolerant of a 
variety of functionality at the homoallylic position, including carbon, oxygen, and nitrogen 
(Table 8, entries 2, 3, and 5–8).  When branching in the homoallylic position generated a 
stereocenter, it was not racemized.  Similarly, a potentially epimerizable stereocenter alpha to a 
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Figure 20: Comparison of the allylic alkylation reaction catalyzed by 1 (red squares) or 49 (blue diamonds), and 
DMSO 
 
 
ketone retained its configuration, thus illustrating how this method is orthogonal to traditional 
carbanion-based C-C bond-forming reactions (entry 4).  A trisubstituted olefin was tolerated 
under the reaction conditions, demonstrating the chemoselectivity of the catalyst for terminal 
olefins (entry 3).  Notably, even an unprotected, allylic secondary alcohol was stable to the 
oxidative conditions—an unusual example of tolerance for readily oxidized functionality by a 
palladium(II) reaction (entry 6).  
Strategically, the C-H alkylation disconnection provided facile entry to products that 
were often difficult to access by conventional means (Table 8, entries 5 and 8).
58
  Whereas 
conventional syntheses require tedious manipulation of oxidized functionality, C-H alkylation 
uses relatively inert, robust -olefins which may be installed at any stage by using versatile, 
stereoselective allylation methods.
59
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Table 8: Scope of the allylic C-H alkylation reaction 
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The C-H alkylation reaction conditions were also suitable for allylbenzene substrates and 
other classes of activated substrates such as amides and enols, thus providing a general reaction 
protocol that encompassed both activated and unactivated -olefin substrates (Table 8, entries 9–
13).  Because complex 49 is a more robust, long lived catalyst, we also found that the alkylation 
reaction could be extended to substrates that had previously reacted too sluggishly to reach high 
conversion.  The alkylation of 1-methylallylbenzene was a unique example of C-H activation of 
a -branched olefin (entry 10).  The 1,1-disubstituted alkene -methylstyrene, a representative of 
a previously unexplored class of olefins, furnished a synthetically useful yield of product 77 
(entry 13).   
The -nitroketone subunit installed in this reaction has been demonstrated to be a 
versatile synthetic handle.  A wide variety of transformations have been reported,
60
 including 
selective reductions,
61,62
 exhaustive reduction,
63
 and cyclization.
64
  In order to complement these 
strategies for elaboration of the -nitroketone, we sought to demonstrate the how the motif could 
be elaborated orthogonally by selectively excising each of the electron-withdrawing moieties 
(Figure 21).  We discovered a novel and extremely mild methanolysis of the benzoyl group to 
furnish homoallylic nitroalkane 78 in nearly quantitative yield.
65
  Alternatively, we demonstrated 
the radical de-nitration by AIBN/tributylstannane to produce the ,-unsaturated ketone 79.66   
Figure 21: Synthetic elaboration of the allylic alkylation products 
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2.3 CONCLUSIONS 
This work resulted in the discovery of the first intermolecular allylic C-H alkylation 
reaction with a general substrate scope.  In previous work, we had discovered a palladium(II) 
catalyzed allylic C-H alkylation reaction, however its substrate scope was limited to allylarenes.  
Standard reaction optimization was not successful in improving the substrate scope, and our 
observations indicated that inhibition of the catalyst was resulting in low conversions and 
premature deactivation of the catalyst.  We endeavored to identify the source of the inhibition by 
applying our understanding of the catalytic cycle, and to rebalance the reaction conditions to 
overcome the inhibition and achieve a reaction with general substrate scope. 
Our mechanistic studies implicated DMSO as a potential inhibitor under the reaction 
conditions.  Although DMSO plays a vital role in promoting functionalization of the -allyl 
intermediate, we suspected that it was also interfering with the formation of the 
palladium(II)/bis-sulfoxide complex which is necessary for allylic C-H cleavage of unactivated 
substrates.  Due to the complex role played by DMSO and the transient nature of the metal-
ligand interaction, we employed indirect methods to test our hypothesis; addition of DMSO to C-
H esterification and amination reactions catalyzed by palladium(II)/bis-sulfoxide complexes 
revealed clear inhibition.  This insight inspired the synthesis of stronger -donor bis-sulfoxide 
ligands which could better compete with DMSO for binding to palladium.  These new complexes 
proved to be more robust catalysts which resisted inhibition by DMSO, leading to the discovery 
of conditions suitable for the allylic C-H alkylation of virtually any -olefin substrate. 
2.4 EXPERIMENTAL SECTION 
General Information: All commercially obtained reagents for the allylic alkylation reaction 
were used as received: 2,6-dimethylbenzoquinone, benzoylnitromethane, 1-undecene, 1-decene, 
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allylcyclohexane, allylbenzene (Sigma-Aldrich); benzoylnitromethane (Acros Organics). 
Catalyst 1 was prepared according to the published procedure.
14a Catalysts 49, 64-66 were 
prepared as described below. Catalysts were stored at 4°C and weighed out in air prior to use. 
Dioxane and benzene were purified prior to use by passage through a bed of activated alumina 
(Glass Contour, Laguna Beach, California). Dimethyl sulfoxide (DMSO) and methanol were 
obtained from Fisher Scientific and used as received. 1,2-dichloroethane (DCE) was obtained 
from Sigma-Aldrich and used as received. All allylic alkylation reactions were run under air with 
no precautions taken to exclude moisture. Thin-layer chromatography (TLC) was conducted with 
E. Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with UV and potassium 
permanganate stain. Flash chromatography was performed as described by Still using ZEOprep 
60 ECO 43-60 micron silica gel (American International Chemical, Inc.).
35
 Medium pressure 
liquid chromatography was performed on a Teledyne Isco CombiFlash Rf machine using pre-
packed RediSep columns (12g C18) at a rate of 30 mL/min. 
1
H NMR spectra were recorded on a 
Varian Unity-400 (400 MHz), Varian Inova-500 (500 MHz), or Varian Unity-500 (500 MHz) 
spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 7.26 ppm). 
Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, m = multiplet, b = 
broad, ap = apparent; coupling constant(s) in Hz; integration. Proton-decoupled 
13
C NMR spectra 
were recorded on a Varian Unity-500 (125 MHz) spectrometer and are reported in ppm using 
solvent as an internal standard (CDCl3 at 77.16 ppm). Regioselectivity of the allylic alkylation 
reaction was determined by 
1
H NMR analysis of the crude reaction mixture. IR spectra were 
recorded as thin films on NaCl plates on a Perkin-Elmer Spectrum BX FT-IR and are reported in 
frequency of absorption (cm
-1
). Chiral high pressure liquid chromatographic (HPLC) analysis 
was performed on an Agilent Technologies 1100 HPLC system with a model 1100 Quaternary 
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Pump, Diode Array Detector, Thermostat, and Autosampler using a Daicel Chemical Industries 
Chiralcel OD-H column (0.46 cm x 25 cm). Chiral gas chromatographic (GC) analysis was 
performed on an Agilent Technologies 5890A Series instrument equipped with an FID detector 
using a J&W Scientific β-cyclodextrin column (30m, 0.25mm, 0.25μm). High-resolution mass 
spectra were obtained at the University of Illinois Mass Spectrometry Laboratory. Optical 
rotations were obtained using a JAS.CO DIP-360 digital polarimeter and a 3.5 x 50 mm cell and 
are reported as follows: concentration (c = g / 100 mL), solvent.  
 
General Procedure for the Allylic Alkylation: A one dram (4 mL) borosilicate vial was 
charged with Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 49 (0.10 equiv, 0.030 mmol), 2,6-
dimethylbenzoquinone 58 (1.1 equiv, 0.33 mmol), benzoylnitromethane 16 (4.0 equiv, 1.20 
mmol), and 1,2-bis(benzylsulfinyl)ethane (0.05 equiv, 0.015 mmol). The olefin (1 equiv, 0.30 
mmol) was weighed out in a ½ dram vial and transferred via 1,2-dichloroethane (3 x 0.105 mL); 
dimethylsulfoxide (0.135 mL); and a stir bar were added sequentially to the reaction vial. No 
precautions were taken to exclude air or moisture. The reaction vial was capped and stirred at 
45°C for 72 hours. The vial was cooled to room temperature, and the reaction mixture was 
diluted with saturated aqueous NH4Cl (40 mL) and extracted with ethyl acetate (3 x 30 mL). For 
products of polarity similar to benzoylnitromethane, the combined organics were washed with 
5% aqueous K2CO3 (3 x 20 mL). The combined organics were dried over MgSO4. The mixture 
was filtered and concentrated in vacuo. Purification by flash chromatography (SiO2, 
EtOAc/hexanes mixtures) provided the pure linear product. In cases where branched product was 
observed, it was readily separated and generally possessed a higher Rf value than linear product. 
NOTE: The allylic alkylation products were observed to be slightly unstable on silica gel. While 
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they may be purified by column chromatography, care should be taken to avoid prolonged 
exposure to silica. 
 
Procedure for preparation of Catalyst 49, 64-66: 
 
Catalyst 49 was prepared as previously reported,
15
 with two modifications to the procedure. First, 
Pd(OAc)2 was recrystallized from benzene 3 times prior to complexation with bis-sulfoxide.
14a  
Second, the time of complexation was reduced to 12 hours from 22 hours to reduce 
decomposition of bis-sulfoxide ligand. Some catalyst batch variability was observed, specifically 
during observation of initial reaction rates, however overall reactivity was reproducible between 
batches. 
Catalyst 64 was prepared by the procedure described for catalyst 49. The ligand was prepared as 
a mixture of sulfoxide diastereomers. 
 
Catalyst 65 was prepared by the procedure above. The ligand was prepared as a mixture of 
sulfoxide diastereomers. 
Catalyst 66 was prepared by the procedure described for catalyst 65. The ligand was prepared as 
a mixture of sulfoxide diastereomers. 
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Stoichiometric studies of unactivated and activated substrates 
   
 
bis[chloro(1,2,3-trihapto-allylbenzene)palladium (II)] [54]: To a ½ dram 
borosilicate vial were added allylbenzene 18 (11.8 mg, 0.10 mmol, 1.0 equiv). 
Catalyst 1 (50.3 mg, 0.10 mmol, 1.0 equiv), dioxane-d8 (300 μL) and a stir bar were added 
sequentially. No precautions were taken to exclude air or moisture. The vial was capped and 
stirred for 60 min at 45°C. The vial was cooled to room temperature and n-Bu4NCl (111.2 mg, 
0.40 mmol, 4.0 equiv) was added in one portion. The anion exchange proceeded at room 
temperature for 60 min. To the crude reaction mixture was added nitrobenzene (4.9 mg, 0.040 
mmol, 0.40 equiv) and the solution was shaken vigorously. A sample was removed for 
1
H NMR 
analysis and diluted with CDCl3. Yield was determined by integration of product peaks at 5.80, 
4.62, 3.97 ppm relative to nitrobenzene. Run 1 (72% yield); run 2 (74% yield). Average yield: 
73%. 
1
H NMR (500 MHz, CDCl3) δ7.50 (d, J = 7.6 Hz, 4H), 7.35 (m, 2H), 7.27 (d, J = 7.6 Hz, 
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4H), 5.80 (td, J = 11.6, 6.8 Hz, 2H), 4.62 (d, J = 11.2 Hz, 2H), 3.97 (d, J = 6.6 Hz, 2H), 3.04 (d, 
J = 11.7 Hz, 2H). Spectral data match those of the reported compound.
36
 
 
bis[chloro(1,2,3-trihapto-undecene)palladium (II)] [55]: A 2 dram (8 mL) 
borosilicate vial was charged with catalyst 1 (101 mg, 0.20 mmol, 1.0 equiv), 
benzoylnitromethane 16 (330 mg, 2.0 mmol, 10 equiv), and a stir bar. To this was added 3 mL 
dioxane and 1-undecene 53 (411 μL, 2.0 mmol, 10 equiv). The reaction was allowed to stir for 
60 min at 45°C under air, at which time an acetone solution (1 mL) of n-Bu4NCl (222 mg, 0.80 
mmol, 4 equiv) was added via syringe. The anion exchange proceeded at room temperature for 
60 min. The mixture was filtered over a plug of Celite (to remove metallic Pd), concentrated and 
purified via column chromatography (0%→15% EtOAc/hexanes gradient) to afford 
bis[chloro(1,2,3-trihapto-undecene)palladium (II)] as a bright yellow solid. Run 1 (46.5 mg, 
0.0788 mmol, 79% yield), run 2 (45.5 mg, 0.0771 mmol, 77% yield). Average yield: 78%. 
1
H 
NMR (500 MHz, CDCl3) δ 5.26 (td, J = 11.6, 6.8 Hz, 2H), 3.88 (d, J = 6.8 Hz, 2H), 3.85 (m, 
2H), 2.82 (d, J = 11.6 Hz, 2H), 1.8-1.2 (m, 28 H), 0.88 (t, J = 7.2 Hz, 6H). Spectral data match 
those of the reported compound.
16
 
 
 (E)-methyl 2-nitro-5-phenylpent-4-enoate [14]: To a 40 mL 
borosilicate vial were added sequentially bis[acetato(1,2,3-trihapto-
allylbenzene)palladium (II)] (28.3 mg, 0.100 mmol, 1.0 equiv), methyl nitroacetate (119.1 mg, 
1.0 mmol, 10 equiv), and a stir bar. Dioxane (2.4 mL) and dimethylsulfoxide (0.60 mL) were 
added. No precautions were taken to exclude air or moisture. The vial was capped and stirred for 
3.5 h at 45°C. The vial was cooled to room temperature and the reaction mixture was diluted 
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with saturated aqueous NH4Cl (20 mL) and extracted with ethyl acetate (3 x 20 mL). The 
combined organics were dried over MgSO4. The mixture was filtered and concentrated in vacuo. 
To the crude reaction mixture was added nitrobenzene (4.9 mg, 0.040 mmol, 0.40 equiv). The 
crude mixture was dissolved completely in CDCl3 and a sample was removed for 
1
H NMR 
analysis. Yield was determined by integration of olefinic product peaks relative to nitrobenzene. 
Run 1 (87% yield, 4.1:1 L:B); run 2 (84% yield, 4.3:1 L:B). Average yield: 86%. 
1
H NMR (500 
MHz, CDCl3) δ 7.32 (m, 4H), 7.25 (m, 1H), 6.65 (d, J = 15.6 Hz, 1H), 6.08 (dt, J = 15.6, 7.3 Hz, 
1H), 5.23 (dd, J = 9.2, 5.5 Hz, 1H), 3.85 (s, 3H), 3.16 (m, 1H), 3.07 (m, 1H); 
13
C NMR (100 
MHz, CDCl3) 164.6, 136.3, 135.6, 128.7, 128.2, 126.5, 121.1, 87.6, 53.8, 33.9; IR (film, cm
-1
): 
3028, 2958, 1954, 1884, 1754, 1563, 1495, 1438; HRMS (ESI) m/z calculated for C12H13NO4Na 
[M+Na]
+
: 258.0742, found 258.0729. Spectral data match those of the reported compound.
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(E)-2-nitro-1-phenyltridec-4-en-1-one [56]: A 1 dram (4 mL) 
borosilicate vial was charged with bis[acetato(1,2,3-trihapto-
undecene)palladium (II)] 2 (15.9 mg, 0.025 mmol, 1.0 equiv), benzoylnitromethane 16 (82.6 mg, 
0.50 mmol, 10 equiv), and a stir bar. To this was added dioxane (525 μL) and DMSO (225 μL). 
The reaction vial was capped and stirred at 45°C for 4 hours. The vial was cooled to room 
temperature, and the reaction mixture was diluted with saturated aqueous NH4Cl (15 mL) and 
extracted with ethyl acetate (3 x 10 mL). The combined organics were dried over MgSO4. The 
mixture was filtered and concentrated in vacuo. To the crude reaction mixture was added 1,4-
dimethoxybenzene (2.1 mg, 0.015 mmol, 0.30 equiv) as a stock solution in CDCl3. The crude 
mixture was dissolved completely in additional CDCl3 and a sample was removed for 
1
H NMR 
analysis. Yield was determined by integration of olefinic product peaks relative to 1,4-
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dimethoxybenzene. Run 1 (74% yield, 12:1 L:B), run 2 (69% yield, 13:1 L:B), run 3 (71% yield, 
12:1 L:B). Average yield: 71%. 
1
H NMR (500 MHz, CDCl3) δ 7.95 (ap. d, J = 7.3 Hz, 2H), 
7.66 (ap. t, J = 7.4 Hz, 1H), 7.53 (ap. t, J = 7.9 Hz, 2H), 6.06 (dd, J = 9.2, 5.0 Hz, 1H), 5.63 (m, 
1H), 5.37 (m, 1H), 3.03 (m, 1H), 2.85 (m, 1H), 1.96 (q, J = 7.0 Hz, 2H), 1.33-1.18 (m, 12H), 
0.88 (t, J = 7.1 Hz, 3H). This reaction was also run at 0.2 mmol scale, and pure linear product 
was isolated in 62% yield. 
Catalytic allylic C-H alkylation of unactivated -olefins 
 
Table 7: Allylic C-H alkylation screening procedure: A ½ dram borosilicate vial was charged 
with catalyst (0.010 mmol, 0.1 equiv), benzoylnitromethane 16 (66.1 mg, 0.40 mmol, 4 equiv) 
and dimethylbenzoquinone 58 (15.0 mg, 0.11 mmol, 1.1 equiv). 1,2-dichloroethane (105 μL), 
dimethylsulfoxide (45 μL), undecene 53 (20.5 μL, 0.10 mmol, 1 equiv), and a stir bar were 
added sequentially. No precautions were taken to exclude air or moisture. The vial was capped 
and stirred for 72 h at 45°C. The vial was cooled to room temperature and the reaction mixture 
was diluted with ethyl acetate (10 mL) and washed sequentially with saturated aqueous NH4Cl 
(10 mL) and 5% aqueous K2CO3 (10 mL). The organic layer was dried over MgSO4. The 
mixture was filtered and concentrated in vacuo. To the crude reaction mixture was added 1,4-
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dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) as a stock solution in CDCl3. The crude 
mixture was dissolved completely in additional CDCl3 and a sample was removed for 
1
H NMR 
analysis. Yield was determined by integration of olefinic product peaks relative to 1,4-
dimethoxybenzene.  
 
Entry 1: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), DCE (150 μL), and 1,4-
dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (<5% yield); run 2 (<5% 
yield). Average yield: <5%. 
 
Entry 2: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), DCE (105 μL), DMSO (45 μL), and 1,4-
dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (25% yield, 12:1 L:B); 
run 2 (24% yield, 13:1 L:B). Average yield: 25%. 
 
Entry 3: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), benzoylacetone (16.2 mg, 0.10 mmol, 1.0 
equiv), DCE (150 μL), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. 
Run 1 (<5% yield); run 2 (<5% yield). Average yield: <5%. 
 
Entry 4: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), DCE (150 μL), and 1,4-
dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (<5% yield); run 2 (<5% 
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yield). Average yield: <5%. 
 
Entry 5: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), DCE (105 μL), DMSO (45 μL), and 1,4-
dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (59% yield, 12:1 L:B); 
run 2 (58% yield, 13:1 L:B); run 3 (58% yield, 12:1 L:B). Average yield: 59%. 
 
Entry 6: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), benzoylacetone (16.2 mg, 0.10 mmol, 1.0 
equiv), DCE (150 μL), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. 
Run 1 (<5% yield); run 2 (<5% yield). Average yield: <5%. 
 
Entry 7: Pd(OAc)2 (2.2 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), DCE (105 μL), DMSO (45 μL), and 1,4-
dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (6% yield); run 2 (6% 
yield). Average yield: 6%. 
 
Entry 8: Catalyst 64 (4.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), DCE (105 μL), DMSO (45 μL), and 1,4-
dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (63% yield, 10:1 L:B); 
run 2 (62% yield, 11:1 L:B). Average yield: 62%. 
 
Entry 9: Catalyst 65 (5.1 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
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benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), DCE (105 μL), DMSO (45 μL), and 1,4-
dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (57% yield, 11:1 L:B); 
run 2 (57% yield, 11:1 L:B). Average yield: 57%. 
 
Entry 10: Catalyst 66 (4.6 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 
equiv), benzoylnitromethane (66.1 mg, 0.40 mmol, 4.0 equiv), DCE (105 μL), DMSO (45 μL), 
and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (40% yield, 9:1 
L:B); run 2 (39% yield, 10:1 L:B). Average yield: 40%. 
 
Effect of additives on the branched allylic C-H esterification 
 
 
Table 5: Allylic C-H esterification screening procedure: A ½ dram borosilicate vial was 
charged with catalyst 1 or 49 (0.010 mmol, 0.1 equiv), benzoic acid 60 (18.3 mg, 0.15 mmol, 1.5 
equiv) and benzoquinone (21.6 mg, 0.2 mmol, 2 equiv). Dioxane (300 μL), undecene (20.5 μL, 
0.10 mmol, 1 equiv), and a stir bar were added sequentially. No precautions were taken to 
exclude air or moisture. The vial was capped and stirred for 72 h at 45°C. The vial was cooled to 
room temperature and the reaction mixture was diluted with hexanes (10 mL) and washed 
sequentially with saturated aqueous NaHSO3 (10 mL) and 5% aqueous K2CO3 (3x10 mL). The 
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combined aqueous layers were extracted with hexanes (2x10 mL). The combined organic layers 
were dried over MgSO4. The mixture was filtered and concentrated in vacuo. To the crude 
reaction mixture was added 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) as a stock 
solution in CDCl3. The crude mixture was dissolved completely in additional CDCl3 and a 
sample was removed for 
1
H NMR analysis. Yield was determined by integration of olefinic 
product peaks relative to 1,4-dimethoxybenzene.  
 
Entry 1: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoic acid (18.3 mg, 0.15 mmol, 1.5 equiv), dioxane (300 μL), and 1,4-dimethoxybenzene (4.1 
mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (78% yield, 1:>20 L:B); run 2 (80% yield, 1:>20 
L:B). Average yield: 79%. 
 
Entry 2: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoic acid (18.3 mg, 0.15 mmol, 1.5 equiv), dioxane (285 μL), DMSO (7.1 μL, 0.1 mmol, 1 
equiv), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (19% 
yield, 1:>20 L:B); run 2 (22% yield, 1:>20 L:B). Average yield: 21%. 
 
Entry 3: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoic acid (18.3 mg, 0.15 mmol, 1.5 equiv), benzoylacetone (16.2 mg, 0.10 mmol, 1.0 equiv), 
dioxane (300 μL), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 
1 (6% yield); run 2 (6% yield). Average yield: 6%. 
 
Entry 4: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
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benzoic acid (18.3 mg, 0.15 mmol, 1.5 equiv), dioxane (300 μL), and 1,4-dimethoxybenzene (4.1 
mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (46% yield, 1:>20 L:B); run 2 (47% yield, 1:>20 
L:B). Average yield: 47%. 
 
Entry 5: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoic acid (18.3 mg, 0.15 mmol, 1.5 equiv), dioxane (285 μL), DMSO (7.1 μL, 0.1 mmol, 1 
equiv), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (34% 
yield, 1:>20 L:B); run 2 (37% yield, 1:>20 L:B); run 3 (33% yield, 1:>20 L:B). Average yield: 
35%. 
 
Entry 6: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
benzoic acid (18.3 mg, 0.15 mmol, 1.5 equiv), benzoylacetone (16.2 mg, 0.10 mmol, 1.0 equiv), 
dioxane (300 μL), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 
1 (9% yield, 1:16 L:B); run 2 (14% yield, 1:20 L:B); run 3 (15% yield, 1:16 L:B), run 4 (14% 
yield, 1:>20 L:B). Average yield: 12%. 
 
Effect of additives on the linear allylic C-H amination 
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Table 6: Allylic C-H amination screening procedure: A ½ dram borosilicate vial was charged 
with catalyst 1 or 49 (0.010 mmol, 0.1 equiv), methyl N-tosylcarbamate 62 (45.9 mg, 0.2 mmol, 
2 equiv) and benzoquinone (21.6 mg, 0.2 mmol, 2 equiv). N,N-Diisopropylethylamine (1.0 μL, 
0.006 mmol, 0.06 equiv) in tert-butyl methyl ether (150 μL), undecene (20.5 μL, 0.10 mmol, 1 
equiv), and a stir bar were added sequentially. No precautions were taken to exclude air or 
moisture. The vial was capped and stirred for 72 h at 45°C. The vial was cooled to room 
temperature and the reaction mixture was diluted with diethyl ether (10 mL) and washed 
sequentially with 5% aqueous K2CO3 (3x10 mL). The combined aqueous layers were extracted 
with diethyl ether (2x10 mL). The combined organic layers were dried over MgSO4. The mixture 
was filtered and concentrated in vacuo. To the crude reaction mixture was added 1,4-
dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) as a stock solution in CDCl3. The crude 
mixture was dissolved completely in additional CDCl3 and a sample was removed for 
1
H NMR 
analysis. Yield was determined by integration of olefinic product peaks relative to 1,4-
dimethoxybenzene.  
 
Entry 1: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
methyl N-tosylcarbamate (45.9 mg, 0.2 mmol, 2 equiv), N,N-diisopropylethylamine (1.0 μL, 
0.006 mmol, 0.06 equiv) in tert-butyl methyl ether (150 μL), and 1,4-dimethoxybenzene (4.1 mg, 
0.030 mmol, 0.30 equiv) were used. Run 1 (69% yield, 12:1 L:B); run 2 (65% yield, 11:1 L:B). 
Average yield: 67%. 
 
Entry 2: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
methyl N-tosylcarbamate (45.9 mg, 0.2 mmol, 2 equiv), N,N-diisopropylethylamine (1.0 μL, 
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0.006 mmol, 0.06 equiv) in tert-butyl methyl ether (143 μL), DMSO (7.5 μL, 0.1 mmol, 1 
equiv), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (<5% 
yield); run 2 (<5% yield). Average yield: <5%. 
 
Entry 3: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
methyl N-tosylcarbamate (45.9 mg, 0.2 mmol, 2 equiv), benzoylacetone (16.2 mg, 0.10 mmol, 
1.0 equiv), N,N-diisopropylethylamine (1.0 μL, 0.006 mmol, 0.06 equiv) in tert-butyl methyl 
ether (150 μL), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 
(<5% yield); run 2 (<5% yield). Average yield: <5%. 
 
Entry 4: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
methyl N-tosylcarbamate (45.9 mg, 0.2 mmol, 2 equiv), N,N-diisopropylethylamine (1.0 μL, 
0.006 mmol, 0.06 equiv) in tert-butyl methyl ether (150 μL), and 1,4-dimethoxybenzene (4.1 mg, 
0.030 mmol, 0.30 equiv) were used. Run 1 (21% yield, 12:1 L:B); run 2 (25% yield, 12:1 L:B). 
Average yield: 23%. 
 
Entry 5: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
methyl N-tosylcarbamate (45.9 mg, 0.2 mmol, 2 equiv), N,N-diisopropylethylamine (1.0 μL, 
0.006 mmol, 0.06 equiv) in tert-butyl methyl ether (143 μL), DMSO (7.5 μL, 0.1 mmol, 1 
equiv), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 (15% 
yield, 11:1 L:B); run 2 (16% yield, 13:1 L:B). Average yield: 16%. 
 
Entry 6: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), undecene (20.5 μL, 0.10 mmol, 1.0 equiv), 
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methyl N-tosylcarbamate (45.9 mg, 0.2 mmol, 2 equiv), benzoylacetone (16.2 mg, 0.10 mmol, 
1.0 equiv), N,N-diisopropylethylamine (1.0 μL, 0.006 mmol, 0.06 equiv) in tert-butyl methyl 
ether (150 μL), and 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) were used. Run 1 
(7% yield); run 2 (8% yield). Average yield: 8%. 
 
Comparison of the allylic alkylation reaction catalyzed by 1 (red squares) or 49 (blue diamonds), and DMSO 
 
 
Figure 20: A ½ dram borosilicate vial was charged with catalyst 1 (5.0 mg, 0.010 mmol, 0.1 
equiv) or catalyst 49 (5.3 mg, 0.010 mmol, 0.1 equiv), benzoylnitromethane 16 (66.1 mg, 0.40 
mmol, 4 equiv), 2,6-dimethylbenzoquinone 58 (15.0 mg, 0.110 mmol, 1.1 equiv) and a stir bar. 
To this was added 1-undecene 53 (20.5 μL, 0.10 mmol, 1 equiv) and 4-nitroanisole (4.6 mg, 
0.030 mmol, 0.3 equiv, internal standard) as a stock solution in DCE (105 μL) and DMSO 
(45μL). The vial was fitted with a cap with a septum and the reaction was allowed to stir for 24 
hours at 45°C under air. Reaction aliquots (7 μL) were periodically removed via syringe and 
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filtered through a silica plug using 
i
PrOH:hexanes (1:4) solvent. The crude samples were 
analyzed by HPLC with Agilent Technologies, Inc. Zorbax CN 0.46 cm x 25 cm column. A flow 
rate of 1.5 mL/min at 35.0°C with 99:1 hexanes:2-propanol with detection at 214 nm gave the 4-
nitroanisole standard at 5.12 min and the linear product at 5.42 min. Yield was determined by 
comparison to a standard curve (see Figure 24). Yields are reported as the average of 3 runs, with 
error bars representing standard deviation. 
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Scope of the allylic C-H alkylation reaction 
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(E)-2-nitro-1-phenyltridec-4-en-1-one [57]: 1-
undecene (46.3 mg, 0.3 mmol, 1.0 equiv) was reacted 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 12:1 and the E/Z isomer ratio was >20:1. Flash chromatography (5% EtOAc/hexanes) 
yielded pure linear product as a light yellow oil. Run 1 (54.6 mg, 0.172 mmol, 57% yield); run 2 
(51.6 mg, 0.163 mmol, 54% yield); run 3 (52.3 mg, 0.165 mmol, 55% yield). Average yield: 
56%. 
1
H NMR (500 MHz, CDCl3) δ 7.95 (ap. d, J = 7.3 Hz, 2H), 7.66 (ap. t, J = 7.4 Hz, 1H), 
7.53 (ap. t, J = 7.9 Hz, 2H), 6.06 (dd, J = 9.2, 5.0 Hz, 1H), 5.63 (m, 1H), 5.37 (m, 1H), 3.03 (m, 
1H), 2.85 (m, 1H), 1.96 (q, J = 7.0 Hz, 2H), 1.33-1.18 (m, 12H), 0.88 (t, J = 7.1 Hz, 3H); 
13
C 
NMR (125 MHz, CDCl3) 188.7, 137.1, 134.8, 134.2, 129.3, 129.0, 121.8, 89.7, 33.9, 32.6, 32.0, 
29.5, 29.4, 29.2, 29.1, 22.8, 14.3; IR (film, cm
-1
): 3064, 2926, 2854, 1697, 1562, 1450, 1255, 
972, 688; HRMS (ESI) m/z calculated for C19H27NO3Na [M+Na]
+
: 340.1889, found 340.1879. 
 
(E)-5-cyclohexyl-2-nitro-1-phenylpent-4-en-1-one [67]: 
Allylcyclohexane (37.3 mg, 0.3 mmol, 1.0 equiv) was reacted 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was >20:1 and the E/Z isomer ratio was >20:1. Flash chromatography (5% EtOAc/hexanes) 
yielded pure linear product as a light yellow oil. Run 1 (57.3 mg, 0.199 mmol, 66% yield); run 2 
(48.5 mg, 0.169 mmol, 56% yield); run 3 (43.4 mg, 0.151 mmol, 0.250 mmol scale, 60% yield). 
Average yield: 61%. 
1
H NMR (500 MHz, CDCl3) δ 7.95 (ap. d, J = 7.1 Hz, 2H), 7.66 (ap. t, J = 
7.4 Hz, 1H), 7.53 (ap. t, J = 7.8 Hz, 2H), 6.05 (dd, J = 9.0, 5.1 Hz, 1H), 5.56 (dd, J = 15.4, 6.8 
Hz, 1H), 5.32 (m, 1H), 3.01 (m, 1H), 2.84 (m, 1H), 1.89 (m, 1H), 1.71-1.58 (m, 5H), 1.22 (m, 
2H), 1.11 (m, 1H), 0.98 (qd, J = 12.2, 3.1 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) 188.8, 142.8, 
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134.8, 134.2, 129.3, 129.0, 119.4, 89.7, 40.7, 33.9, 32.7, 26.2, 26.0; IR (film, cm
-1
): 3062, 2924, 
2852, 1969, 1907, 1693, 1564, 1448, 1255, 1228, 972, 910, 735, 688; HRMS (ESI) m/z 
calculated for C17H21NO3Na [M+Na]
+
: 310.1419, found 310.1411. 
 
(6S,E)-6,10-dimethyl-2-nitro-1-phenylundeca-4,9-dien-1-
one [68]: (S)-4,8-dimethylnona-1,7-diene (45.7 mg, 0.3 
mmol, 1.0 equiv) was reacted following the general procedure. By 
1
H NMR analysis of the crude 
product, the linear:branched ratio was >20:1 and the E/Z isomer ratio was >20:1. By 
13
C NMR 
the diastereomeric ratio was 1:1.
67
 Flash chromatography (8% EtOAc/hexanes) yielded linear 
product contaminated by ca. 5 wt% (8S,E)-4,8-dimethyl-2-nitro-1-phenylundeca-4,10-dien-1-one 
as a light yellow oil. A pure spectroscopic sample was obtained by medium pressure liquid 
chromatography (SP: 15% AgNO3/SiO2; MP: 0%→10% EtOAc/hexanes). Run 1 (46.8 mg, 
0.148 mmol, 49% yield); run 2 (46.2 mg, 0.146 mmol, 49% yield). Average yield: 49%. 
1
H 
NMR (500 MHz, CDCl3) δ 7.95 (ap. d, J = 7.3 Hz, 2H), 7.66 (ap. t, J = 7.4 Hz, 1H), 7.53 (ap. t, J 
= 7.8 Hz, 2H), 6.06 (dd, J = 9.0, 5.1 Hz, 1H), 5.50 (ddd, J = 15.3, 7.8, 4.0 Hz, 1H), 5.34 (m, 1H), 
5.04 (m, 1H), 3.03 (m, 1H), 2.86 (m, 1H), 2.07 (septet, J = 6.9 Hz, 1H), 1.86 (m, 2H), 1.67 (s, 
3H), 1.57 (m, 3H), 1.24 (m, 2H), 0.91 (d, J = 6.3 Hz, 3H, diastereomer A), 0.89 (d, J = 6.6 Hz, 
3H, diastereomer B); 
13
C NMR (125 MHz, CDCl3) Mixture of diastereomers 188.8, 188.7, 
142.8, 142.7, 134.8, 134.2, 131.6, 131.6, 129.3, 129.0, 124.5, 120.2, 89.6, 36.9, 36.8, 36.5, 36.4, 
33.9, 33.8, 25.9, 25.8, 20.4, 17.8; IR (film, cm
-1
): 3062, 2962, 2924, 2854, 1967, 1907, 1695, 
1562, 1450, 1373, 1255, 1227, 974, 735, 688; HRMS (ESI) m/z calculated for C19H25NO3Na 
[M+Na]
+
: 338.1732, found 338.1737. 
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(7R,E)-7-methyl-2-nitro-1-phenyldodec-4-ene-1,8-dione 
[69]: (R)-6-methyldec-9-en-5-one (67.3 mg, 0.4 mmol, 1.0 
equiv) was reacted following the general procedure. Dioxane was used in place of DCE as a 
cosolvent. By 
1
H NMR analysis of the crude product, the linear:branched ratio was >20:1 and the 
E/Z isomer ratio was >20:1. By 
13
C NMR the diastereomeric ratio was 1:1.
67
 Flash 
chromatography (12% EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 
(83.8 mg, 0.253 mmol, 63% yield); run 2 (72.4 mg, 0.218 mmol, 55% yield); run 3 (42.7 mg, 
0.129 mmol, 0.250 mmol scale, 52% yield. Average yield: 56%. 
1
H NMR (500 MHz, CDCl3) δ 
7.95 (ap. d, J = 7.3 Hz, 2H), 7.67 (ap. t, J = 7.4 Hz, 1H), 7.53 (ap. t, J = 7.8 Hz, 2H), 6.04 (m, 
1H), 5.55 (m, 1H), 5.43 (m, 1H), 3.02 (m, 1H), 2.84 (m, 1H), 2.51 (septet, J = 6.8 Hz, 1H), 2.45-
2.29 (m, 3H), 2.01 (m, 1H), 1.51 (m, 2H), 1.28 (m, 2H), 1.02 (d, J = 7.1 Hz, 3H, diastereomer 
A), 1.01 (d, J = 6.3 Hz, 3H, diastereomer B), 0.90 (m, 3H); 
13
C NMR (125 MHz, CDCl3) 
Mixture of diastereomers 214.1, 214.0, 188.5, 188.4, 134.9, 134.0, 134.0, 133.9, 133.8, 129.4, 
128.9, 124.4, 124.4, 89.5, 89.3, 45.9, 41.3, 41.2, 35.7, 35.6, 33.8, 33.7, 25.8, 22.5, 16.3, 16.3, 
14.0; IR (film, cm
-1
): 3064, 2960, 2931, 2873, 1695, 1554, 1450, 1371, 1257, 1228, 974, 733, 
688; HRMS (ESI) m/z calculated for C19H26NO4 [M+H]
+
: 332.1862, found 332.1855.  
 
(6R,E)-6-(benzyloxy)-6-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-
nitro-1-phenylhex-4-en-1-one [70]: (R)-4-((R)-1-(benzyloxy)but-
3-en-1-yl)-2,2-dimethyl-1,3-dioxolane (65.6 mg, 0.25 mmol, 1.0 
equiv) was reacted following the general procedure, including 
K2CO3 washes during workup. Dioxane was used in place of DCE as a cosolvent. By 
1
H NMR 
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analysis of the crude product, the linear:branched ratio was >20:1, the E/Z isomer ratio was 
>20:1, and the diastereomeric ratio was 1:1. Flash chromatography (25% EtOAc/hexanes) 
yielded linear product contaminated by ca. 3 wt% 4-(1-(benzyloxy)-5-nitropent-2-en-1-yl)-2,2-
dimethyl-1,3-dioxolane as a light yellow oil. A pure spectroscopic sample was obtained by 
reverse phase medium pressure liquid chromatography (SP: C18; MP: 50→90% MeCN/H2O). 
Run 1 (67.3 mg, 0.158 mmol, 63% yield); run 2 (66.4 mg, 0.156 mmol, 62% yield); run 3 (67.2 
mg, 0.158 mmol, 63%). Average yield: 63%. 
1
H NMR (500 MHz, CDCl3) δ 7.97 (m, 2H), 7.67 
(ap. t, J = 7.6 Hz, 1H), 7.53 (ap. t, J = 7.8 Hz, 2H), 7.33 (m, 2H), 7.27 (m, 3H), 6.13 (dd, J = 9.3, 
4.9 Hz, 1H, diastereomer A), 6.09 (dd, J = 8.8, 5.4 Hz, 1H, diastereomer B), 5.77-5.60 (m, 2H), 
4.52 (d, J = 11.7 Hz, 1H), 4.33 (d, J = 12.0 Hz, 1H, diastereomer A), 4.30 (d, J = 11.7 Hz, 1H, 
diastereomer B), 4.02 (m, 2H), 3.80 (ddd, J = 12.4, 7.6, 4.8 Hz, 1H), 3.69 (ap. q, J = 6.0 Hz, 1H), 
3.15 (m, 1H), 2.99 (m, 1H), 1.35 (m, 6H); 
13
C NMR (125 MHz, CDCl3) Mixture of 
diastereomers 188.3, 188.2, 138.0, 137.9, 135.0, 134.0, 133.9, 133.3, 133.1, 129.4, 129.0, 128.9, 
128.5, 128.0, 128.0, 127.9, 127.6, 127.2, 109.7, 89.1, 88.8, 79.8, 77.6, 77.5, 70.8, 70.6, 66.8, 
66.8, 33.7, 33.5, 26.7, 26.6, 25.4, 25.3; IR (film, cm
-1
): 3064, 2989, 2931, 1693, 1554, 1452, 
1371, 1213, 1153, 1091, 849, 752; HRMS (ESI) m/z calculated for C24H28NO6 [M+H]
+
: 
426.1917, found 426.1905. 
 
(±)-(E)-6-hydroxy-2-nitro-1-phenyltridec-4-en-1-one 
[71]: 1-undecen-4-ol (51.1 mg, 0.3 mmol, 1.0 equiv) was 
reacted following the general procedure, including K2CO3 washes during workup. By 
1
H NMR 
analysis of the crude product, the linear:branched ratio was >20:1 and the E/Z isomer ratio was 
>20:1. By 
13
C NMR the diastereomeric ratio was 1:1.
67
 Flash chromatography (30% 
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EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (78.1 mg, 0.234 mmol, 
0.400 mmol scale, 59% yield); run 2 (57.2 mg, 0.172 mmol, 57% yield), run 3 (58.4 mg, 0.175 
mmol, 58% yield). Average yield: 58%. 
1
H NMR (500 MHz, CDCl3) δ 7.96 (ap. d, J = 8.3 Hz, 
2H), 7.67 (ap. t, J = 7.4 Hz, 1H), 7.54 (ap. t, J = 7.1 Hz, 1H), 6.09 (dd, J = 9.2, 5.0 Hz, 1H), 5.66 
(m, 2H), 4.05 (1, J = 6.0 Hz, 1H), 3.08 (m, 1H), 2.91 (m, 1H), 1.44 (m, 2H), 1.26 (m, 10H), 0.88 
(t, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) Mixture of diastereomers 188.5, 139.1, 139.1, 
134.9, 134.0, 129.4, 129.0, 122.8, 122.6, 89.2, 89.0, 72.3, 72.3, 37.2, 33.4, 33.3, 31.9, 29.6, 29.3, 
25.4, 22.8, 14.2; IR (film, cm
-1
): 3392, 3066, 2927, 2858, 1969, 1905, 1693, 1564, 1450, 1369, 
1257, 1227, 974, 910, 733, 688; HRMS (ESI) m/z calculated for C19H27NO4Na [M+Na]
+
: 
356.1838, found 356.1844. 
 
 (±)-(E)-tert-butyl (2-methyl-7-nitro-8-oxo-8-phenyloct-4-en-3-
yl)carbamate [72]: tert-butyl (2-methylhex-5-en-3-yl)carbamate (53.3 
mg, 0.25 mmol, 1.0 equiv) was reacted following the general 
procedure. By 
1
H NMR analysis of the crude product, the linear:branched ratio was >20:1 and 
the E/Z isomer ratio was >20:1. By HPLC the diastereomeric ratio was 1:1. Flash 
chromatography (20% EtOAc/hexanes) yielded pure linear product as a white solid. Run 1 (50.7 
mg, 0.135 mmol, 54% yield); run 2 (49.7 mg, 0.132 mmol, 53% yield). Average yield: 53%. 
1
H 
NMR (500 MHz, CDCl3) δ 7.95 (ap. d, J = 8.3 Hz, 2H), 7.67 (ap. t, J = 7.4 Hz, 1H), 7.53 (ap. t, J 
= 7.8 Hz, 2H), 6.09 (dd, J = 9.3, 4.9 Hz, 1H), 5.55 (m, 2H), 4.44 (m, 1H), 3.91 (br. s, 1H), 3.08 
(m, 1H), 2.91 (m, 1H), 1.69 (m, 1H), 1.44 (s, 9H, diastereomer A), 1.42 (s, 9H, diastereomer B), 
0.83 (m, 6H); 
13
C NMR (125 MHz, CDCl3) Mixture of diastereomers 188.4, 155.5, 135.6, 135.4, 
134.9, 133.9, 129.4, 129.0, 123.4, 123.0, 89.2, 89.1, 79.5, 57.5, 57.2, 33.6, 32.4, 32.3, 28.5, 18.7, 
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18.3, 18.1; IR (film, cm
-1
):3415, 3064, 2964, 2927, 2873, 1695, 1556, 1504, 1367, 1252, 1171, 
1003, 974, 688; HRMS (ESI) m/z calculated for C20H29N2O5 [M+H]
+
: 377.2076, found 
377.2085. 
  
 
(E)-2-nitro-1-phenyl-5-((R)-1-tosylpiperidin-2-yl)pent-4-en-1-one 
[73]: (R)-2-allyl-1-tosylpiperidine (69.9 mg, 0.25 mmol, 1.0 equiv) 
was reacted following the general procedure, including K2CO3 washes 
during workup. By 
1
H NMR analysis of the crude product, the linear:branched ratio was >20:1, 
the E/Z isomer ratio was >20:1, and the diastereomeric ratio was 1:1. Flash chromatography 
(25% EtOAc/hexanes) yielded linear product contaminated by ca. 3 wt% 2-(4-nitrobut-1-en-1-
yl)-1-tosylpiperidine as a light yellow oil. A pure spectroscopic sample was obtained by reverse 
phase medium pressure liquid chromatography (SP: C18; MP: 50→90% MeCN/H2O). Run 1 
(71.4 mg, 0.161 mmol, 65% yield); run 2 (75.1 mg, 0.170 mmol, 68% yield). Average yield: 
66%. 
1
H NMR (500 MHz, CDCl3) δ 7.94 (ap. t, J = 7.3 Hz, 2H), 7.66 (m, 3H), 7.54 (ap. t, J = 
7.8 Hz, 2H), 7.27 (d, J = 8.3 Hz, 2H), 6.04 (dd, J = 9.0, 5.1 Hz, 1H, diastereomer A), 6.00 (dd, J 
= 9.3, 4.6 Hz, 1H, diastereomer B), 5.55 (m, 2H), 4.52 (m, 1H), 3.61 (m, 1H), 3.06-2.78 (m, 3H), 
2.41 (s, 3H, diastereomer A), 2.40 (s, 3H, diastereomer B), 1.64-1.41 (m, 4H), 1.40-1.24 (m, 
2H); 
13
C NMR (125 MHz, CDCl3) Mixture of diastereomers 188.4, 143.2, 137.8, 137.6, 135.0, 
135.0, 133.9, 133.8, 133.6, 133.5, 129.7, 129.6, 129.4, 129.4, 128.9, 128.9, 127.3, 127.2, 124.7, 
124.7, 88.9, 88.8, 54.4, 54.0, 41.9, 41.7, 33.6, 33.5, 30.1, 29.8, 24.9, 24.8, 21.6, 19.1, 19.1; IR 
(film, cm
-1
): 3026, 2941, 2860, 1919, 1693, 1562, 1336, 1153, 1093, 935, 752, 660; HRMS (ESI) 
m/z calculated for C23H27N2O5S [M+H]
+
: 443.1641, found 443.1645. 
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(E)-N,N-diethyl-5-nitro-6-oxo-6-phenylhex-2-enamide [74]: N,N-
diethylbut-3-enamide (35.3 mg, 0.25 mmol, 1.0 equiv) was reacted 
following the general procedure. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was >20:1 and the E/Z isomer ratio was >20:1. A short silica plug (100% CH2Cl2; 5% 
MeOH/CH2Cl2), followed by flash chromatography (60% EtOAc/hexanes) yielded pure linear 
product as a light yellow oil. Run 1 (46.7 mg, 0.153 mmol, 61% yield); run 2 (27.9 mg, 0.0917 
mmol, 0.156 mmol scale, 59 % yield). Average yield: 60%. 
1
H NMR (500 MHz, CDCl3) δ 7.98 
(ap. d, J = 7.3 Hz, 2H), 7.68 (ap. t, J = 7.4 Hz, 1H), 7.55 (ap. t, J = 7.9 Hz, 2H), 6.79 (ddd, J = 
14.9, 8.2, 6.6 Hz, 1H), 6.38 (dt, J = 15.1, 1.3Hz, 1H), 6.18 (dd, J = 9.2, 5.0 Hz, 1H), 3.41 (q, J = 
7.1 Hz, 2H), 3.32 (q, J = 7.0 Hz, 2H), 3.27 (m, 1H), 3.07 (m, 1H), 1.16 (t, J = 7.1 Hz, 3H), 1.13 
(t, J = 7.1 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) 187.9, 164.7, 136.3, 135.1, 133.7, 129.5, 129.1, 
126.0, 87.9, 42.4, 41.0, 33.2, 15.0, 13.2; IR (film, cm
-1
): 3440, 3064, 2978, 2935, 1693, 1662, 
1610, 1562, 1450, 1362, 1265, 1146, 943, 781, 692; HRMS (ESI) m/z calculated for C16H21N2O4 
[M+H]
+
: 305.1501, found 305.1498. 
 
(E)-2-(4-nitro-5-oxo-5-phenylpent-1-en-1-yl)cyclohex-1-en-1-yl 
acetate [75]: 2-allylcyclohex-1-en-1-yl acetate (54.1 mg, 0.3 mmol, 
1.0 equiv) was reacted following the general procedure, including 
K2CO3 washes during workup. By 
1
H NMR analysis of the crude product, the linear:branched 
ratio was 5.2:1 and the E/Z isomer ratio was >20:1. Flash chromatography (20% 
EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (63.7 mg, 0.186 mmol, 
62% yield); run 2 (62.8 mg, 0.183 mmol, 0.286 mmol scale, 64% yield). Average yield: 63%. 
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1
H NMR (500 MHz, CDCl3) δ 7.95 (ap. d, J = 7.3 Hz, 2H), 7.67 (ap. t, J = 7.4 Hz, 1H), 7.53 (ap. 
t, J = 7.8 Hz, 2H), 6.41 (d, J = 15.6 Hz, 1H), 6.07 (dd, J = 9.0, 5.1 Hz, 1H), 5.51 (dt, J = 15.2, 7.5 
Hz, 1H), 3.15 (m, 1H), 2.96 (m, 1H), 2.20 (m, 2H), 2.17 (s, 3H), 2.14 (m, 2H), 1.70 (m, 2H), 
1.64 (m, 2H); 
13
C NMR (125 MHz, CDCl3) 188.5, 169.1, 146.6, 134.9, 134.1, 129.6, 129.4, 
129.0, 121.2, 120.3, 89.3, 34.3, 27.9, 24.3, 22.6, 22.0, 21.0; IR (film, cm
-1
): 3064, 2941, 2864, 
1815, 1747, 1693, 1554, 1450, 1371, 1211, 1134, 970, 914, 733; HRMS (ESI) m/z calculated for 
C19H22NO5 [M+H]
+
: 344.1498, found 344.1499. 
 
 
(E)-2-nitro-1,5-diphenylpent-4-en-1-one [47]: Allylbenzene (29.5 
mg, 0.25 mmol, 1.0 equiv) was reacted following the general 
procedure. By 
1
H NMR analysis of the crude product, the linear:branched ratio was 11:1 and the 
E/Z isomer ratio was >20:1. Flash chromatography (12% EtOAc/hexanes) yielded pure linear 
product as a light yellow oil. Run 1 (48.3 mg, 0.172 mmol, 69% yield); run 2 (53.1 mg, 0.189 
mmol, 76% yield), run 3 (63.7 mg, 0.226 mmol, 0.300 mmol scale, 75% yield). Average yield: 
73%. 
1
H NMR (500 MHz, CDCl3) δ 7.99 (m, 2H), 7.67 (m, 1H), 7.54 (m, 2H), 7.30 (m, 4H), 
7.24 (m, 1H), 6.56 (d, J = 15.9 Hz, 1H), 6.17 (dd, J = 9.0, 5.1 Hz, 1H), 6.13 (dt, J = 15.7, 7.2 Hz, 
1H), 3.26 (dddd, J = 15.1, 8.9, 7.6, 1.3 Hz, 1H), 3.08 (dddd, J = 15.0, 6.8, 5.2, 1.5 Hz, 1H); 
13
C 
NMR (125 MHz, CDCl3) 188.4, 136.4, 135.4, 135.0, 134.0, 129.4, 129.0, 128.8, 128.1, 126.5, 
121.7, 89.3, 34.2; IR (film, cm
-1
): 3064, 3027, 2922, 1695, 1559, 1449, 967; HRMS (ESI) m/z 
calculated for C17H15NO3Na [M+Na]
+
: 304.0950, found 304.0941. 
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(E)-2-nitro-1,5-diphenylhex-4-en-1-one [76]: But-3-en-2-ylbenzene 
(39.7 mg, 0.3 mmol, 1.0 equiv) was reacted following the general 
procedure. By 
1
H NMR analysis of the crude product, the linear:branched ratio was >20:1 and 
the E/Z isomer ratio was >20:1. Flash chromatography (15% EtOAc/hexanes) yielded pure linear 
product as a light yellow oil. Run 1(48.0 mg, 0.163 mmol, 54% yield); run 2 (38.8 mg, 0.131 
mmol, 0.250 mmol scale, 53% yield). Average yield: 54%. 
1
H NMR (500 MHz, CDCl3) δ 7.99 
(ap. d, J = 7.3 Hz, 2H), 7.67 (ap. t, J = 7.4 Hz, 1H), 7.54 (ap. t, J = 7.8 Hz, 2H), 7.28 (m, 5H), 
6.15 (dd, J = 8.8, 5.4 Hz, 1H), 5.66 (ap. t, J = 7.4 Hz, 1H), 3.30 (m, 1H), 3.08 (m, 1H), 2.06 (s, 
3H); 
13
C NMR (125 MHz, CDCl3) 188;8, 142.9, 140.7, 134.9, 134.1, 129.4, 129.0, 128.4, 127.5, 
125.9, 119.5, 89.0, 30.3, 16.4; IR (film, cm
-1
): 3059, 2924, 2856, 1693, 1554, 1448, 1371, 1255, 
1184, 760, 696; HRMS (ESI) m/z calculated for C18H17NO3Na 
[M+Na]
+
: 318.1106, found 318.1106. 1D NOE experiments (500 
MHz, CDCl3): Irradiation of the H-6 resonance at δ 2.06 showed 
NOEs to H-3a at δ 3.08, to H-3b at δ 3.30, and to H-2’ at δ 7.28. Irradiation of the H-3a 
resonance at δ 3.08 showed NOEs to H-6 at δ 2.06, to H-3b at δ 3.30, to H-4 at δ 5.66, to H-2 at 
δ 6.15, and to H-2” at δ 7.99. Irradiation of the H-4 resonance at δ 5.66 showed NOEs to H-2’ at 
δ 7.28, to H-3a at δ 3.08, to H-3b at δ 3.30, and to H-2 at δ 6.15.  
 
2-nitro-1,4-diphenylpent-4-en-1-one [77]: -Methylstyrene (39.0 L, 
0.30 mmol, 1.0 equiv) was reacted following the general procedure. 
Flash chromatography (5% EtOAc/hexanes) yielded pure linear product as a light yellow oil. 
Run 1 (41.8 mg, 0.149 mmol, 50% yield). 
1
H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 7.6 Hz, 
2H), 7.64 (t, J = 7.5 Hz, 1H), 7.47 (t, J = 7.8 Hz, 2H), 7.42 – 7.30 (m, 5H), 6.09 (dd, J = 9.2, 5.0 
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Hz, 1H), 5.37 (s, 1H), 5.23 (s, 1H), 3.53 (dd, J = 15.3, 9.2 Hz, 1H), 3.40 (ddd, J = 15.3, 5.1, 1.3 
Hz, 1H); 
13
C NMR (126 MHz, CDCl3) δ 188.77, 141.91, 139.08, 134.82, 134.05, 129.22, 128.94, 
128.91, 128.53, 126.51, 117.53, 87.92, 36.68. 
 
Synthetic elaboration of the allylic alkylation products 
 
 
(E)-5-cyclohexyl-1-phenylpent-4-en-1-one [79]: Prior to use, 
tributyltin hydride was vacuum distilled and α,α′-azoisobutyronitrile 
(AIBN) was recrystallized from acetone. NOTE: The substrate must also be carefully purified, as 
trace quinone impurities were observed to catalyze undesired cleavage of the phenyl ketone to 
yield products such as 79. A 10 mL flame dried round bottom flask fitted with a water cooled 
condenser under argon atmosphere was charged with (E)-5-cyclohexyl-2-nitro-1-phenylpent-4-
en-1-one 67 (57.5 mg, 0.2 mmol, 1.0 equiv) dissolved in benzene (1.5 mL) and a stir bar. To the 
flask was added AIBN (6.6 mg, 0.04 mmol, 0.20 equiv) dissolved in benzene (0.5 mL) and 
tributyltin hydride (106 μL, 0.4 mmol, 2.0 equiv). The reaction was refluxed for 8 h. The crude 
reaction mixture was filtered through a plug of silica and concentrated in vacuo. Purification by 
flash chromatography (0→5% EtOAc/hexanes gradient) provided the pure product. Run 1 (31.3 
mg, 0.129 mmol, 65%); run 2 (31.8 mg, 0.131 mmol, 66%). Average yield: 66%. 
1
H NMR (500 
MHz, CDCl3) δ 7.96 (ap. d, J = 7.1 Hz, 2H), 7.55 (ap. t, J = 7.3 Hz, 1H), 7.46 (ap. t, J = 7.7 Hz, 
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2H), 5.43 (m, 2H), 3.02 (ap. t, J = 7.4 Hz, 2H), 2.42 (m, 2H), 1.89 (m, 1H), 1.72-1.60 (m, 5H), 
1.24 (m, 2H), 1.13 (m, 1H), 1.03 (m, 2H); 
13
C NMR (125 MHz, CDCl3) 200.0, 137.7, 137.2, 
133.0, 128.7, 128.2, 126.0, 40.7, 38.8, 33.2, 27.5, 26.3, 26.2; IR (film, cm
-1
): 3060, 3024, 2924, 
2850, 1687, 1448, 1201, 968, 742, 690; HRMS (ESI) m/z calculated for C17H22ONa [M+Na]
+
: 
265.1568, found 265.1564.  
(E)-1-nitrododec-3-ene [78]: A 50 mL round bottom flask 
was charged with (E)-2-nitro-1-phenyltridec-4-en-1-one 57 (47.6 mg, 0.15 mmol, 1.0 equiv) and 
a stir bar. To the flask was added silica gel (1.5 g) and MeOH (15 mL, 0.01M). The reaction vial 
was capped and stirred for 12 h at room temperature. The crude reaction mixture was filtered and 
concentrated in vacuo. Purification by flash chromatography (3% Et2O/pet. ether) provided the 
pure product. Run 1 (29.6 mg, 0.139 mmol, 93%); run 2 (20.1 mg, 0.094 mmol, 0.100 mmol 
scale, 94%). Average yield: 94%. 
1
H NMR (500 MHz, CDCl3) δ 5.58 (m, 1H), 5.34 (m, 1H), 
4.39 (t, J = 7.0 Hz, 2H), 2.68 (qd, J = 7.0, 0.9 Hz, 2H), 1.99 (q, J = 6.8 Hz, 2H), 1.36-1.22 (m, 
12H), 0.88 (t, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) 135.8, 123.0, 75.6, 32.6, 32.0, 30.7, 
29.6, 29.4, 29.3, 29.2, 22.8, 14.3; IR (film, cm
-1
): 2956, 2926, 2854, 1554, 1433, 1379, 970; 
HRMS (CI) m/z calculated for C12H24NO2 [M+H]
+
: 214.1807, found 214.1797.  
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Stoichiometric Kinetic Studies 
Figure 22: Stoichiometric allylic C-H cleavage 
 
 
 
Figure 22: A ½ dram borosilicate vial was charged with catalyst 1 (10.1 mg, 0.020 mmol, 1.0 
equiv) or catalyst 49 (10.6 mg, 0.020 mmol, 1.0 equiv) and a stir bar. To this was added 1-
undecene 53 (3.1 mg, 0.020 mmol, 1 equiv) as a stock solution in dioxane (300 μL). The reaction 
was allowed to stir for the desired interval at 45°C under air, at which time an acetone solution 
(250 μL) of n-Bu4NCl (22.2 mg, 0.080 mmol, 4 equiv) was added via syringe. The anion 
exchange proceeded at room temperature for 60 min. The mixture was filtered over a plug of 
Celite (to remove metallic Pd) and concentrated and in vacuo. To the crude reaction mixture was 
added 1,4-dimethoxybenzene (0.8 mg, 0.0060 mmol, 0.30 equiv) as a stock solution in CDCl3. 
The crude mixture was dissolved completely in additional CDCl3 and a sample was removed for 
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1
H NMR analysis. Yield was determined by integration of olefinic product peaks relative to 1,4-
dimethoxybenzene. Yields are reported as the average of 3 runs, with error bars representing 
standard deviation. 
 
Figure 23: Stoichiometric -allyl functionalization 
 
 
 
Figure 23: A 1 dram (4 mL) borosilicate vial was charged with 1,2-bis(phenylsulfinyl)ethane L1 
(20.9 mg, 0.075 mmol, 1.5 equiv) or 1,2-bis(benzylsulfinyl)ethane L2 (23.0 mg, 0.075 mmol, 1.5 
equiv), bis[acetato(1,2,3-trihapto-undecene)palladium (II)] 2 (15.9 mg, 0.025 mmol, 1.0 equiv), 
benzoylnitromethane 16 (82.6 mg, 0.50 mmol, 10 equiv), and a stir bar. To this was added 
dioxane (525 μL) and DMSO (225 μL). The reaction vial was capped and stirred at 45°C for the 
desired interval. The vial was cooled to room temperature, and the reaction mixture was diluted 
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with saturated aqueous NH4Cl (15 mL) and extracted with diethyl ether (10 mL). The organic 
layer was washed with 5% aqueous K2CO3 (15 mL). The combined aqueous layers were 
extracted with diethyl ether (2 x 10 mL). The combined organics were dried over MgSO4. The 
mixture was filtered and concentrated in vacuo. To the crude reaction mixture was added 1,4-
dimethoxybenzene (2.1 mg, 0.015 mmol, 0.30 equiv) as a stock solution in CDCl3. The crude 
mixture was dissolved completely in additional CDCl3 and a sample was removed for 
1
H NMR 
analysis. Yield was determined by integration of olefinic product peaks relative to 1,4-
dimethoxybenzene. Yields are reported as the average of 2 runs. 
 
Catalytic Kinetic Studies 
Catalytic kinetics rule out product inhibition 
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Figure 18: A ½ dram borosilicate vial was charged with catalyst 1 (5.0 mg, 0.010 mmol, 0.1 
equiv), benzoylnitromethane 16 (66.1 mg, 0.40 mmol, 4 equiv), dimethylbenzoquinone 58 (15.0 
mg, 0.11 mmol, 1.1 equiv), product 57 (varied equivalents) and a stir bar. To this was added 1-
undecene 53 (20.5 μL, 0.10 mmol, 1 equiv) and 4-nitrophenetole (5.0 mg, 0.030 mmol, 0.3 
equiv, internal standard) as a stock solution in DCE (105 μL) and DMSO (45μL). The vial was 
fitted with a cap with a septum and the reaction was allowed to stir for 2 hours at 45°C under air. 
Reaction aliquots (10 μL) were periodically removed via syringe and filtered through a silica 
plug using 
i
PrOH:hexanes (1:4) solvent. The crude samples were analyzed by HPLC with 
Agilent Technologies, Inc. Zorbax CN 0.46 cm x 25 cm column. A flow rate of 1.5 mL/min at 
35.0°C with 99:1 hexanes:2-propanol with detection at 214 nm gave the 4-nitrophenetole 
standard at 4.53 min and the linear product at 5.47 min. Yield was determined by comparison to 
a standard curve (see Figure 24). Initial rate was determined from a plot of yield versus time (see 
Figure 25 for example). Rates are reported as the average of 3 runs, with error bars representing 
standard deviation. 
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Figure 24: HPLC calibration curve for (E)-2-nitro-1-phenyldodec-4-en-1-one versus nitrophenetole standard 
 
 
Figure 25: Sample plot for initial rates with varied DMSO equivalents 
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Enantiomeric Excess 
 
 
Retention of configuration at the C6 stereocenter was determined by NMR analysis of a bis-
Mosher ester derivative of the product. Comparison of the 
1
H NMR spectrum to the reported 
spectra
68
 revealed only one diastereomer at S/N >200:1, confirming retention of configuration at 
the stereocenter. 
 
Retention of configuration at 
the C7 stereocenter was 
determined by chiral GC 
analysis of a derivative of the product using a J&W Scientific β-cyclodextrin column (30m, 
0.25mm, 0.25μm). Using an isothermal method at 105°C gave the major enantiomer at 249.1 
min and the minor enantiomer at 254.6 min. Enantiopurity was determined to be 92%. 
Enantiopurity of (R)-6-methyldec-9-en-5-one was determined by chiral GC 
analysis using a J&W Scientific β-cyclodextrin column (30m, 0.25mm, 
0.25μm). Using an isothermal method at 60°C gave the major enantiomer at 40.71 min and the 
minor enantiomer at 41.70 min. Enantiopurity was determined to be 92%. 
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Retention of configuration at the C2’ 
stereocenter was determined by chiral 
HPLC analysis of a derivative of the 
product using a Daicel Chemical Industries, Ltd. Chiralcel OJ-H 0.46 cm x 25 cm column. Using 
the reported conditions,
69
 a flow rate of 1.0 mL/min at 30.0°C with 80:20 hexanes:2-propanol 
with detection at 260 nm gave the major enantiomer at 9.86 min and the minor enantiomer at 
10.64 min. Enantiopurity was determined to be 89%. 
Enantiopurity of (R)-2-allyl-1-tosylpiperidine was determined by HPLC analysis 
using a Daicel Chemical Industries, Ltd. Chiralcel OD-H 0.46 cm x 25 cm 
column. Using the reported conditions,
70
 a flow rate of 0.5 mL/min at 25.0°C with 98:2 
hexanes:2-propanol with detection at 260 nm gave the major enantiomer at 18.08 min and the 
minor enantiomer at 20.83 min. Enantiopurity was determined to be 89%. 
 
Starting Materials 
 
Spectral data for known compounds: 
(S)-4,8-dimethylnona-1,7-diene
56
 
 (R)-4-((R)-1-(benzyloxy)but-3-en-1-yl)-2,2-dimethyl-1,3-dioxolane
71
 
1-undecen-4-ol
72
 
tert-butyl (2-methylhex-5-en-3-yl)carbamate
73
 
2-allyl-1-tosylpiperidine
74
 
N,N-diethylbut-3-enamide
75
 
2-allylcyclohex-1-en-1-yl acetate
76
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but-3-en-2-ylbenzene
77
 
 
 
(R)-6-methyldec-9-en-5-one: 
1
H NMR (500 MHz, CDCl3) δ 5.77 
(ddt, J = 17.1, 10.3, 6.7 Hz, 1H), 5.01 (m, 1H), 4.96 (m, 1H), 2.54 
(sextet, J = 6.9 Hz, 1H), 2.43 (m, 2H), 2.02 (m, 2H), 1.77 (m, 1H), 1.54 (m, 2H), 1.40 (m, 1H), 
1.30 (sextet, J = 7.4 Hz, 2H), 1.07 (d, J = 7.1 Hz, 3H), 0.91 (t, J = 7.3 Hz, 3H); 
13
C NMR (125 
MHz, CDCl3) 214.9, 138.3, 115.1, 45.6, 41.2, 32.1, 31.6, 25.9, 22.5, 16.6, 14.0; IR (film, cm
-1
): 
3078, 2960, 2933, 2873, 1712, 1460, 1377, 910; HRMS (ESI) m/z calculated for C11H21O 
[M+H]
+: 169.1592, found 169.1594; [α]D
23
= -17.9° (c=1.0, CHCl3).  
 
1,2-bis(cyclohexylsulfinyl)ethane: 
1
H NMR (500 MHz, CDCl3) δ 3.17 
(m, 2H), 3.01 (m, 2H), 2.66 (m, 2H), 2.15 (m, 2H), 1.91 (m, 6H), 1.72 
(m, 2H), 1.54-1.26 (m, 10H); 
13
C NMR (125 MHz, CDCl3) Mixture of diastereomers 60.5, 59.8, 
42.6, 41.5, 26.3, 26.2, 25.6, 25.6, 25.5, 25.4, 25.4, 25.3, 25.2, 25.2; IR (film, cm
-1
): 2916, 2850, 
1446, 1128, 1113, 1020, 800, 592; HRMS (ESI) m/z calculated for C14H27O2S2 [M+H]
+
: 
291.1452, found 291.1451.  
 
1,2-bis(tert-butylsulfinyl)ethane: 
1
H NMR (500 MHz, CDCl3) δ 2.98 (m, 
2H), 2.92 (m, 1H), 2.81 (m, 1H), 1.29 (s, 18H); 
13
C NMR (125 MHz, CDCl3) 
Mixture of diastereomers 54.3, 53.9 40.5, 39.4, 22.9, 22.9; IR (film, cm
-1
): 2960, 2929, 2870, 
1468, 1180, 1099, 1039, 812, 584; HRMS (ESI) m/z calculated for C10H23O2S2 [M+H]
+
: 
239.1139, found 239.1139.  
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1,2-bis(propylsulfinyl)ethane: 
1
H NMR (500 MHz, CDCl3) δ 3.21 
(m, 2H), 3.02 (m, 2H), 2.83 (m, 2H), 2.69 (m, 2H), 1.84 (sextet, J = 7.5 
Hz, 4H), 1.10 (t, J = 7.4 Hz, 6H); 
13
C NMR (125 MHz, CDCl3) Mixture of diastereomers 55.2, 
54.8, 45.0, 44.4, 16.5, 16.4, 13.4; IR (film, cm
-1
): 2960, 2922, 2873, 1425, 1321, 1136, 1011, 
740; HRMS (ESI) m/z calculated for C8H18O2S2Na [M+Na]
+
: 233.0646, found 233.0648.  
 
Spectroscopic Studies 
Infrared Spectroscopy: Spectra were collected on a Perkin-Elmer Spectrum BX FT-IR 
instrument with a resolution of 1.0 cm
-1
 using an International Crystal Labs model SL-4 0.2 mm 
NaCl solution cell. Solution phase samples were prepared by dissolving 0.01 mmol substrate in 1 
mL CH2Cl2 and waiting 30 min for equilibration. Solid phase samples were prepared by grinding 
0.01 mmol substrate with ca. 500 mg KBr and producing a solid disk using a manual press. 
 
UV-Visible Spectroscopy: Spectra were collected on a Shimadzu Pharma-Spec UV-1700 
instrument with a sampling frequency of 0.5 nm using a 10.00 mm quartz cuvette. Samples were 
prepared by dissolving 0.01 mmol substrate in 1 mL CH2Cl2 and waiting 30 min for 
equilibration, from which an aliquot of 10 μL was removed and diluted with 0.6 mL CH2Cl2.  
 
1
H NMR Spectroscopy: Spectra were collected on a Varian Unity-500 (500 MHz) spectrometer 
equipped with variable temperature control. Samples were prepared by dissolving 0.01 mmol 
substrate in 0.7 mL CDCl3 and waiting 30 min for equilibration. Spectra were collected at +20°C 
and -60°C. 
117 
 
 
 
Notes: No association between Pd(OAc)2 and bis-sulfoxide ligand can be observed by standard 
spectroscopic techniques (IR, UV-Vis, NMR), as judged by a lack of new peaks and no 
significant shifts in existing peaks. Most samples were allowed 30 min for equilibration; 
however, spectra were unchanged after 24 h equilibration. Similarly, catalyst 1 (complexed 24 h 
in refluxing CH2Cl2) was spectroscopicaly indistinguishable from mixed Pd(OAc)2+bis-
sulfoxide. Attempts to crystallize the catalyst result in isolation of separate Pd(OAc)2 trimer and 
bis-sulfoxide crystals.
78
 Previously characterized complexes with Pd-sulfoxide coordination 
exhibit large shifts in spectra from non-complexed materials.
79
 McDonald and Stahl reported 
observation of Pd(TFA)2/DMSO association by NMR and IR, however under identical 
conditions no association of Pd(OAc)2/DMSO was observed (data not shown).
80
 In the absence 
of any observable association of metal and ligand, it is impractical to attempt to monitor ligand 
exchange to provide evidence for alkyl sulfoxides competing with DMSO. 
 
Pd(OAc)2: 
1
H NMR (500 MHz, CDCl3, 23°C) δ 2.00 (s, 6H); 
1
H NMR (500 MHz, CDCl3, -
60°C) δ 2.04 (s, 6H); IR (CH2Cl2, cm
-1
): 1614, 1434, 1354; UV-Vis (CH2Cl2, λmax, nm) 397. 
 
1,2-bis(phenylsulfinyl)ethane (meso diastereomer): 
1
H NMR (500 MHz, CDCl3, 23°C) δ 7.55 
(m, 10H), 3.05 (s, 4H); 
1
H NMR (500 MHz, CDCl3, -60°C) δ 7.54 (m, 10H), 3.03 (s, 4H); IR 
(CH2Cl2, cm
-1
): 1478, 1444, 1412, 1085, 1070, 1046, 1022, 999; UV-Vis (CH2Cl2, λmax, nm) 250. 
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1,2-bis(benzylsulfinyl)ethane (mixture of diastereomers): 
1
H NMR (500 MHz, CDCl3, 23°C) δ 
7.37 (m, 6H), 7.27 (m, 4H), 4.03 (m, 4H), 3.06-2.82 (m, 4H); 
1
H NMR (500 MHz, CDCl3, -
60°C) δ 7.38 (m, 6H), 7.26 (m, 4H), 4.07 (m, 4H), 3.03-2.79 (m, 4H); IR (CH2Cl2, cm
-1
): 1497, 
1456, 1070, 1047, 1031; UV-Vis (CH2Cl2, λmax, nm) N/A. 
 
Pd(OAc)2 + 1 equiv 1,2-bis(phenylsulfinyl)ethane) [1]: 
1
H NMR (500 MHz, CDCl3, 23°C) δ 
7.56 (m, 10H), 3.05 (s, 4H), 2.00 (s, 6H); 
1
H NMR (500 MHz, CDCl3, -60°C) δ 7.55 (m, 10H), 
3.03 (s, 4H), 2.05 (s, 6H); IR (CH2Cl2, cm
-1
): 1614, 1478, 1444, 1439, 1435, 1432, 1428, 1424, 
1084, 1070, 1046, 1023, 999; UV-Vis (CH2Cl2, λmax, nm) 392, 247. 
 
Pd(OAc)2 + 1 equiv 1,2-bis(benzylsulfinyl)ethane) [49]: 
1
H NMR (500 MHz, CDCl3, 23°C) δ 
7.37 (m, 6H), 7.27 (m, 4H), 4.04 (m, 4H), 3.04-2.81 (m, 4H), 2.00 (s, 6H); 
1
H NMR (500 MHz, 
CDCl3, -60°C) δ 7.37 (m, 6H), 7.25 (m, 4H), 4.07 (m, 4H), 3.03-2.79 (m, 4H), 2.05 (s, 6H); IR 
(CH2Cl2, cm
-1
): 1614, 1497, 1455, 1439, 1432, 1354, 1070, 1046, 1031; UV-Vis (CH2Cl2, λmax, 
nm) 394. 
 
bis[acetato(1,2,3-trihapto-undecene)palladium (II)]: 
1
H NMR (500 MHz, CDCl3, 23°C) δ 5.17 
(m, 1H), 3.65 (m, 2H), 2.63 (m, 1H), 2.01 (bs, 3H), 1.56-1.16 (m, 14H), 0.88 (t, J = 6.8 Hz, 3H); 
1
H NMR (500 MHz, CDCl3, -60°C) δ 5.34-4.97 (m, 1H), 3.89-3.43 (m, 2H), 2.84-2.43 (m, 1H), 
2.04 (m, 3H), 1.57-1.25 (m, 14H), 0.82 (m, 3H); IR (CH2Cl2, cm
-1
): 2929, 2859, 1577, 1422, 
1217; UV-Vis (CH2Cl2, λmax, nm) 277. 
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bis[acetato(1,2,3-trihapto-undecene)palladium (II)] + 1 equiv 1,2-bis(phenylsulfinyl)ethane): 
1
H NMR (500 MHz, CDCl3, 23°C) δ 7.53 (m, 10H), 5.19 (m, 1H), 3.64 (m, 2H), 2.63 (m, 1H), 
3.05 (s, 4H), 2.02 (bs, 3H), 1.53-1.17 (m, 14H), 0.87 (t, J = 6.8 Hz, 3H); 
1
H NMR (500 MHz, 
CDCl3, -60°C) δ 7.54 (m, 10H), 5.33-4.97 (m, 1H), 3.89-3.41 (m, 2H), 3.04 (s, 4H), 2.83-2.43 
(m, 1H), 2.04 (m, 3H), 1.60-1.26 (m, 14H), 0.82 (m, 3H); IR (CH2Cl2, cm
-1
): 2926, 2854, 1577, 
1478, 1444, 1423, 1085, 1070, 1047, 1022, 999; UV-Vis (CH2Cl2, λmax, nm) 248. 
 
bis[acetato(1,2,3-trihapto-undecene)palladium (II)] + 1 equiv 1,2-bis(benzylsulfinyl)ethane): 
1
H NMR (500 MHz, CDCl3, 23°C) δ 7.37 (m, 6H), 7.27 (m, 4H), 5.17 (m, 1H), 4.04 (m, 4H), 
3.65 (m, 2H), 3.05-2.82 (m, 4H), 2.63 (m, 1H), 2.00 (bs, 3H), 1.55-1.13 (m, 14H), 0.87 (t, J = 6.7 
Hz, 3H); 
1
H NMR (500 MHz, CDCl3, -60°C) δ 7.37 (m, 6H), 7.26 (m, 4H), 5.37-4.95 (m, 1H), 
4.07 (m, 4H), 3.89-3.43 (m, 2H), 3.03-2.43 (m, 5H), 2.05 (m, 3H), 1.51-1.26 (m, 14H), 0.81 (bs, 
3H); IR (CH2Cl2, cm
-1
): 2931, 2856, 1577, 1497, 1455, 1430, 1422, 1072, 1046, 1030, 897; UV-
Vis (CH2Cl2, λmax, nm) N/A. 
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CHAPTER 3 
ALLYLIC C-H ALKYLATION USING TERTIARY NUCLEOPHILES 
3.1 INTRODUCTION 
The work discussed in Chapters 1 and 2 described the discovery of an allylic C-H 
alkylation reaction and the expansion of the substrate scope of this reaction to encompass 
virtually any -olefin.  However, the reaction remained relatively limited in the scope of 
nucleophiles that could be appended to the olefin substrate.  The nucleophiles which were 
suitable for this reaction were activated methylene compounds bearing two strongly electron-
withdrawing groups.  Relatively little variation of the nucleophile was possible beyond 
interchanging different electron-withdrawing moieties.   
While considering the options for future development of the allylic C-H alkylation we 
concluded that, rather than appending a predefined subunit to a substrate, a reaction that could 
support variation of each coupling partner would be preferable.  This principle is demonstrated in 
the Pd(0)-catalyzed allylic alkylation literature, for example in the first asymmetric synthesis of 
strychnine by Overman and coworkers.
81
  A palladium(0)-catalyzed alkylation of an allylic 
oxygenate substrate stereospecifically forges the C14-C21 bond, found in the final product, at an 
early stage in the sequence (Figure 26).  Notably, all of the core carbon atoms of both the 
electrophile and the nucleophile are included in the final product.  This application was possible 
because both of the coupling partners could be tailored to meet the requirements of the desired  
Figure 26: Total synthesis of strychnine using allylic alkylation as a key step 
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reaction; the nucleophile and the electrophile must each tolerate a degree of modification.   
As an initial step toward a more versatile nucleophile coupling partner, we envisioned 
substituting the parent compound with an aliphatic chain.  This activated methine compound 
would be more sterically hindered, but its pKa should remain within the desired range.  Tertiary 
nucleophiles are commonly used in palladium(0) catalyzed allylic alkylations;
82
 substitution of 
the nucleophile prevents overalkylation.
83
  Two allylic C-H alkylation methods have been 
reported which employ tertiary nucleophiles, however, in both cases the regio- and 
stereoselectivities are variable and the reaction is constrained to a narrow substrate scope; 
propene and 1,4 dienes, respectively, are the only reported substrates.
14f,84
   
If we could develop a more versatile and reliable allylic C-H alkylation with tertiary 
nucleophiles, we envisioned a number of synthetic applications.  By tethering the nucleophile to 
the substrate through the aliphatic substituent, a macrocyclization protocol could be envisioned 
(Figure 27).  An analogous Pd(0)-catalyzed macrocyclization has been applied repeatedly in total 
synthesis.
85,86
  Alternatively, we reasoned that a tertiary nucleophile could be well-suited to the 
development of an asymmetric allylic alkylation.  The stereogenic center formed in the reaction 
would be fully substituted and therefore not susceptible to epimerization, which is a rapid 
process for enolizable centers under these conditions.
87
   
Figure 27: Proposed synthetic applications for tertiary nucleophiles 
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3.2 RESULTS AND DISCUSSION 
Our investigation began with a prototypical tertiary nucleophile, methyl 2-
nitropropionate.  We were delighted to find that upon reaction with allylbenzene under our 
reported conditions this nucleophile afforded a 30% yield of the desired product (Table 9, entry 
1).  Encouragingly, the reaction proceeded with excellent regioselectivity and stereoselectivity 
(>20:1 linear:branch, >20:1 E:Z).  The yield of the process was improved through standard 
optimization of reaction conditions.  A more acidic nucleophile, 2-nitropropiophenone, led to a 
moderate improvement in yield (entry 2).  Consistent with our expectation that tertiary 
nucleophiles would react more slowly due to their steric bulk, switching from 1 to the more 
robust and longer-lived catalyst 49 (see Chapter 2) was productive (entry 3).  Finally, adjusting 
the ratio of the cosolvents to 1:4 dioxane:DMSO provided the final improvement to a 
synthetically useful yield (entry 4). 
Table 9: Optimization of the allylic alkylation with tertiary nucleophiles 
 
We investigated the scope of tertiary nucleophiles suitable for the allylic C–H alkylation 
reaction (Table 10).  A variety of functionalities, including ketone, ester, sulfonyl and nitro 
moieties were found to be suitable electron withdrawing groups (entries 1, 4, 5).  Substitution of 
the aromatic ring of the nucleophile was tolerated, including an aryl chloride which provided a 
handle for further derivatization (entries 2, 3).  The alkyl substituent of the nucleophile could be 
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varied to longer chains or a cyclic tetralone derivative (entries 6, 7), and additional non-
participating functional groups could be included on the nucleophile (entry 11).  Product 92 was 
notable because the alcohol moiety could potentially be esterified to a carboxylate on the 
substrate, thereby providing a macrocyclic annulation protocol.  For reactions in which the 
nucleophile coupling partner was particularly valuable, it could be used in limiting quantities 
with good yields (entry 12). 
A nucleophile pKa dependence was noted, consistent with the notion that the nucleophile 
must undergo facile keto-enol tautomerisation or deprotonation by endogenous acetate base in  
Table 10: Nucleophile scope of the allylic C-H alkylation 
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situ. Methyl Meldrum’s acid, a uniquely acidic dicarbonyl compound, was found to be a suitable 
nucleophile (entry 8). Additionally, other carbonyl compounds were found to effect C-C bond 
formation provided that all three substituents were electron withdrawing (entries 9, 10). 
Our investigation subsequently shifted to an exploration of the scope of -olefin 
substrates suitable for the reaction (Table 11).  We found that a variety of substituted 
allylbenzenes were readily functionalized, including substrates bearing electron donating and 
electron withdrawing groups (entries 2, 3).  Notably, in all cases high regioselectivity for 
formation of linear alkylation product was observed.  This selectivity, arising from nucleophilic 
attack at the least hindered terminus of the -allyl intermediate, contrasted with our previous 
observation of variable regioselectivity with less bulky nucleophiles.  The reaction was relatively 
insensitive to steric hindrance of the substrate (entry 6), and functional groups which may be 
further elaborated via Pd(0) cross-coupling were inert to the reaction conditions (entries 4, 5).  A 
number of activated, non-aromatic compounds were efficiently alkylated (entries 7-9).  We 
found, however, that unactivated -olefin substrates furnished only modest yields of 20-30%.  A 
variety of heterocyclic functionalities which are prevalent in biologically active molecules, such 
as indole, chromene and diketopiperazine was tolerated (entries 10-12). The xanthene core, 
important in materials and synthetic applications, was functionalized smoothly (entry 14). This 
method was also suitable for derivatization of natural products. The common steroid (+)-estrone 
was elaborated via a short synthetic route (entry 13). Similarly, (-)-maculosin, a naturally 
occurring diketopiperazine phytotoxin isolated from a fungal pathogen of spotted knapweed,
88
 
was readily derivatized (entry 12). 
135 
 
Table 11: Olefin scope of the allylic C-H alkylation 
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The strategy of C–H activation is often described as a means to rapidly build molecular 
complexity.  It possesses an inherent advantage over traditional methods because it eliminates 
preactivation of substrates common to many C-C bond forming reactions.  We sought to 
demonstrate this principle by effecting two sequential allylic alkylation reactions, exploiting the 
divergent reactivities of our previously reported conditions and the present work (Figure 28).  
Thus, beginning with three simple compounds available in bulk quantities from commercial 
sources, we first coupled allylcyclohexane and benzoylnitromethane to furnish 67 (see Table 8, 
entry 2).  Taking advantage of the latent nucleophilicity of this product, we subsequently reacted 
it with allylbenzene to produce the fully substituted compound 107 in only two steps, having 
incorporated all but four hydrogen atoms of the substrates in the final product.  Notably, the 
sequence proceeded in 56% overall yield.  In the second step, the more complex and valuable 
nucleophile component was used in limiting quantities with good results. 
Figure 28: Sequential allylic C-H alkylation reactions 
 
3.3 CONCLUSIONS 
This work resulted in the development of an intermolecular allylic C-H alkylation 
reaction using trisubstituted nucleophiles.  Modest optimization of the reaction conditions 
allowed a variety of nucleophiles bearing two electron-withdrawing groups and an aliphatic 
substituent to participate in the alkylation.  The addition of an aliphatic chain opens a window for 
diversification of the nucleophile coupling partner.  A wide variety of nucleophiles was explored, 
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including examples bearing more elaborate side chains.  Future efforts will focus on the 
development of a macrocyclization protocol by tethering the nucleophile to the substrate, and an 
enantioselective allylic alkylation.   
3.4 EXPERIMENTAL SECTION 
General Information: All commercially obtained reagents for the allylic alkylation reaction 
were used as received: 2,6-dimethylbenzoquinone, allylbenzene, estragole, triacetylmethane, 
2,2,5-trimethyl-1,3-dioxane-4,6-dione (Sigma-Aldrich); 1-allylcyclohexene (ChemSampCo), 
ethyl diacetoacetate (Alfa Aesar). Catalyst 49 was prepared according to the published 
procedure.
54
 Catalysts 49 was stored at 4°C and weighed out in air prior to use. Dioxane was 
purified prior to use by passage through a bed of activated alumina (Glass Contour, Laguna 
Beach, California). Dimethyl sulfoxide (DMSO) was obtained from Fisher Scientific and stored 
under argon. All allylic alkylation reactions were run under air. Thin-layer chromatography 
(TLC) was conducted with E. Merck silica gel 60 F254 precoated plates (0.25 mm) and 
visualized with UV and potassium permanganate stain. Flash chromatography was performed as 
described by Still using ZEOprep 60 ECO 43-60 micron silica gel (American International 
Chemical, Inc.).
35
 Medium pressure liquid chromatography was performed on a Teledyne Isco 
CombiFlash Rf machine using pre-packed RediSep columns (12g C18) at a rate of 30 mL/min. 
1
H NMR spectra were recorded on a Varian Unity-400 (400 MHz), Varian Inova-500 (500 
MHz), or Varian Unity-500 (500 MHz) spectrometer and are reported in ppm using solvent as an 
internal standard (CHCl3 at 7.26 ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, m = multiplet, b = broad, ap = apparent; coupling constant(s) in Hz; 
integration. Proton-decoupled 
13
C NMR spectra were recorded on a Varian Unity-500 (125 
MHz) spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 
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77.16 ppm). Stereoselectivity of the allylic alkylation reaction was determined by 
1
H NMR 
analysis of the crude reaction mixture. IR spectra were recorded as thin films on NaCl plates on a 
Perkin-Elmer Spectrum BX FT-IR and are reported in frequency of absorption (cm
-1
). High-
resolution mass spectra were obtained at the University of Illinois Mass Spectrometry 
Laboratory. Optical rotations were obtained using a JAS.CO DIP-360 digital polarimeter and a 
3.5 x 50 mm cell and are reported as follows: concentration (c = g / 100 mL), solvent.  
 
General Procedure for the Allylic Alkylation: An oven dried one dram (4 mL) borosilicate 
vial was charged with Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 49 (0.10 equiv, 0.030 mmol) and 
2,6-dimethylbenzoquinone (1.5 equiv, 0.45 mmol). The olefin (1 equiv, 0.30 mmol), nucleophile 
(2.0 equiv, 0.60 mmol). dimethylsulfoxide (0.72 mL), dioxane (0.18 mL) and a stir bar were 
added sequentially via syringe to the reaction vial. The reaction setup is performed open to the 
atmosphere. The reaction vial was capped and stirred at 45°C for 24 hours in an oil bath. The vial 
was cooled to room temperature, and the reaction mixture was diluted with saturated aqueous 
NH4Cl (40 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organics were dried 
over MgSO4. The mixture was filtered and concentrated in vacuo. Purification by flash 
chromatography (SiO2, EtOAc/hexanes mixtures) provided the pure linear product.  
Optimization of the allylic alkylation with tertiary nucleophiles 
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Table 9: Allylic C-H alkylation screening procedure: A ½ dram oven dried borosilicate vial 
was charged with catalyst (0.010 mmol, 0.1 equiv) and 2,6-dimethylbenzoquinone 58 (20.4 mg, 
0.15 mmol, 1.5 equiv). 1,4-dioxane, dimethylsulfoxide, allylbenzene 18 (13.2 μL, 0.10 mmol, 1 
equiv), nucleophile (0.20 mmol, 2 equiv), and a stir bar were added sequentially. No further 
precautions were taken to exclude air or moisture. The vial was capped and stirred for 24h at 
45°C. The vial was cooled to room temperature and the reaction mixture was quenched with 
saturated aqueous NH4Cl (10 mL) and extracted with two 10mL portions of diethyl ether. The 
organic extracts were dried over MgSO4. The mixture was filtered and concentrated in vacuo. To 
the crude reaction mixture was added 1,4-dimethoxybenzene (4.1 mg, 0.030 mmol, 0.30 equiv) 
as a stock solution in CDCl3. The crude mixture was dissolved completely in additional CDCl3 
and a sample was removed for 
1
H NMR analysis. Yield was determined by integration of olefinic 
product peaks relative to 1,4-dimethoxybenzene.  
 
Entry 1: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), methyl 2-nitropropionate 80 (26.6 mg, 0.20 
mmol, 2.0 equiv), dioxane (240 μL), DMSO (60 μL) and 1,4-dimethoxybenzene (4.1 mg, 0.030 
mmol, 0.30 equiv) were used. Run 1 (30% yield); run 2 (30% yield). Average yield: 30%. 
 
Entry 2: Catalyst 1 (5.0 mg, 0.10 mmol, 1.0 equiv), 2-nitropropiophenone 81 (35.8 mg, 0.20 
mmol, 2.0 equiv), dioxane (240 μL), DMSO (60 μL) and 1,4-dimethoxybenzene (4.1 mg, 0.030 
mmol, 0.30 equiv) were used. Run 1 (33% yield); run 2 (30% yield). Average yield: 32%. 
 
Entry 3: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), 2-nitropropiophenone 81 (26.6 mg, 0.20 
mmol, 2.0 equiv), dioxane (240 μL), DMSO (60 μL) and 1,4-dimethoxybenzene (4.1 mg, 0.030 
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mmol, 0.30 equiv) were used. Run 1 (39% yield); run 2 (36 yield). Average yield: 38%. 
 
Entry 4: Catalyst 49 (5.3 mg, 0.10 mmol, 1.0 equiv), 2-nitropropiophenone 81 (26.6 mg, 0.20 
mmol, 2.0 equiv), dioxane (60 μL), DMSO (240 μL) and 1,4-dimethoxybenzene (4.1 mg, 0.030 
mmol, 0.30 equiv) were used. Run 1 (50% yield); run 2 (50% yield). Average yield: 50%. 
 
Nucleophile scope of the allylic C-H alkylation 
 
141 
 
(E)-2-methyl-2-nitro-1,5-diphenylpent-4-en-1-one [82] : 
Allylbenzene (39.7 L, 0.3 mmol, 1.0 equiv) and 2-
nitropropiophenone (108 mg, 0.6 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (4% EtOAc/hexanes) yielded pure linear product as a light 
yellow oil. Run 1 (52.2 mg, 0.177 mmol, 59% yield); run 2 (49.8 mg, 0.169 mmol, 56% yield). 
Average yield: 57%. 
1
H NMR (500 MHz, CDCl3) δ 7.80 (dd, J = 7.5, 1.6 Hz, 2H), 7.59 (t, J = 
7.5 Hz, 1H), 7.45 (t, J = 7.8 Hz, 2H), 7.36 – 7.28 (m, 4H), 7.26 – 7.20 (m, 1H), 6.49 (d, J = 15.6 
Hz, 1H), 6.02 (dt, J = 15.5, 7.6 Hz, 1H), 3.26 (dd, J = 14.4, 7.3 Hz, 1H), 3.15 (dd, J = 14.4, 7.9 
Hz, 1H), 1.96 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 191.7, 136.5, 136.4, 133.9, 133.5, 129.0, 
128.7, 128.6, 128.0, 126.6, 120.8, 95.5, 42.0, 22.5; IR (film, cm
-1
): 3060, 3028, 2941, 2875, 
1967, 1815, 1691, 1597, 1545, 1495, 1448, 1385, 1346, 1255, 972, 744, 692; HRMS (ESI) m/z 
calculated for C18H18NO3 [M+H]
+
: 296.1287, found 296.1292. 
 
(E)-1-(4-chlorophenyl)-2-methyl-2-nitro-5-phenylpent-4-en-1-
one [83] : Allylbenzene (39.7 L, 0.3 mmol, 1.0 equiv) and 4′-
chloro-2-nitropropiophenone (128 mg, 0.6 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (4% EtOAc/hexanes) yielded pure linear product as a light 
yellow oil. Run 1 (57.7 mg, 0.175 mmol, 58% yield); run 2 (59.0 mg, 0.179 mmol, 60% yield). 
Average yield: 59%. 
1
H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 8.6 Hz, 2H), 7.43 (d, J = 8.6 
Hz, 2H), 7.35 – 7.28 (m, 4H), 7.26 – 7.23 (m, 1H), 6.48 (d, J = 15.7 Hz, 1H), 6.00 (dt, J = 15.5, 
7.5 Hz, 1H), 3.24 (dd, J = 14.5, 7.2 Hz, 1H), 3.13 (dd, J = 14.4, 7.9 Hz, 1H), 1.94 (s, 3H); 
13
C 
NMR (126 MHz, CDCl3) δ 190.6, 140.5, 136.5, 136.4, 131.8, 130.0, 129.4, 128.7, 128.1, 126.6, 
120.5, 95.4, 41.9, 22.5; IR (film, cm
-1
): 3028, 2924, 1691, 1589, 1543, 1491, 1448, 1385, 1254, 
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1093, 970, 845, 744, 692; HRMS (EI) m/z calculated for C18H16NO3Cl [M]
+
: 329.0819, found 
329.0810. 
 
(E)-1-(4-methoxyphenyl)-2-methyl-2-nitro-5-phenylpent-4-
en-1-one [84] : Allylbenzene (39.7 L, 0.3 mmol, 1.0 equiv) and 
4′-methoxy-2-nitropropiophenone (188 mg, 0.9 mmol, 3.0 equiv) were reacted following the 
general procedure. Flash chromatography (510% EtOAc/hexanes gradient) yielded pure linear 
product as a light yellow oil. Run 1 (48.9 mg, 0.150 mmol, 50% yield); run 2 (47.7 mg, 0.147 
mmol, 49% yield). Average yield: 50%. 
1
H NMR (500 MHz, CDCl3) δ 7 .80 (d, J = 9.0 Hz, 
2H), 7.36 – 7.27 (m, 4H), 7.24 – 7.20 (m, 1H), 6.92 (d, J = 9.0 Hz, 2H), 6.48 (d, J = 15.6 Hz, 
1H), 6.03 (dt, J = 15.4, 7.5 Hz, 1H), 3.87 (s, 3H), 3.24 (dd, J = 14.4, 7.3 Hz, 1H), 3.13 (dd, J = 
14.4, 7.9 Hz, 1H), 1.94 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 190.0, 164.1, 136.6, 136.2, 131.2, 
128.7, 128.0, 126.6, 126.1, 121.1, 114.3, 95.4, 55.7, 42.1, 22.7; IR (film, cm
-1
): 3082, 3026, 
2939, 2843, 1680, 1601, 1574, 1543, 1512, 1450, 1385, 1315, 1257, 1178, 1144, 1028, 972, 845, 
742, 692; HRMS (ESI) m/z calculated for C19H19NO4Na [M+Na]
+
: 348.1212, found 348.1214. 
 
(E)-methyl 2-methyl-2-nitro-5-phenylpent-4-enoate [85] : 
Allylbenzene (39.7 L, 0.3 mmol, 1.0 equiv) and methyl 2-
nitropropanoate (79.9 mg, 0.6 mmol, 2.0 equiv) were reacted following the general procedure. 
Flash chromatography (510% EtOAc/hexanes gradient) yielded pure linear product as a light 
yellow oil. Run 1 (39.4 mg, 0.158 mmol, 53% yield); run 2 (38.8 mg, 0.156 mmol, 52% yield). 
Average yield: 53%. 
1
H NMR (500 MHz, CDCl3) δ 7.36 – 7.29 (m, 4H), 7.27 – 7.22 (m, 1H), 
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6.52 (d, J = 15.7 Hz, 1H), 6.01 (dt, J = 15.4, 7.5 Hz, 1H), 3.83 (s, 3H), 3.16 (ddd, J = 14.3, 7.4, 
1.3 Hz, 1H), 3.02 (ddd, J = 14.3, 7.7, 1.3 Hz, 1H), 1.81 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 
167.8, 136.5, 136.4, 128.7, 128.1, 126.5, 120.7, 92.4, 53.7, 40.4, 21.4; IR (film, cm
-1
): 3026, 
2956, 1955, 1888, 1755, 1552, 1496, 1450, 1387, 1352, 1261, 1215, 1130, 972, 741, 694; HRMS 
(ESI) m/z calculated for C13H15NO4Na [M+Na]
+
: 272.0899, found 272.0905. 
 
(E)-(4-nitro-4-(phenylsulfonyl)pent-1-en-1-yl)benzene [86] : 
Allylbenzene (39.7 L, 0.3 mmol, 1.0 equiv) and 1-
(phenylsulfonyl)nitroethane (129 mg, 0.6 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (1015% EtOAc/hexanes gradient) yielded pure linear 
product as a light yellow oil. Run 1 (66.4 mg, 0.200 mmol, 67% yield); run 2 (66.9 mg, 0.202 
mmol, 67% yield). Average yield: 67%. 
1
H NMR (500 MHz, CDCl3) δ 7.90 (d, J = 7.6 Hz, 2H), 
7.78 (t, J = 7.4 Hz, 1H), 7.63 (t, J = 7.8 Hz, 2H), 7.33 – 7.28 (m, 4H), 7.28 – 7.24 (m, 1H), 6.54 
(d, J = 15.7 Hz, 1H), 5.90 (dt, J = 15.3, 7.4 Hz, 1H), 3.41 (dd, J = 14.4, 6.8 Hz, 1H), 3.05 (dd, J 
= 14.3, 8.0 Hz, 1H), 1.97 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 137.7, 136.0, 135.5, 132.8, 
131.1, 129.4, 128.8, 128.4, 126.5, 118.6, 106.5, 37.2, 17.2; IR (film, cm
-1
): 3062, 3032, 2924, 
1552, 1448, 1333, 1155, 1074, 972, 742, 719, 688; HRMS (ESI) m/z calculated for 
C17H17SNO4Na [M+Na]
+
: 354.0776, found 354.0777. 
 
2-cinnamyl-2-nitro-3,4-dihydronaphthalen-1(2H)-one [87] : 
Allylbenzene (39.7 L, 0.3 mmol, 1.0 equiv) and 2-nitro-1-tetralone 
(115 mg, 0.6 mmol, 2.0 equiv) were reacted following the general procedure. Flash 
chromatography (510% EtOAc/hexanes gradient) yielded pure linear product as a light yellow 
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oil. Run 1 (69.8 mg, 0.227 mmol, 76% yield); run 2 (69.0 mg, 0.225 mmol, 75% yield). Average 
yield: 76%. 
1
H NMR (500 MHz, CDCl3) δ 8.12 (d, J = 7.7 Hz, 1H), 7.55 (t, J = 7.6 Hz, 1H), 
7.38 (t, J = 7.6 Hz, 1H), 7.36 – 7.20 (m, 6H), 6.57 (d, J = 15.8 Hz, 1H), 6.16 (dt, J = 15.4, 7.4 
Hz, 1H), 3.23 (dd, J = 14.5, 7.2 Hz, 1H), 3.16 – 2.93 (m, 4H), 2.50 (ddd, J = 14.2, 8.9, 4.6 Hz, 
1H); 
13
C NMR (126 MHz, CDCl3) δ 188.1, 142.5, 136.5, 136.1, 134.7, 130.8, 129.1, 128.9, 
128.7, 128.1, 127.6, 126.5, 121.7, 94.0, 38.2, 31.8, 25.4; IR (film, cm
-1
): 3068, 3024, 2937, 1693, 
1601, 1545, 1454, 1290, 1232, 970, 742, 692; HRMS (ESI) m/z calculated for C19H18NO3 
[M+H]
+
: 308.1287, found 308.1294. 
 
(E)-2-ethyl-2-nitro-1,5-diphenylpent-4-en-1-one [88] : Allylbenzene 
(39.7 L, 0.3 mmol, 1.0 equiv) and 2-nitrobutylphenone (116 mg, 0.6 
mmol, 2.0 equiv) were reacted following the general procedure. Flash chromatography (3% 
EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (53.9 mg, 0.174 mmol, 
58% yield); run 2 (52.7 mg, 0.170 mmol, 57% yield). Average yield: 58%. 
1
H NMR (500 MHz, 
CDCl3) δ 7.80 (d, J = 7.8 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.45 (t, J = 7.8 Hz, 2H), 7.33 – 7.27 
(m, 4H), 7.25 – 7.20 (m, 1H), 6.45 (d, J = 15.7 Hz, 1H), 5.91 (dt, J = 15.5, 7.6 Hz, 1H), 3.27 – 
3.21 (m, 2H), 2.55 – 2.39 (m, 2H), 0.91 (t, J = 7.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 
191.1, 136.5, 136.0, 134.0, 133.8, 129.0, 128.7, 128.5, 128.0, 126.5, 120.6, 99.0, 38.1, 27.7, 7.9; 
IR (film, cm
-1
): 3059, 3026, 2980, 2885, 1689, 1597, 1539, 1495, 1448, 1360, 1230, 1186, 968, 
746, 692; HRMS (ESI) m/z calculated for C19H19NO3Na [M+Na]
+
: 332.1263, found 332.1257. 
 
145 
 
5-cinnamyl-2,2,5-trimethyl-1,3-dioxane-4,6-dione [89] : 
Allylbenzene (39.7 L, 0.3 mmol, 1.0 equiv) and 2,2,5-trimethyl-1,3-
dioxane-4,6-dione (94.9 mg, 0.6 mmol, 2.0 equiv) were reacted following the general procedure. 
Flash chromatography (1020% EtOAc/hexanes gradient) yielded pure linear product as a light 
yellow oil. Run 1 (51.1 mg, 0.186 mmol, 62% yield); run 2 (50.4 mg, 0.184 mmol, 61% yield). 
Average yield: 62%. 
1
H NMR (500 MHz, CDCl3) δ 7.34 – 7.27 (m, 4H), 7.25 – 7.21 (m, 1H), 
6.52 (d, J = 15.7 Hz, 1H), 6.04 (dt, J = 15.6, 7.7 Hz, 1H), 2.91 (d, J = 7.7 Hz, 2H), 1.72 (s, 3H), 
1.69 (s, 3H), 1.63 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 170.1, 136.5, 135.9, 128.7, 128.0, 
126.5, 122.0, 105.3, 50.5, 43.4, 29.7, 29.0, 24.4; IR (film, cm
-1
): 3030, 2999, 2941, 1778, 1745, 
1452, 1381, 1279, 1203, 1146, 1059, 976, 945, 742, 692; HRMS (EI) m/z calculated for 
C16H18O4 [M]
+
: 274.1205, found 274.1198. 
 
3-acetyl-3-cinnamylpentane-2,4-dione [90] : Allylbenzene (39.7 L, 0.3 
mmol, 1.0 equiv) and triacetylmethane (80.0 L, 0.6 mmol, 2.0 equiv) 
were reacted following the general procedure. Flash chromatography (1015% EtOAc/hexanes 
gradient) yielded pure linear product as a light yellow oil. Run 1 (51.6 mg, 0.200 mmol, 67% 
yield); run 2 (50.5 mg, 0.196 mmol, 65% yield). Average yield: 66%. 
1
H NMR (500 MHz, 
CDCl3) δ 
1
H NMR (500 MHz, Chloroform-d) δ 7.31 – 7.27 (m, 4H), 7.24 – 7.19 (m, 1H), 6.47 
(dt, J = 15.8, 1.5 Hz, 1H), 6.00 (dt, J = 15.7, 7.3 Hz, 1H), 3.06 (dd, J = 7.3, 1.4 Hz, 2H), 2.21 (s, 
9H); 
13
C NMR (126 MHz, CDCl3) δ 203.1, 136.6, 134.4, 128.7, 127.9, 126.5, 123.3, 84.9, 34.9, 
28.5; IR (film, cm
-1
): 3026, 2918, 1699, 1495, 1427, 1358, 1201, 1167, 972, 746, 694; HRMS 
(ESI) m/z calculated for C16H18O3Na [M+Na]
+
: 281.1154, found 281.1163. 
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(E)-ethyl 2,2-diacetyl-5-phenylpent-4-enoate [91] : Allylbenzene (39.7 
L, 0.3 mmol, 1.0 equiv) and ethyl diacetoacetate (93.6 L, 0.6 mmol, 
2.0 equiv) were reacted following the general procedure. Flash chromatography (1020% 
EtOAc/hexanes gradient) yielded pure linear product as a light yellow oil. Run 1 (59.7 mg, 0.207 
mmol, 69% yield); run 2 (57.7 mg, 0.200 mmol, 67% yield). Average yield: 68%. 
1
H NMR 
(500 MHz, CDCl3) δ 7.33 – 7.27 (m, 4H), 7.24 – 7.18 (m, 1H), 6.45 (d, J = 15.8 Hz, 1H), 6.15 
(dt, J = 15.7, 7.3 Hz, 1H), 4.28 (q, J = 7.2 Hz, 2H), 2.99 (dd, J = 7.4, 1.4 Hz, 2H), 2.28 (s, 6H), 
1.30 (t, J = 7.1 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 201.4, 168.1, 136.9, 134.3, 128.6, 127.7, 
126.4, 123.9, 77.5, 62.3, 35.9, 28.8, 14.1; IR (film, cm
-1
): 3026, 2981, 2929, 1712, 1448, 1427, 
1358, 1234, 1173, 1099, 972, 748, 694; HRMS (ESI) m/z calculated for C17H20O4Na [M+Na]
+
: 
311.1259, found 311.1267. 
 
(E)-5-benzoyl-5-nitro-8-phenyloct-7-en-1-yl benzoate 
[92] : Allylbenzene (26.5 L, 0.2 mmol, 1.0 equiv) and 5-
nitro-6-oxo-6-phenylhexyl benzoate (137 mg, 0.4 mmol, 
2.0 equiv) were reacted following the general procedure. Flash chromatography (510% 
EtOAc/hexanes gradient) yielded pure linear product as a light yellow oil. Run 1 (47.0 mg, 0.103 
mmol, 51% yield); run 2 (47.7 mg, 0.104 mmol, 52% yield). Average yield: 52%. Alternate 
stoichiometry: Allylbenzene (53.0 L, 0.4 mmol, 2.0 equiv) and 5-nitro-6-oxo-6-phenylhexyl 
benzoate (68.3 mg, 0.2 mmol, 1.0 equiv) were reacted following the general procedure. Flash 
chromatography (510% EtOAc/hexanes gradient) yielded pure linear product as a light yellow 
oil. Run 1 (72.7 mg, 0.159 mmol, 80% yield); run 2 (72.2 mg, 0.158 mmol, 79% yield). Average 
yield: 80%. 
1
H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 7.6 Hz, 2H), 7.78 (d, J = 7.8 Hz, 2H), 
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7.60 – 7.52 (m, 2H), 7.42 (ap. t, J = 7.7 Hz, 4H), 7.31 – 7.19 (m, 5H), 6.44 (d, J = 15.7 Hz, 1H), 
5.91 (dt, J = 15.4, 7.6 Hz, 1H), 4.28 (t, J = 6.3 Hz, 2H), 3.31 – 3.19 (m, 2H), 2.57 – 2.42 (m, 
2H), 1.85 – 1.73 (m, 2H), 1.51 – 1.41 (m, 1H), 1.40 – 1.31 (m, 1H); 13C NMR (126 MHz, 
CDCl3) δ 190.9, 166.5, 136.4, 136.2, 133.9, 133.8, 133.1, 130.2, 129.6, 129.0, 128.7, 128.5, 
128.4, 128.0, 126.5, 120.4, 98.3, 64.0, 38.7, 33.9, 28.6, 20.0; IR (film, cm
-1
): 3062, 3032, 2953, 
2873, 1718, 1689, 1599, 1543, 1450, 1315, 1275, 1115, 968, 714, 692; HRMS (ESI) m/z 
calculated for C19H27NO3Na [M+Na]
+
: 458.1967, found 458.1977. 
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Olefin scope of the allylic C-H alkylation 
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(E)-5-(4-methoxyphenyl)-2-methyl-2-nitro-1-phenylpent-4-
en-1-one [93] : Estragole (46.1 L, 0.3 mmol, 1.0 equiv) and 2-
nitropropiophenone (108 mg, 0.6 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (10% EtOAc/hexanes) yielded pure linear product as a light 
yellow oil. Run 1 (62.1 mg, 0.191 mmol, 64% yield); run 2 (59.3 mg, 0.182 mmol, 61% yield). 
Average yield: 63%. 
1
H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 2H), 7.58 (t, J = 7.4 Hz, 
1H), 7.45 (t, J = 7.8 Hz, 2H), 7.26 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 6.42 (d, J = 15.7 
Hz, 1H), 5.87 (dt, J = 15.4, 7.6 Hz, 1H), 3.80 (s, 3H), 3.23 (dd, J = 14.4, 7.3 Hz, 1H), 3.12 (dd, J 
= 14.4, 7.9 Hz, 1H), 1.95 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 191.9, 159.6, 135.8, 133.8, 
133.6, 129.4, 129.0, 128.6, 127.8, 118.5, 114.1, 95.6, 55.5, 42.0, 22.6; IR (film, cm
-1
): 3033, 
3005, 2927, 2837, 1691, 1606, 1537, 1512, 1448, 1385, 1346, 1300, 1248, 1176, 1034, 972, 808, 
700; HRMS (ESI) m/z calculated for C19H19NO4Na [M+Na]
+
: 348.1212, found 348.1219. 
 
(E)-2-methyl-2-nitro-1-phenyl-5-(4-
(trifluoromethyl)phenyl)pent-4-en-1-one [94] : 4-
allylbenzotrifluoride (55.9 mg, 0.3 mmol, 1.0 equiv) and 2-nitropropiophenone (108 mg, 0.6 
mmol, 2.0 equiv) were reacted following the general procedure. Flash chromatography (5% 
EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (73.1 mg, 0.201 mmol, 
67% yield); run 2 (71.6 mg, 0.197 mmol, 66% yield). Average yield: 67%. 
1
H NMR (500 MHz, 
CDCl3) δ 7.83 – 7.77 (m, 2H), 7.60 (t, J = 7.4 Hz, 1H), 7.55 (d, J = 8.2 Hz, 2H), 7.46 (t, J = 7.9 
Hz, 2H), 7.42 (d, J = 8.1 Hz, 2H), 6.52 (d, J = 15.8 Hz, 1H), 6.15 (dt, J = 15.5, 7.6 Hz, 1H), 3.29 
(dd, J = 14.5, 7.1 Hz, 1H), 3.15 (dd, J = 14.4, 7.9 Hz, 1H), 1.97 (s, 3H); 
13
C NMR (126 MHz, 
CDCl3) δ 191.5, 139.9, 135.0, 134.0, 133.4, 129.9 (q, JCF = 32.6 Hz), 129.1, 128.6, 126.8, 125.7 
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(q, JCF = 3.8 Hz), 124.2 (q, JCF = 271.8 Hz), 123.9, 95.4, 42.0, 22.6; IR (film, cm
-1
): 3068, 3012, 
2943, 2875, 1923, 1691, 1616, 1599, 1545, 1448, 1416, 1387, 1327, 1255, 1165, 1124, 1068, 
974, 862, 700; HRMS (ESI) m/z calculated for C19H16NO3F3Na [M+Na]
+
: 386.0980, found 
386.0986. 
 
(E)-5-(3-bromophenyl)-2-methyl-2-nitro-1-phenylpent-4-en-1-
one [95] : 1-allyl-3-bromobenzene (59.1 mg, 0.3 mmol, 1.0 equiv) 
and 2-nitropropiophenone (108 mg, 0.6 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (5% EtOAc/hexanes) yielded pure linear product as a light 
yellow oil. Run 1 (75.5 mg, 0.202 mmol, 67% yield); run 2 (72.3 mg, 0.193 mmol, 64% yield). 
Average yield: 66%. 
1
H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 2H), 7.59 (t, J = 7.4 Hz, 
1H), 7.49 – 7.42 (m, 3H), 7.37 (d, J = 7.8 Hz, 1H), 7.23 (d, J = 7.8 Hz, 1H), 7.17 (t, J = 7.8 Hz, 
1H), 6.41 (d, J = 15.7 Hz, 1H), 6.05 (dt, J = 15.5, 7.6 Hz, 1H), 3.26 (dd, J = 14.4, 7.2 Hz, 1H), 
3.13 (dd, J = 14.4, 7.9 Hz, 1H), 1.96 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 191.6, 138.6, 134.9, 
134.0, 133.4, 130.9, 130.2, 129.4, 129.1, 128.6, 125.3, 122.9, 122.7, 95.4, 41.9, 22.6; IR (film, 
cm
-1
): 3060, 3010, 2924, 1691, 1595, 1543, 1473, 1448, 1385, 1346, 1257, 1072, 976, 850, 777; 
HRMS (ESI) m/z calculated for C18H16NO3BrNa [M+Na]
+
: 396.0211, found 396.0230. 
 
(E)-6-methyl-2-(3-(4-methyl-4-nitro-5-oxo-5-
phenylpent-1-en-1-yl)phenyl)-1,3,6,2-dioxazaborocane-
4,8-dione [96] : 2-(3-allylphenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione (81.9 mg, 0.3 
mmol, 1.0 equiv) and 2-nitropropiophenone (108 mg, 0.6 mmol, 2.0 equiv) were reacted 
following the general procedure. Flash chromatography (2030% acetone/Et2O gradient), 
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followed by flash chromatography (2% MeOH/CH2Cl2) yielded pure linear product as a white 
solid. Run 1 (87.4 mg, 0.194 mmol, 65% yield); run 2 (85.1 mg, 0.189 mmol, 63% yield). 
Average yield: 64%. 
1
H NMR (500 MHz, CDCl3) δ 7.82 – 7.77 (m, 2H), 7.59 (t, J = 7.5 Hz, 
1H), 7.49 – 7.30 (m, 6H), 6.48 (d, J = 15.8 Hz, 1H), 6.06 (dt, J = 15.4, 7.6 Hz, 1H), 3.92 (d, J = 
16.4 Hz, 2H), 3.78 (dd, J = 16.4, 1.6 Hz, 2H), 3.26 (dd, J = 14.4, 7.4 Hz, 1H), 3.13 (dd, J = 14.4, 
7.6 Hz, 1H), 2.57 (s, 3H), 1.97 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 191.8, 168.1, 136.5, 
136.3, 133.9, 133.5, 132.0, 130.8, 129.1, 128.8, 128.6, 127.8, 121.3, 95.7, 62.1, 47.9, 42.1, 22.5 
(NOTE: The C-B signal is not visible due to quadrupolar relaxation by 
11
B); IR (film, cm
-1
): 
3018, 2947, 2924, 1768, 1693, 1597, 1543, 1450, 1336, 1288, 1255, 1184, 1039, 1003, 706; 
HRMS (ESI) m/z calculated for C23H24N2O7B [M+H]
+
: 451.1677, found 451.1676. 
 
(E)-5-(2-((tert-butyldimethylsilyl)oxy)phenyl)-2-methyl-2-nitro-1-
phenylpent-4-en-1-one [97] : (2-allylphenoxy)(tert-
butyl)dimethylsilane (74.5 mg, 0.3 mmol, 1.0 equiv) and 2-
nitropropiophenone (108 mg, 0.6 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (3% EtOAc/hexanes) yielded pure linear product as a light 
yellow oil. Run 1 (79.3 mg, 0.186 mmol, 62% yield); run 2 (80.3 mg, 0.189 mmol, 63% yield). 
Average yield: 63%. 
1
H NMR (500 MHz, CDCl3) δ 7.83 – 7.77 (m, 2H), 7.58 (t, J = 7.5 Hz, 
1H), 7.45 (t, J = 7.9 Hz, 2H), 7.39 (dd, J = 7.7, 1.8 Hz, 1H), 7.12 (td, J = 7.7, 1.8 Hz, 1H), 6.90 
(t, J = 7.6 Hz, 1H), 6.82 (d, J = 15.9 Hz, 1H), 6.77 (dd, J = 8.2, 1.2 Hz, 1H), 5.93 (dt, J = 15.4, 
7.5 Hz, 1H), 3.26 (ddd, J = 14.3, 7.2, 1.4 Hz, 1H), 3.15 (ddd, J = 14.3, 7.8, 1.3 Hz, 1H), 1.95 (s, 
3H), 0.99 (s, 9H), 0.19 (s, 3H), 0.19 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 191.8, 152.9, 133.8, 
133.6, 131.7, 129.0, 128.9, 128.6, 128.0, 126.7, 121.5, 120.4, 119.7, 95.5, 42.4, 25.9, 22.6, 18.4, 
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-4.06, -4.08; IR (film, cm
-1
): 3066, 3030, 2951, 2931, 2860, 1693, 1597, 1545, 1485, 1452, 1385, 
1346, 1255, 976, 914, 837, 783, 758, 700, 665; HRMS (ESI) m/z calculated for C24H32NO4Si 
[M+H]
+
: 426.2101, found 426.2097. 
 
(E)-2-(4-methyl-4-nitro-5-oxo-5-phenylpent-1-en-1-yl)cyclohex-1-
en-1-yl acetate [98] : 2-allylcyclohex-1-en-1-yl acetate (54.1 mg, 0.3 
mmol, 1.0 equiv) and 2-nitropropiophenone (108 mg, 0.6 mmol, 2.0 
equiv) were reacted following the general procedure. Flash chromatography (712% 
EtOAc/hexanes gradient) yielded pure linear product as a light yellow oil. Run 1 (56.6 mg, 0.158 
mmol, 53% yield); run 2 (52.9 mg, 0.148 mmol, 49% yield). Average yield: 51%. 
1
H NMR 
(500 MHz, CDCl3) δ 7.79 – 7.73 (m, 2H), 7.57 (t, J = 7.5 Hz, 1H), 7.44 (t, J = 7.9 Hz, 2H), 6.32 
(d, J = 15.7 Hz, 1H), 5.39 (dt, J = 15.3, 7.5 Hz, 1H), 3.14 (dd, J = 14.4, 7.1 Hz, 1H), 3.03 (dd, J 
= 14.4, 8.0 Hz, 1H), 2.24 – 2.16 (m, 4H), 2.16 (s, 3H), 1.88 (s, 3H), 1.74 – 1.62 (m, 4H); 13C 
NMR (126 MHz, CDCl3) δ 191.8, 169.1, 146.4, 133.8, 133.6, 130.7, 129.0, 128.6, 121.4, 119.3, 
95.5, 42.0, 27.9, 24.4, 22.6, 22.5, 22.0, 21.0; IR (film, cm
-1
): 3045, 2933, 2862, 1753, 1691, 
1664, 1597, 1545, 1448, 1360, 1215, 1134, 974, 706; HRMS (ESI) m/z calculated for C20H24NO5 
[M+H]
+
: 358.1654, found 358.1658. 
 
(E)-5-(cyclohex-1-en-1-yl)-2-methyl-2-nitro-1-phenylpent-4-en-1-
one [99] : 1-allylcyclohexene (36.7 mg, 0.3 mmol, 1.0 equiv) and 2-
nitropropiophenone (108 mg, 0.6 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (3% EtOAc/hexanes) yielded pure linear product as a light 
yellow oil. Run 1 (55.5 mg, 0.185 mmol, 62% yield); run 2 (55.9 mg, 0.187 mmol, 62% yield). 
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Average yield: 62%. 
1
H NMR (500 MHz, CDCl3) δ 7.81 – 7.74 (m, 2H), 7.57 (t, J = 7.3 Hz, 
1H), 7.44 (t, J = 7.9 Hz, 2H), 6.09 (d, J = 15.5 Hz, 1H), 5.70 (t, J = 4.2 Hz, 1H), 5.29 (dt, J = 
15.4, 7.5 Hz, 1H), 3.12 (dd, J = 14.3, 7.3 Hz, 1H), 3.01 (dd, J = 14.3, 7.8 Hz, 1H), 2.14 – 2.03 
(m, 4H), 1.89 (s, 3H), 1.69 – 1.53 (m, 4H); 13C NMR (126 MHz, CDCl3) δ 192.0, 140.0, 135.2, 
133.8, 133.7, 130.5, 129.0, 128.6, 116.2, 95.7, 41.9, 25.9, 24.6, 22.5, 22.5, 22.5; IR (film, cm
-1
): 
3030, 2929, 2860, 2837, 1691, 1649, 1597, 1545, 1448, 1385, 1346, 1255, 970, 791, 702; HRMS 
(ESI) m/z calculated for C18H21NO3Na [M+Na]
+
: 322.1419, found 322.1422. 
 
(E)-N,N-diethyl-5-methyl-5-nitro-6-oxo-6-phenylhex-2-
enamide [100] : N,N-diethylbut-3-enamide (42.4 mg, 0.3 mmol, 
1.0 equiv) and 2-nitropropiophenone (108 mg, 0.6 mmol, 2.0 equiv) were reacted following the 
general procedure. A short silica plug (100% CH2Cl2; 5% MeOH/CH2Cl2), followed by flash 
chromatography (60% EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 
(73.5 mg, 0.231 mmol, 77% yield); run 2 (74.4 mg, 0.234 mmol, 78% yield). Average yield: 
78%. 
1
H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 7.7 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.44 (t, J 
= 7.8 Hz, 2H), 6.73 (dt, J = 15.2, 7.8 Hz, 1H), 6.27 (d, J = 14.9 Hz, 1H), 3.41 (q, J = 7.1 Hz, 2H), 
3.30 (q, J = 7.2 Hz, 2H), 3.21 (dd, J = 14.5, 8.2 Hz, 1H), 3.16 (dd, J = 14.5, 7.4 Hz, 1H), 1.96 (s, 
3H), 1.18 – 1.10 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 191.2, 164.7, 135.3, 133.9, 133.2, 
129.0, 128.5, 127.1, 95.1, 42.3, 41.0, 40.9, 22.2, 14.9, 13.2; IR (film, cm
-1
): 3064, 2978, 2935, 
2875, 1691, 1662, 1616, 1543, 1483, 1448, 1433, 1385, 1348, 1277, 1257, 1221, 1149, 978, 694; 
HRMS (ESI) m/z calculated for C17H22N2O4 [M+H]
+
: 319.1658, found 319.1651. 
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(E)-tert-butyl 3-(4-methyl-4-nitro-5-oxo-5-phenylpent-1-en-1-
yl)-1H-indole-1-carboxylate [101] : tert-butyl 3-allyl-1H-
indole-1-carboxylate (77.2 mg, 0.3 mmol, 1.0 equiv) and 2-
nitropropiophenone (108 mg, 0.6 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (5% EtOAc/hexanes) yielded pure linear product as a light 
yellow oil. Run 1 (69.0 mg, 0.159 mmol, 53% yield); run 2 (68.2 mg, 0.157 mmol, 52% yield). 
Average yield: 53%. 
1
H NMR (500 MHz, CDCl3) δ 8.16 (d, J = 8.3 Hz, 1H), 7.84 – 7.78 (m, 
2H), 7.68 (d, J = 7.9 Hz, 1H), 7.63 – 7.56 (m, 2H), 7.46 (t, J = 7.9 Hz, 2H), 7.34 (t, J = 7.6 Hz, 
1H), 7.30 – 7.23 (m, 1H), 6.57 (d, J = 15.8 Hz, 1H), 6.10 (dt, J = 15.5, 7.5 Hz, 1H), 3.30 (dd, J = 
14.4, 7.1 Hz, 1H), 3.18 (dd, J = 14.4, 7.8 Hz, 1H), 1.99 (s, 3H), 1.67 (s, 9H); 
13
C NMR (126 
MHz, CDCl3) δ 191.8, 149.6, 136.0, 133.9, 133.6, 129.0, 128.6, 128.6, 127.6, 124.9, 124.3, 
123.2, 121.2, 120.0, 118.1, 115.5, 95.6, 84.1, 42.7, 28.3, 22.6; IR (film, cm
-1
): 3060, 2926, 2860, 
1738, 1693, 1599, 1547, 1452, 1371, 1308, 1255, 1157, 1090, 1024, 966, 910, 856, 742; HRMS 
(EI) m/z calculated for C25H26N2O5 [M]
+
: 434.1842, found 434.1837. 
 
(E)-5-(2,2-dimethyl-2H-chromen-6-yl)-2-methyl-2-nitro-1-
phenylpent-4-en-1-one [102] : 6-allyl-2,2-dimethyl-2H-
chromene (68.3 mg, 88% pure, 0.3 mmol, 1.0 equiv) and 2-nitropropiophenone (108 mg, 0.6 
mmol, 2.0 equiv) were reacted following the general procedure. [NOTE: The substrate contained 
12% (E)-2,2-dimethyl-6-(prop-1-en-1-yl)-2H-chromene, which was inert under standard 
alkylation conditions.] Flash chromatography (5% EtOAc/hexanes) yielded pure linear product 
as a light yellow oil. Run 1 (66.8 mg, 0.177 mmol, 59% yield); run 2 (68.4 mg, 0.181 mmol, 
60% yield). Average yield: 60%. 
1
H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 7.4 Hz, 2H), 7.58 
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(t, J = 7.4 Hz, 1H), 7.45 (t, J = 7.9 Hz, 2H), 7.07 (dd, J = 8.3, 2.2 Hz, 1H), 6.95 (d, J = 2.2 Hz, 
1H), 6.70 (d, J = 8.3 Hz, 1H), 6.37 (d, J = 15.7 Hz, 1H), 6.29 (d, J = 9.8 Hz, 1H), 5.84 (dt, J = 
15.4, 7.6 Hz, 1H), 5.62 (d, J = 9.8 Hz, 1H), 3.22 (dd, J = 14.4, 7.2 Hz, 1H), 3.11 (dd, J = 14.4, 
7.9 Hz, 1H), 1.94 (s, 3H), 1.42 (s, 6H); 
13
C NMR (126 MHz, CDCl3) δ 191.9, 153.1, 135.9, 
133.8, 133.6, 131.3, 129.4, 129.0, 128.6, 127.5, 124.3, 122.2, 121.3, 118.2, 116.5, 95.6, 76.6, 
42.0, 28.2, 22.5; IR (film, cm
-1
): 3041, 2974, 2931, 1691, 1637, 1597, 1543, 1491, 1448, 1385, 
1265, 1211, 1155, 1128, 964, 766; HRMS (ESI) m/z calculated for C23H23NO4Na [M+Na]
+
: 
400.1525, found 400.1519. 
 
(E)-5-(2,7-di-tert-butyl-9,9-dimethyl-9H-xanthen-4-yl)-2-
methyl-2-nitro-1-phenylpent-4-en-1-one [105] : 4-allyl-2,7-di-
tert-butyl-9,9-dimethyl-9H-xanthene (72.5 mg, 0.2 mmol, 1.0 
equiv) and 2-nitropropiophenone (71.7 mg, 0.4 mmol, 2.0 equiv) 
were reacted following the general procedure. Flash chromatography (2% EtOAc/hexanes) 
yielded pure linear product as a light yellow oil. Run 1 (56.6 mg, 0.105 mmol, 52% yield); run 2 
(56.0 mg, 0.104 mmol, 52% yield). Average yield: 52%. 
1
H NMR (500 MHz, CDCl3) δ 7.83 (d, 
J = 7.2 Hz, 2H), 7.59 (t, J = 7.4 Hz, 1H), 7.46 (t, J = 7.8 Hz, 2H), 7.39 (d, J = 2.4 Hz, 1H), 7.33 
(d, J = 2.3 Hz, 1H), 7.24 (d, J = 2.3 Hz, 1H), 7.22 (dd, J = 8.5, 2.3 Hz, 1H), 6.98 (d, J = 8.5 Hz, 
1H), 6.92 (d, J = 15.8 Hz, 1H), 6.14 (dt, J = 15.5, 7.5 Hz, 1H), 3.33 (dd, J = 14.6, 7.1 Hz, 1H), 
3.25 (dd, J = 14.3, 7.9 Hz, 1H), 2.00 (s, 3H), 1.63 (s, 3H), 1.62 (s, 3H), 1.33 (s, 9H), 1.33 (s, 9H); 
13
C NMR (126 MHz, CDCl3) δ 192.0, 148.3, 146.0, 145.8, 145.1, 133.8, 133.8, 131.8, 130.1, 
129.4, 129.0, 128.6, 124.4, 123.6, 122.6, 122.5, 122.3, 122.0, 115.9, 95.6, 42.5, 34.7, 34.6, 34.6, 
32.4, 32.2, 31.7, 31.7, 22.7; IR (film, cm
-1
): 3010, 2958, 2868, 1693, 1545, 1500, 1458, 1363, 
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1290, 1269, 1223, 974, 756; HRMS (ESI) m/z calculated for C35H42NO4 [M+H]
+
: 540.3114, 
found 540.3123. 
 
(8R,9S,13S,14S)-13-methyl-3-((E)-4-methyl-4-nitro-5-
oxo-5-phenylpent-1-en-1-yl)-7,8,9,11,12,13,15,16-
octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one 
[104] : (8R,9S,13S,14S)-3-allyl-13-methyl-7,8,9,11,12,13,15,16-octahydro-6H-
cyclopenta[a]phenanthren-17(14H)-one (58.9 mg, 0.2 mmol, 1.0 equiv) and 2-
nitropropiophenone (71.7 mg, 0.4 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (1520% EtOAc/hexanes gradient) yielded pure linear 
product as a light yellow oil. Run 1 (58.1 mg, 0.123 mmol, 62% yield); run 2 (56.9 mg, 0.121 
mmol, 60% yield). Average yield: 61%. 
1
H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 7.5 Hz, 2H), 
7.58 (t, J = 7.5 Hz, 1H), 7.49 – 7.41 (m, 2H), 7.24 (d, J = 8.2 Hz, 1H), 7.12 (d, J = 8.1 Hz, 1H), 
7.07 (s, 1H), 6.43 (d, J = 15.7 Hz, 1H), 5.98 (dt, J = 15.4, 7.6 Hz, 1H), 3.24 (dd, J = 14.4, 7.2 Hz, 
1H), 3.13 (dd, J = 14.5, 7.9 Hz, 1H), 2.93 – 2.87 (m, 2H), 2.51 (dd, J = 19.0, 8.7 Hz, 1H), 2.45 – 
2.38 (m, 1H), 2.32 – 2.27 (m, 1H), 2.15 (dt, J = 18.5, 8.8 Hz, 1H), 2.11 – 1.95 (m, 3H), 1.94 (s, 
3H), 1.67 – 1.42 (m, 6H), 0.91 (s, 3H); 13C NMR (126 MHz, CDCl3) Mixture of diastereomers δ 
220.9, 191.8, 139.8, 136.8, 136.1, 134.1, 133.8, 133.5, 129.0, 128.6, 127.1, 125.7, 124.0, 120.1, 
95.5, 50.6, 48.1, 44.5, 42.0, 38.2, 36.0, 31.7, 29.5, 26.6, 25.8, 22.5, 21.7, 13.9; IR (film, cm
-1
): 
3012, 2927, 2860, 1738, 1691, 1597, 1543, 1498, 1450, 1385, 1344, 1255, 972, 910, 731; HRMS 
(ESI) m/z calculated for C30H34NO4 [M+H]
+
: 472.2488, found 472.2486. 
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(3S,8aS)-3-(4-((E)-4-methyl-4-nitro-5-oxo-5-
phenylpent-1-en-1-yl)benzyl)hexahydropyrrolo[1,2-
a]pyrazine-1,4-dione [103] : (3S,8aS)-3-(4-
allylbenzyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione (85.3 mg, 0.3 mmol, 1.0 equiv) and 2-
nitropropiophenone (108 mg, 0.6 mmol, 2.0 equiv) were reacted following the general 
procedure. Flash chromatography (25% MeOH/CH2Cl2 gradient) yielded pure linear product 
as a light yellow oil. Run 1 (69.6 mg, 0.151 mmol, 50% yield); run 2 (68.6 mg, 0.149 mmol, 
50% yield). Average yield: 50%. 
1
H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 7.5 Hz, 2H), 7.59 
(t, J = 7.4 Hz, 1H), 7.45 (t, J = 7.9 Hz, 2H), 7.27 (d, J = 8.1 Hz, 2H), 7.14 (d, J = 8.1 Hz, 2H), 
6.44 (d, J = 15.7 Hz, 1H), 6.08 – 5.98 (m, 1H), 5.96 (s, 1H), 4.22 – 4.14 (m, 1H), 3.64 (dt, J = 
12.2, 8.4 Hz, 1H), 3.46 – 3.37 (m, 1H), 3.25 (dd, J = 14.4, 7.3 Hz, 1H), 3.19 – 3.02 (m, 4H), 2.28 
– 2.18 (m, 1H), 1.96 (s, 3H), 1.95 – 1.90 (m, 1H), 1.89 – 1.68 (m, 2H); 13C NMR (126 MHz, 
CDCl3) Mixture of diastereomers δ 191.6, 169.5, 164.9, 135.8, 135.6, 135.1, 133.9, 133.4, 130.2, 
129.0, 128.6, 126.8, 121.3, 95.4, 59.0, 57.9, 45.3, 42.0, 40.2, 29.1, 22.6, 22.5, 21.8; IR (film, cm
-
1
): 3248, 3053, 2924, 2883, 1915, 1678, 1658, 1597, 1543, 1512, 1448, 1344, 1306, 1254, 1119, 
974, 912, 729; HRMS (ESI) m/z calculated for C26H28N3O5 [M+H]
+
: 462.2029, found 462.2028. 
Sequential allylic C-H alkylation reactions 
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(E)-5-cyclohexyl-2-nitro-1-phenylpent-4-en-1-one [67] : 
Allylcyclohexane 106 (37.3 mg, 0.3 mmol, 1.0 equiv) and 
benzoylnitromethane 16 (198 mg, 1.2 mmol, 4.0 equiv) were reacted and purified following the 
previously published procedure.
54
 Spectral data matched those reported. 
 
(E)-2-cinnamyl-5-cyclohexyl-2-nitro-1-phenylpent-4-en-1-one 
[107] : (E)-5-cyclohexyl-2-nitro-1-phenylpent-4-en-1-one 67 (57.5 
mg, 0.2 mmol, 1.0 equiv) and allylbenzene 18 (53.0 L, 0.4 
mmol, 2.0 equiv) were reacted following the general procedure. Flash chromatography (3% 
EtOAc/hexanes) yielded pure linear product as a light yellow oil. Run 1 (73.6 mg, 0.182 mmol, 
91% yield); run 2 (72.6 mg, 0.180 mmol, 90% yield). Average yield: 91%. 
1
H NMR (500 MHz, 
CDCl3) δ 7.79 (d, J = 7.9 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.45 (t, J = 7.7 Hz, 2H), 7.34 – 7.20 
(m, 5H), 6.43 (d, J = 15.7 Hz, 1H), 5.90 (dt, J = 15.4, 7.6 Hz, 1H), 5.45 (dd, J = 15.3, 7.0 Hz, 
1H), 5.13 (dt, J = 15.1, 7.4 Hz, 1H), 3.25 (dd, J = 14.6, 7.4 Hz, 1H), 3.18 (dd, J = 14.6, 7.7 Hz, 
1H), 3.11 – 3.02 (m, 2H), 1.94 – 1.86 (m, 1H), 1.73 – 1.59 (m, 4H), 1.36 – 1.08 (m, 4H), 1.01 
(m, 2H); 
13
C NMR (126 MHz, CDCl3) δ 190.7, 144.1, 136.5, 136.2, 134.1, 133.8, 129.0, 128.7, 
128.6, 128.0, 126.5, 120.5, 117.8, 98.0, 40.9, 38.5, 38.1, 32.8, 32.8, 26.1, 26.0; IR (film, cm
-1
): 
3060, 3032, 2927, 2850, 1691, 1597, 1545, 1495, 1448, 1356, 1259, 1186, 970, 692; HRMS 
(ESI) m/z calculated for C26H30NO3 [M+H]
+
: 404.2226, found 404.2230. 
 
Starting Materials 
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General procedure for preparation of allylarenes:
39
 An oven-dried 10 mL Schlenk flask under 
argon atmosphere was charged with Pd(dba)2 (34.5 mg, 0.060 mmol, 0.03 equiv), PCy3 (33.7 
mg, 0.12 mmol, 0.06 equiv), CsF (668 mg, 4.40 mmol, 2.2 equiv), aryl halide (2.00 mmol, 1 
equiv), and a stir bar. Allyltributyltin (644 μL, 2.10 mmol, 1.05 equiv) and dioxane (2 mL, 1.0M) 
were added via syringe. The mixture was stirred and heated to 80-100°C. Conversion was 
monitored by GC. When complete consumption of aryl halide was observed (8-24 h), the 
reaction was cooled to room temperature. The reaction mixture was diluted with saturated 
aqueous NH4Cl (40 mL) and extracted with diethyl ether (2 x 40 mL). The combined organics 
were dried over MgSO4. The mixture was filtered and concentrated in vacuo. Purification by 
flash chromatography (SiO2, Et2O/pentane mixtures) provided the pure product.  
NOTE: In some cases isomerization was observed, yielding small amounts of internal olefin 
product [characteristic peaks, 
1
H NMR: 6.4 (m, 2H), 1.9 (d, 3H)]. This isomer was generally not 
separable from the desired allyl compound by column chromatography. However, the internal 
isomer was unreactive under standard allylic alkylation conditions and could be recovered 
quantitatively from the reaction mixture. 
 
General procedure for preparation of 2-nitro ketones:
89
 An oven-dried 25 mL flask under 
argon atmosphere was charged with silyl enol ether (2.00 mmol, 1 equiv), CH2Cl2 (8 mL), and a 
stir bar. The flask was wrapped in aluminum foil to exclude light. Tetranitromethane (263 L, 
2.20 mmol, 1.1 equiv) in CH2Cl2 (2 mL) was added dropwise via syringe. The mixture was 
stirred at room temperature. Conversion was monitored by GC or TLC. When complete 
consumption of silyl enol ether was observed (10 min - 24 h), the reaction mixture was diluted 
with CH2Cl2 (40 mL). The mixture was washed repeatedly with 40 mL portions of H2O until the 
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washes were no longer colored. The organic layer was dried over MgSO4. The mixture was 
filtered and concentrated in vacuo. Purification by flash chromatography (SiO2, EtOAc/hexanes 
mixtures) provided the pure product.  
 
Spectral data for known compounds: 
2-nitropropiophenone [81]
89
 
4′-chloro-2-nitropropiophenone90 
4′-methoxy-2-nitropropiophenone91 
methyl 2-nitropropanoate [80]
92
 
1-(phenylsulfonyl)nitroethane
93
 
2-nitro-1-tetralone
89
 
2-nitrobutylphenone
94
 
4-allylbenzotrifluoride
95
 
1-allyl-3-bromobenzene
96
 
 (2-allylphenoxy)(tert-butyl)dimethylsilane
97
 
2-allylcyclohex-1-en-1-yl acetate
76
 
N,N-diethylbut-3-enamide
75
 
tert-butyl 3-allyl-1H-indole-1-carboxylate
98
 
 
 
5-nitro-6-oxo-6-phenylhexyl benzoate: 
1
H NMR (500 MHz, 
CDCl3) δ 8.01 (d, J = 6.8 Hz, 2H), 7.96 (d, J = 7.2 Hz, 2H), 
7.66 (t, J = 7.5 Hz, 1H), 7.56 (t, J = 7.4 Hz, 1H), 7.52 (t, J = 7.9 Hz, 2H), 7.44 (t, J = 7.8 Hz, 
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2H), 6.08 (dd, J = 9.4, 4.7 Hz, 1H), 4.39 – 4.27 (m, 2H), 2.51 – 2.41 (m, 1H), 2.30 – 2.20 (m, 
1H), 1.92 – 1.82 (m, 2H), 1.67 – 1.57 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 188.8, 166.6, 
134.9, 133.9, 133.1, 130.2, 129.7, 129.4, 128.9, 128.5, 89.7, 64.2, 30.3, 28.3, 22.8; IR (film, cm
-
1
): 3064, 2956, 2872, 1971, 1913, 1712, 1554, 1450, 1275, 1117, 712, 688; HRMS (ESI) m/z 
calculated for C19H20NO5 [M+H]
+
: 342.1341, found 342.1346.  
 
2-(3-allylphenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione: 
1
H 
NMR (500 MHz, CDCl3) δ 7.38 – 7.29 (m, 3H), 7.28 – 7.22 (m, 1H), 
5.95 (ddt, J = 15.8, 11.2, 6.7 Hz, 1H), 5.08 – 5.01 (m, 2H), 3.92 (d, J = 16.4 Hz, 2H), 3.77 (d, J = 
16.3 Hz, 2H), 3.39 (d, J = 6.7 Hz, 2H), 2.56 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.3, 
140.2, 137.6, 132.6, 130.3, 130.1, 128.6, 116.0, 62.0, 47.8, 40.4 (NOTE: The C-B signal is not 
visible due to quadrupolar relaxation by 
11
B); IR (film, cm
-1
): 3010, 2964, 1766, 1457, 1336, 
1292, 1250, 1039, 1005; HRMS (ESI) m/z calculated for C14H17NO4B [M+H]
+
: 274.1251, found 
274.1252.  
 
6-allyl-2,2-dimethyl-2H-chromene: 
1
H NMR (500 MHz, CDCl3) δ 6.92 
(dd, J = 8.2, 2.2 Hz, 1H), 6.79 (d, J = 2.2 Hz, 1H), 6.70 (d, J = 8.1 Hz, 
1H), 6.29 (d, J = 9.8 Hz, 1H), 5.94 (ddt, J = 16.8, 10.0, 6.7 Hz, 1H), 5.59 (d, J = 9.8 Hz, 1H), 
5.10 – 5.01 (m, 2H), 3.28 (d, J = 6.7 Hz, 2H), 1.42 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 
151.3, 138.0, 132.2, 130.9, 129.2, 126.4, 122.5, 121.3, 116.3, 115.6, 76.1, 39.5, 28.1; IR (film, 
cm
-1
): 3076, 3039, 2976, 2927, 1639, 1491, 1261, 1209, 1151, 962, 914; HRMS (EI) m/z 
calculated for C14H16O [M]
+
: 200.1201, found 200.1207.  
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4-allyl-2,7-di-tert-butyl-9,9-dimethyl-9H-xanthene: 
1
H NMR (500 
MHz, CDCl3) δ 7.40 (d, J = 2.4 Hz, 1H), 7.28 (d, J = 2.4 Hz, 1H), 
7.21 (dd, J = 8.5, 2.3 Hz, 1H), 7.07 (d, J = 2.4 Hz, 1H), 6.98 (d, J = 
8.5 Hz, 1H), 6.06 (ddt, J = 16.8, 10.0, 6.7 Hz, 1H), 5.14 (dq, J = 17.0, 1.7 Hz, 1H), 5.05 (dq, J = 
10.0, 1.5 Hz, 1H), 3.53 (d, J = 6.7 Hz, 2H), 1.64 (s, 6H), 1.33 (s, 9H), 1.32 (s, 9H); 
13
C NMR 
(126 MHz, CDCl3) δ 148.7, 146.5, 145.6, 145.0, 137.3, 129.6, 129.5, 126.7, 125.0, 124.3, 122.5, 
120.7, 115.9, 115.6, 35.0, 34.8, 34.6, 32.4, 31.8, 31.6; IR (film, cm
-1
): 3076, 3043, 2966, 2906, 
2873, 1757, 1639, 1579, 1500, 1460, 1408, 1363, 1290, 1269, 1221, 1115, 910, 822, 735; HRMS 
(EI) m/z calculated for C26H34O [M]
+
: 362.2610, found 362.2605.  
 
(8R,9S,13S,14S)-3-allyl-13-methyl-7,8,9,11,12,13,15,16-octahydro-
6H-cyclopenta[a]phenanthren-17(14H)-one: 
1
H NMR (500 MHz, 
CDCl3) δ 7.23 (d, J = 8.0 Hz, 1H), 6.99 (d, J = 8.0 Hz, 1H), 6.94 (s, 
1H), 5.96 (ddt, J = 16.9, 10.0, 6.8 Hz, 1H), 5.10 (dq, J = 17.0, 1.7 Hz, 1H), 5.06 (dq, J = 10.0, 
1.4 Hz, 1H), 3.34 (d, J = 6.8 Hz, 2H), 2.94 – 2.87 (m, 2H), 2.50 (dd, J = 19.0, 8.7 Hz, 1H), 2.46 
– 2.38 (m, 1H), 2.33 – 2.25 (m, 1H), 2.14 (dt, J = 18.8, 8.9 Hz, 1H), 2.09 – 1.92 (m, 3H), 1.69 – 
1.38 (m, 6H), 0.91 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 221.1, 137.7, 137.7, 137.6, 136.6, 
129.3, 126.1, 125.6, 115.8, 50.6, 48.1, 44.4, 39.9, 38.3, 36.0, 31.7, 29.5, 26.7, 25.9, 21.7, 14.0; 
IR (film, cm
-1
): 3456, 3076, 2929, 2864, 1739, 1637, 1498, 1454, 1435, 1257, 1084, 1053, 1007, 
912, 820; HRMS (ESI) m/z calculated for C21H27O [M+H]
+: 295.2062, found 295.2057; [α]D
25
= 
+144.3° (c=1.0, CHCl3).  
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(3S,8aS)-3-(4-allylbenzyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-
dione: 
1
H NMR (500 MHz, CDCl3) δ 7.14 (ap. s, 4H), 5.98 (s, 1H), 
5.93 (ddt, J = 16.9, 10.4, 6.7 Hz, 1H), 5.09 – 5.01 (m, 2H), 4.18 (dt, J 
= 6.8, 4.2 Hz, 1H), 3.63 (dt, J = 12.1, 8.4 Hz, 1H), 3.41 (ddd, J = 12.2, 9.3, 2.9 Hz, 1H), 3.36 (d, 
J = 6.6 Hz, 2H), 3.13 – 3.01 (m, 3H), 2.24 – 2.16 (m, 1H), 1.99 – 1.90 (m, 1H), 1.86 – 1.76 (m, 
1H), 1.75 – 1.66 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 169.8, 165.1, 139.3, 137.3, 132.9, 
130.1, 128.9, 115.9, 58.8, 57.7, 45.0, 40.0, 39.7, 28.8, 21.6; IR (film, cm
-1
): 3469, 3236, 3024, 
2978, 2927, 2889, 1666, 1512, 1452, 1302, 1119, 918, 731; HRMS (ESI) m/z calculated for 
C17H21N2O2 [M+H]
+
: 285.1603, found 285.1609; [α]D
26
= +1.3° (c=1.0, CHCl3).  
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